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Non-communicable diseases (NCDs), such as cardiovascular disease (CVD) and type 2 diabetes 
mellitus (T2DM), represent an ever-rising threat to the effective management of national health in 
South Africa. This especially among low versus high socio-economic urban communities as 
evidenced almost a decade ago. The results of which are likely to lead to an even higher demand for 
chronic public health care provision, and thus put immediate economic strain on the imminent South 
African (SA) National Health Insurance fund soon to be launched in 2026. However, one could argue 
that the evidence needed to reformulate the existing SA health policies, especially those directed at 
NCD-risk management and inclusive of modifiable behavioural/lifestyle factors, is either: i) not 
implemented and no action is taken; or ii) implemented, yet ineffective; or iii) limited and thus unable 
to detect a clinically significant effect to date. 
 
Thus, the primary aim of this study was to characterise behavioural/lifestyle factors namely physical 
activity (PA) and sedentary behaviour, as well as physical health-related fitness and cardiometabolic 
disease risk profiles for CVD and T2DM in a group of urban women from an under-resourced Western 
Cape community. In addition, to determine whether physical inactivity, sedentarism and poor health-
related fitness levels are important predictors of obesity and other cardiometabolic disease risk 
outcomes associated with CVD and T2DM.  
  
Fifty-one (N=51) apparently healthy women (42 ± 13 yrs) underwent the following measurements: 
physical activity (PA) and sedentary time (ST), anthropometric, cardiovascular and physical-health 
related fitness (cardiorespiratory fitness [CRF] and muscular strength). Results from the study showed 
that less than a third of the women met the World Health Organisation (WHO) Global Health 
Recommendations for moderate to vigorous-intensity PA (MVPA) using accelerometry. Although 
overweight, women who accumulated ≥ 30-min of MVPA per day presented with more favourable 
body composition and regional body fat measures, compared to those who did not. In addition, 
women who were sufficiently active presented with reduced cardiometabolic disease risk. Although 
the associations between PA (intensities and volume) and CRF were not statistically significant, all 
were positive and showed clinically important associations. Independent of steps/day, higher CRF 
was associated with women who were younger and with reduced measures of total and central 
adiposity (p < 0.001). Whereas higher physical health-related fitness as opposed to ST and MVPA, 
was independently associated with reduced cardiometabolic risk but potentially mediated by adiposity. 
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In an attempt to combat cardiometabolic disease risk for CVD and T2DM among low socio-economic 
community urban-dwelling women, public health interventions should target domains in which time 
is already spent physically active. Such as walking briskly for travel- and/or occupational-related 
activities, while also aiming to increase public awareness of the health-enhancing benefits associated 
with meeting MVPA recommendations. Furthermore, intervention strategies also aimed at reducing 
cardiometabolic risk should target physical health-related fitness while also reducing ST especially 
among women who are already sarcopenic. Although the success of which will only be met once we 
understand the community’s specific barriers to PA and healthy dietary habits.  
 
Stellenbosch University https://scholar.sun.ac.za







Nie-oordraagbare siektes (NOS), soos kardiovaskulêre siektes (KVS) en tipe 2 diabetes mellitus 
(T2DM), verteenwoordig ’ n steeds stygende bedreiging vir die effektiewe bestuur van nasionale 
gesondheid in Suid-Afrika (SA). Dit is veral so in die geval van lae versus hoë sosio-ekonomiese 
stedelike gemeenskappe, soos wat reeds ongeveer ‘n dekade gelede bevind is. Hierdie resultate gaan 
heel waarskynlik aanleiding gee tot ’n selfs hoër aanvraag na die voorsiening van kroniese openbare 
gesondheidsorg wat onmiddellik ekonomiese druk gaan plaas op die nuut voorgestelde Suid-
Afrikaanse Nasionale Gesondheidsversekering (NGV) fonds wat in 2026 in werking tree. Daar kan 
egter geargumenteer word dat die nodige bewyse om die bestaande Suid-Afrikaanse 
gesondheidsbeleide te herformuleer, veral dié gerig op NOS-risikobestuur en die inklusiwiteit van 
aanpasbare gedrag-/leefstylfaktore is óf: i) nie geïmplimenteer en geen aksie vind plaas nie; óf ii) 
geïmplimenteer, maar oneffektief; óf iii) beperk en daarom nie in staat om ’n klinies betekenisvolle 
effek te bespeur nie. 
 
Gevolglik was die primêre doel van die studie om die gedrag-/leefstylfaktore, naamlik fisieke 
aktiwiteit (FA) en sedentêre gedrag, asook fisieke gesondheidsverwante fiksheid en die risiko vir 
kardiometaboliese siekte profiele vir KVS en T2DM in ’n groep stedelike vrouens vanuit ’n voorheen 
benadeelde Wes-Kaaplandse gemeenskap, te bepaal. Daarmee saam het die studie ten doel gehad om 
te bepaal of fisieke onaktiwiteit, sedentêre gedrag en swak gesondheidsverwante fiksheidsvlakke 
belangrike voorspellers van vetsug en ander kardiometaboliese risiko’s wat met KVS en T2DM 
geassosieer kan word.  
 
Een-en-vyftig (N=51), klaarblyklik gesonde vrouens (42 ± 13 jr) is aan die volgende metings 
onderwerp: fisieke aktiwiteit (FA) en sedentêre tyd (ST); antropometrie; kardiovaskulêre en fisieke 
gesondheidsverwante fiksheid (kardiorespiratoriese fiksheid [KRF] en spierkrag). Die resultate, soos 
bepaal met draagbare versnellingsmeters, het aangedui dat minder as ’n derde van die vroue aan die 
Wêreld Gesondheidsorganisasie (WGO) se Globale Gesondheidsaanbevelings vir matige tot hoë 
intensiteit FA (MHFA) voldoen het. Alhoewel oorgewig, het die vroue wat ≥ 30-min MHFA per dag 
geakkumuleer het, ’n meer gunstige liggaamsamestelling en liggamsvetmates getoon in vergelyking 
met vroue wat nie aan die vereiste MHFA per dag voldoen het nie. Daarmee saam het vroue wat 
voldoende aktief was ’n verminderde risiko vir kardiometaboliese siektes getoon. Alhoewel die 
assosiasies tussen FA (intensiteit en volume) en KRF nie statisties betekenisvol was nie, was almal 
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positief en het klinies belangrike assosiasies getoon. Uitsluitend die treë per dag, is hoër KRF in 
jonger vroue met verminderde mates van totale en sentrale adipositeit, geassosieer (p < 0.001). 
Alhoewel hoër fisieke gesondheidsverwante fiksheid, in teenstelling met ST en MHFA, onafhanklik 
met verminderde kardiometaboliese risiko geassosieer het, kon dit heel moontlik deur adipositeit 
bemiddel gewees het. 
 
In ’n poging om die risiko vir kardiometaboliese siekte vir KVS en T2DM onder vrouens in ŉ lae 
sosio-ekonomiese stedelike gemeenskap te beveg, moet openbare gesondheidsintervensies domeine 
teiken waarin tyd reeds spandeer word om fisiek aktief te wees - byvoorbeeld, aktiwiteite soos vinnig 
stap om by ’n bestemming uit te kom en/of beroepsverwante aktiwiteite. Die doel behoort ook te wees 
om openbare bewustheid van die gesondheidsvoordele wat gepaard gaan met die bereiking van die 
MHFA aanbevelings te verhoog. Verder moet intervensiestrategieë gerig op die vermindering van 
kardiometaboliese risiko’s veral fisieke gesondheidsverwante fiksheid teiken en terselfdertyd ST, 
veral onder vroue wie alreeds sarkopenies is, verminder. Sukses sal egter net bereik word wanneer 
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Table 4.7 Associations between objectively measured sedentary time with individual cardiometabolic 
risk outcomes and clustered cardiometabolic risk score. 
 
Table 4.8 Correlation coefficients of independent associations between physical health-related fitness 
(muscular strength and cardiorespiratory fitness) with serum triglyceride and clustered 
cardiometabolic risk score.    
 
Table 5.1 The main objectives of this thesis and related cross-sectional findings.  
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Structure of the Chapters presented in this Doctoral Dissertation  
 
This doctoral dissertation follows the article by publication format, however prior to presenting each 
article (1, 2 and 3) a review of the literature and overview of the dissertation are provided in chapter 
1.     
  
 
The reference list for chapter’s 1 and chapter’s 5 are combined, and follow on from chapter 5 which 
includes the general discussion of the dissertation presented as well as conclusions. Alternatively, the 
reference lists for chapter’s 2, 3, and 4, are separate and appear at the end of each chapter (article) 
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Non-communicable diseases (NCDs), such as cardiovascular disease (CVD) and diabetes mellitus, 
represent an ever-rising threat to the effective management of national health in all World Health 
Organization (WHO) member countries.1 These countries are categorised according to gross national 
income per capita estimates and grouped together as either: low-income; lower to middle-income; 
upper to middle-income and high-income, respectively. South Africa, described as an upper to 
middle-income country, reported an estimated 44% of total NCD-related mortalities in 2014 
alone.1CVD constituted the highest accountable cause (18%), compared to diabetes mellitus (6%) 
which ranked third (Figure 1.1).1 
 
 
Figure 1.1 All-cause mortality among all South Africans (2014).1 
 
A similar survey  in 2016 reflects different findings and indicates a rise in mortality attributed to 
diabetes mellitus leading it to rank  second (5.5%) in comparison to Tuberculosis (TB) (6.5%, ranked 
first) and CVD (5.1%, ranked third).2 Of major concern to national health authorities was: i) the 
significantly higher estimate of diabetes mellitus-related mortalities among adult women (62.7%) 
compared to their male counterparts (37.3%) and ii) the notable increase in estimated NCD-related 
mortalities for both men and women in comparison to survey findings reported in 2014 (57.4% vs. 
44.0%, respectively). Given the above, the aim to reduce the NCD-burden by 28.0% by the year 2030, 






















as written in the South African (SA) National Development Plan released in 2012, seems highly 
unattainable under its provisos. However, one could argue that the evidence needed to reformulate 
the existing SA health policies, especially those directed at NCD-risk management is either: i) not 
implemented and no action is taken; or ii) implemented, yet ineffective; or iii) limited and thus unable 
to detect a clinically  significant effect to date. Either way, the WHO predicts NCD-related mortality 
to rise to new and unprecedented proportions, which is particularly alarming given South Africa’s 
NCD-related mortality trend. Considering too the added significance of specific historical research 
inferences reported by Mayosi et al.3 almost a decade ago, which have failed to bring about change 
in the way public health is addressed in South Africa. Notably identified by Mayosi et al.3 was the 
steady overall rise in total NCD-burden among urban and rural communities, while at the same time 
identifying a disproportionate burden of NCDs affecting lower- versus higher-income urban 
community residents of South Africa. Both findings may in part, be explained by the influence of 
ongoing and rapid epidemiological transition in South Africa,4,5 similar to other sub-Saharan African 
countries. This trend will likely  lead to an even higher demand for chronic public health care 
provision,3 and thus put immediate economic strain on the imminent SA National Health Insurance 6 
fund, which is expected to be launched in 2026. 
 
According to the WHO, any attribute, characteristic or exposure that predisposes an individual to 
disease or injury, is described as a risk factor.7 However, unlike exposure to a harmful and 
transmissible virus (e.g. TB) resulting in communicable disease, NCDs are considered largely 
preventable. Factors, associated with behaviour or lifestyle, including physical inactivity, a poor diet, 
tobacco and alcohol use, are modifiable.7 Arguably, some factors may be non-modifiable owing to 
aspects related to governance, economics, culture and the environment, and may in part, influence an 
individual’s personal choice to modify his or her behaviour. Figure 1.2 shows that numerous factors 




















Figure 1.2 Drivers of obesity - a recognisable intermediate NCD risk factor in South Africa.8 
 
Other recognisable intermediate NCD-risk factors include hypertension, dyslipidaemia and impaired 
glucose tolerance (IGT).7 Alternatively, when clustered together with obesity, these are identified as 
the metabolic syndrome (MetS), or an indicator of cardiometabolic disease risk for CVD and diabetes 
mellitus. 
 
To my knowledge, a dissonance exists in the evidence from large- and small-scale published SA 
studies,9,10,11,12,13,14 with the majority of adult women shown to be obese (urban-dwellers)9,11,12,14 and 
overweight (rural-dwellers),10,12,13 yet sufficiently active in meeting health-enhancing physical 
activity (PA) guidelines.15,16,17 Thus, the extent to which meeting current international PA guidelines, 
especially among adult women who are already obese or overweight, requires further investigation. 
In its policy, “Strategy for the Prevention and Management of Obesity [2015 – 2020]” the South 
African government draws upon the WHO 2010 Global Recommendations on PA for Health,17 to 
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international PA recommendations, such as daily step counts, if South Africa is to assess PA and its 
effect on preventing obesity among its citizens.18  
 
Independent of physical activity level, the associated risk of excess weight gain poses an even greater 
challenge in trying to curb the NCD-burden in South Africa, especially among adult women. Other 
behavioural/lifestyle factors (e.g. diet19 or combining diet and exercise20) are probably of greater 
significance in weight loss efforts, bringing with it a relative reduction in obesity-related 
cardiometabolic disease risk for CVD and specifically type 2 diabetes mellitus (T2DM). Physical 
health-related fitness and specifically a moderate-to-high cardiorespiratory fitness (CRF) level has 
been shown to counteract the negative consequences associated with excess adiposity.21,22 Although 
acknowledging the influence of diet and exercise on cardiometabolic disease risk, both fall beyond 
the scope of this descriptive study, which aims to characterise other behavioural/lifestyle factors (e.g. 
PA and sedentary behaviour) and physical health-related fitness components (e.g. body composition, 
muscular strength and CRF) as key influences. 
 
In the context of South Africa’s historical backdrop, it is important to highlight the references drawn 
to “racial categorisation” namely: “Black (African)”, “White”, “Coloured” and “Asian/Indian” 
reported herein. Although recognised as a non-biological and rather a social construct, racial 
categories are referenced according to the SA Demographic Health Survey statistics, as well as those 
reported by numerous small- and large-scale SA studies.9,10,11,12,13,14 As such, I acknowledge the 
difficulties and complexities that surround the durability of their continued post-apartheid use. 
Notably, the use of “Coloured” and proposed alternatives, namely “mixed race” or “mixed ancestry”, 
are all controversial as these terms imply that some people are racially pure when in reality all people 
are technically of mixed genetic origin. Furthermore, some people within the “Coloured” racial 
category consider themselves not of mixed race. They identify as being “Khoisan” or the equivalent 
of “First Nations South Africans”, whose identity is said to have been violated by colonial rule.162 
Given these considerations, I have chosen to make use of the terminology currently used in the SA 
legislative system, namely the “2019 Codes of Good Practice on Broad Based Black Economic 
Empowerment,” which uses the term “Coloured”.163  
 
The subsequent sections of this literature review will firstly provide a brief overview and discussion 
of the prevalence of CVD and diabetes mellitus among SA adult women according to racial 
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categorisation. A more in-depth account follows in which the factors associated with cardiometabolic 
disease risk are highlighted, and in particular, as seen among “Coloured” SA adult women who have 
the highest prevalence of severe obesity compared to other SA women racial groupings (e.g. “Black 
[African]”, “White” and “Asian/Indian”). 
 
This review also aims to include observational data on the associations between behavioural/lifestyle 
factors (e.g. PA and sedentary behaviour) and components of physical health-related fitness, with 
cardiometabolic disease risk. The former, along with the measurement methods are compared to data 
and methodologies from other sub-Saharan African countries’ studies, including non-African low to 
middle-income and high-income countries, respectively. Lastly, it is important within the context of 
this study  to highlight that, as in the case of diet (e.g. poor dietary practices23,24,25 and food 
insecurity26) and exercise,27,28 I also acknowledge the equal importance of genetic influences,29,30,31 
as well as other behavioural/lifestyle (e.g. poor eating practices,23,24,25 food insecurity26 and sleep 
deprivation32) and environmental risk factors (e.g. chemical and air pollutants33), that contribute 
towards the prevalence of cardiometabolic disease risk for both CVD and T2DM in adults. However, 
these factors are beyond the scope of the current doctoral dissertation. 
 
1.2 Prevalence of cardiovascular disease and diabetes mellitus in South African adult women 
 
Data from the first comprehensive National Health and Nutrition Examination Survey (SANHANES-
1) (2011 – 2012),34 show the prevalence of CVD (29.9%) to be higher compared to diabetes mellitus 
(6.0%) in SA women. Notably, the prevalence of CVD (39.6%) was the highest, and diabetes (8.0%) 
the second highest, among “Coloured” SA women, as compared to their age-matched “Black 
(African)”, “White”, and “Asian/Indian” SA counterparts (Figure 1.3).34  
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Figure 1.3 Prevalence (%) of cardiovascular disease (CVD) and diabetes mellitus among SA women 
(aged: 15 to 65+ yrs) and according to racial categories.34  
 
In addition, more recent prevalence data from the 2016 SA Demographic Health Survey (SADHS) 
indicate that 46% of SA women aged ≥ 15 yrs are hypertensive.35 On observation, only 9% of the 
women who reported their use of anti-hypertensive medication presented with normal BP.35 
Furthermore, the prevalence of hypertension was shown to increase with age, as well as to differ 
according to residential setting (urban: 46.5% vs. rural: 43.5%) and racial catergory.35  In particular, 
“White” and “Coloured” women had the highest and second highest prevalence of hypertension 
(60.4% and 57.4%, respectively), compared to “Indian/Asian” and “Black (African)” women (43.8% 
and 46.4%, respectively).35    
 
Similar to these SA inferences, the Centers for Disease Control and Prevention (CDC)36 raises 
specific awareness of the importance of including non-behavioural NCD-risk factors, namely 
ethnicity, when analysing population data trends from the USA. Large historical datasets derived 
from nationally funded public health organisations, allowed the CDC to highlight the proportional 
differences in the prevalence of diabetes mellitus among adults from different racial and ethnic 
backgrounds.36 Their use of “ethnic background” refers to shared cultural traditions which the 
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mellitus is highest among the “American Indian” or “Alaskan Native” group (15.9%), followed by 
the “African American” group (13.2%), “Hispanic (Latino American)” group (12.8%) and “Asian 
American” group (9.0%). All of these groups are at higher risk to develop diabetes mellitus compared 
to the “American (Non-Hispanic) White” group (7.6%).36 
 
Figure 1.4 The prevalence (%) of diabetes mellitus in USA adults (both sexes and older than 20 yrs) 
according to race and ethnicity (2010 – 2012).36 
 
Given this understanding, the need to explore factors associated with cardiometabolic disease risk for 
CVD and diabetes mellitus among SA women who are already overweight or obese is needed, and 
which the subsequent section will aim to discuss. 
 
1.3 Intermediate cardiometabolic disease risk factors associated with cardiovascular disease 
and diabetes mellitus among South African adult women 
 
A previous African study37 and numerous SA studies38,39 help in part, to explain possible reasons 
underpinning differences in the prevalence of CVD among SA adults. One particular reason being 
the relatively low prevalence of dyslipidaemia reported among “Black (African descent)” diagnosed 
CVD-patients compared to their age- and CVD-matched counterparts categorised according to three 
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Figure 1.5 Frequency distributions (n) of plasma lipid levels among CVD-patients from the Heart of 
Soweto cohort study (2012).40 
 
CVD-patients from the “Black (African descent)” group had the lowest plasma lipid levels (i.e. TC: 
< 5.0 mmol/L; LDL-C: < 3.0 mmol/L; and TG: < 1.7 mmol/L) compared to all other groups. Thus, 
contrary to the 1976 “lipid hypothesis” (or “cholesterol theory”), which postulates the link between 
hyperlipidaemia and CVD (e.g. hypertensive heart failure and coronary artery disease), this study  
suggests an unlikely causal link due to the relatively low circulating plasma lipid levels found among 
the “Black (African descent)” group. As suggested by the researchers of the Heart of Soweto cohort 
study40 the steady increase in the prevalence of cardiometabolic disease risk for both CVD37,38 and 
T2DM,39 especially among “Black (African descent)” SA women, is most likely explained by other 
factors (i.e. behavioural/lifestyle and environmental).40 However, notwithstanding the disparity in 
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additional CVD-associated risk which behavioural/lifestyle and environmental factors cannot account 
for in full, the findings also point to  the concomitant influence of ongoing epidemiological transition 
in South Africa.4,5 All of these factors go hand in hand, as a growing body of evidence highlights the 
behavioural/lifestyle changes associated with rapid urbanisation, and specifically the decrease in 
levels of physical activity9,14,41 and changes in dietary intake.26,42,43 Both of which have previously 
been shown to contribute to the significant progression and prevalence of obesity in South Africa, 
particularly among urban “Black (African)” SA women (2003: 33.8% vs. 2012: 40.9%).44,34 
Although, when comparing the prevalence of overweight and obesity according to BMI, 68.0% of all 




Figure 1.6 Prevalence (%) of overweight and obesity among SA women (n = 4 658, aged: ≥15 yrs).35 
 
Of even greater concern is the increased prevalence of SA adult women who are severely obese (BMI: 
≥ 35.0 kg/m2), and thus at greater risk for CVD and T2DM.35 In 2016 it was reported that one in five 
adult women were severely obese. Most notably, the highest and second highest ranked proportions 
were reported among  “Coloured” and “Black (African)”  women (26.0% and 20.0%, respectively) 
compared to the lower proportions  among “Indian/Asian” and “White”  women (18.0% and 15.0%, 
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alarmingly between 2003 and 2012 (25.7% vs. 45.9% and 28.5% vs. 40.9%, respectively).34,35 Some 
plausible reasons may include changes in socio-economic standing which influences both food 
security and selection, as well as the influence of the urban living environment. When financial 
resources are low, evidence suggests that eating healthy, whole foods are limited due to restrictions 
in choice and access, as opposed to a lack of awareness. Furthermore, the influence of strong 
aspirations to consume more fast foods is associated with higher socio-economic status and therefore 
more desirable.164 The latest SA national survey (2016)35 specifically highlighted the increasing 
number of severe obesity among women according to quintiles of wealth, namely, those in the highest 
quintile have the highest prevalence of severe obesity. These quintiles were derived from a “wealth 
index” which consisted of household assets, namely: ownership of a television, car, livestock, as well 
as housing characteristics (e.g. source of drinking water, toilet facilities and flooring materials) 
(Figure 1.7).35  
 
Figure 1.7 Prevalence (%) of severe obesity among SA women (aged: ≥15 yrs) which is shown to 
increase according to increases in wealth.35 
 
The available SA statistics thus correlate with the previously described determinants of obesity, i.e. 
socio-cultural, behavioural/lifestyle and environmental factors, as well as their inter-relationships as 


































Figure 1.8 A schematic representation of the inter-relationships between socio-cultural, 
behavioural/lifestyle and environmental determinants of obesity among “Black” sub-Saharan African 
women.45 
 
Although specific to only urban “Black (African)” SA adult women, the study by Micklesfield et al.45 
provides compelling evidence of the links between the increasing prevalence of obesity and 
urbanisation, economic development and the concomitant behavioural/lifestyle risk factors (e.g. 
physical inactivity,46 inadequate dietary practices23,24,25 and food insecurity,47 body image linked to a 
greater body size tolerance48 and maternal/early life factors).49 Given these inferences, it is very likely 
that similar inter-relationships exist among “Coloured”  women . However, descriptive studies are 
required to confirm this and contribute to our understanding of how to create public health 
interventions that addresses the contributing factors to the health status of “Black (African)” and 
“Coloured”  women. 
 
Peer et al.50 suggested that the rapid rise in diabetes mellitus prevalence is strongly related to higher 
levels of adiposity. More than 80.0% of the diabetic urban “Black (African)” participants in their 
study were overweight or obese (BMI-defined) and had higher measures of central adiposity 
compared to their non-diabetic counterparts. Similar findings were reported by earlier SA studies,51,52 
namely an atypical presentation of CVD-risk factors among urban “Black (African)” women when 
compared to age-matched urban “White” women. In particular, the urban “Black (African)” women 
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had significantly lower levels of visceral adipose tissue area (i.e. a measure of central adiposity) and 
more favourable lipid profiles compared to the urban “White” women. However, the “Black 
(African)” women were more insulin resistant compared to the “White” women and thus were at 
higher risk for developing T2DM.52 
 
South Africa’s historic political background was characterised by marginalisation and inequalities 
among minority sub-groups of the population. In particular, during the Apartheid era (1948-1994) 
certain individuals were classified as “Coloured”.  In more recent times,  De Witt et al.53 attempted to 
contextualise this sub-group as those  individuals whose ancestry represents “Khoisan” (32.0–43.0%), 
“Black (African)” (20.0–36.0%), “White” (21.0–28.0%), and “Asian” (9.0–11.0%), and with regards 
to adult individuals living in urban and rural settings. To my knowledge, descriptive data pertaining 
to the cardiometabolic disease risk profiles for CVD and T2DM among women, other than “Whites” 
and “Black (African)” are limited. 
 
Almost a decade ago (2008 – 2009) the cardiometabolic disease risk profiles associated with obesity 
and T2DM among “Coloured” women (n = 454, median age [interquartile range]: 51 yrs [43 – 48])54 
from the Bellville-South urban community in Cape Town (Western Cape Province) were published. 
The study highlighted the prevalence of T2DM55 and the MetS according to the three international 
definitions (i.e. National Cholesterol Education Program Adult Treatment Panel III [NCEP ATP 
III],56 International Diabetes Federation [IDF],57 and the Harmonised Guidelines 58). Of most 
significance was the finding of the increasing trend in frequency of undiagnosed T2DM with 










Figure 1.9 Prevalence (%) of undiagnosed T2DM according to age groups among urban “Coloured” 
women from the Bellville-South community cohort study.54 
 
In contrast, those with prediabetes (impaired FPG: ≥ 5.6 – 7.7 mmol/L)59 showed the opposite 
frequency trend with increasing age; in other words, a higher prevalence of prediabetes among the 
younger than the older age groups (Figure 1.10). However, the same frequency trend in prediabetes 










































Figure 1.10 Prevalence (%) of impaired fasting plasma glucose (prediabetes) according to age groups 
among urban “Coloured” women from the Bellville-South community cohort study.54 
 
 
Figure 1.11 Prevalence (%) of impaired glucose tolerance (prediabetes) according to age groups 
among urban “Coloured” SA women from the Bellville-South community cohort study.54 
 
The identification of the MetS according to each set of criteria varied (i.e. NCEP ATP III criteria: 
62.2% [n = 280]56 vs. IDF criteria: 67.8% [n = 305]57 vs. Harmonised Guidelines: 68.4% [n = 
308]58).54 Overall, these results highlight the progressive and age-related trends in undiagnosed 
T2DM among “Coloured” women living in a urban community setting, as well as the presence of 





















































More recent cross-sectional findings from the same Bellville-South community cohort provide further 
insight into the prevalence of obesity (53.7%) and diabetes mellitus (28.6%).60 The results reflect a 
combined  sample of women and men (73.5% vs. 24.5%) (mean age: 54 yrs),60 thus, sex-specific 
differences were neither investigated nor reported. However, in the presence of the MetS (i.e. 
hypertension, IFG and dyslipidaemia) an equal frequency of cardiometabolic disease risk was shown 
among normal weight (BMI: 18.5 – 24.9 kg/m2), overweight, and obese BMI-categories. A total of 
31.0% of the sample was characterised as “metabolically healthy obese” (MHO), compared to 29.0% 
who was “metabolically obese normal weight” [MONW]).60 The distinct presence of these two 
different obese phenotypes is of particular interest, as it proposes that cardiometabolic-related 
abnormalities are not uniform among all obese individuals.  
 
In contrast to the urban setting, age-standardised prevalence data for T2DM and prediabetes among 
rural “Coloured” communities seems considerably outdated. Results from Mamre, a small village   
near Cape Town (Western Cape) were reported as far back as 199961. However, it still provides 
valuable insight into the prevalence of prediabetes (IGT) (10.2%) and T2DM (10.8%) in a non-urban 
setting and thus, also specific to “Coloured” adults (n = 974, age range: 30 – 65 yrs). 
 
Of perhaps most concern are the recent survey results reported among middle-aged (~ 50 yrs), urban 
SA women already diagnosed with T2DM. The majority were “Coloured” and from a low-income 
group (i.e. family income: ≤ R4 167/month) and already using pharmacological treatment for T2DM 
and hypertension.24 However, on routine follow-up examination at a primary health care district 
hospital (e.g. False Bay, Cape Town, Western Cape), the majority were shown to be hypertensive 
(83.4%) (SBP [mean ± SD]: 145.6 ± 21.0 mm Hg) (DBP: 84.5 ± 12.0 mm Hg) and presented with 
dyslipidaemia (69.5%) (TC: 5.4 ± 1.2 mmol/L).24 Other intermediate risk factors associated with 
cardiometabolic disease for CVD and T2DM were also reported. Notably, obesity (BMI: 39.3 ± 7.3 
kg/m2), central obesity (WC: 117 ± 12 cm) and uncontrolled plasma glucose (HbA1c: 9.1 ± 2.0%) 
stood out.24 Furthermore, only 14.0% were deemed physically active, while television viewing, 
reported as a proxy measure of sedentary behaviour, averaged > 2-hours/day. In addition, mean daily 
intake of fruit and vegetables was considered relatively low (mean: 2.2 portions/day), whereas the 
consumption of added sugar (mean: 5 teaspoons/day) and sugar-sweetened beverages (mean: 1.3 
glasses/day) were relatively high.  
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Overall, these results demonstrate the high prevalence of T2DM and prediabetes among “Coloured” 
women from both urban and rural settings. Furthermore, there is an increasing frequency of 
undiagnosed T2DM and when diagnosed, is shown among women as young as 30 yrs of age. Distinct 
and different obesity phenotypes (MHO and MONW), specific to urban “Coloured” women were 
also noted. However, of most concern is the high prevalence of T2DM, as well as measurable 
cardiometabolic disease risk for CVD, among “Coloured” obese women who are already receiving 
pharmacological treatment and actively seeking medical advice from the public health sector. Thus, 
knowledge pertaining to behavioural/lifestyle factors (e.g. PA and sedentary behaviour) as well as 
physical health-related fitness, and each of their associations with obesity and cardiometabolic disease 
risk outcomes for CVD and T2DM, requires urgent investigation. This especially among urban 
“Coloured” women, who are already at risk for severe obesity.35 
 
Prior to presenting a summary of evidence detailing the associations between PA (Table 1.1) and 
sedentary behaviour (Table 1.2), with cardiometabolic disease risk outcomes for CVD and T2DM 
among SA women, the definitions and methodologies used to measure both will be presented. 
 
1.4 Behavioural/lifestyle factors  
 
1.4.1 Definitions: physical activity and sedentary behaviour 
 
According to Caspersen et al.62 physical activity (PA) refers to any bodily movement produced by 
skeletal muscle contraction, resulting in a sizeable increase in energy requirements over resting 
energy expenditure. It is important to note that PA is not the same as “exercise”. Simply stated, 
“exercise” is a sub-type of PA and described as planned, structured, and repetitive bodily movements 
executed to either improve or maintain various physical fitness components (Figure 1.12). 62 
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Figure 1.12 The term “physical activity” represents the full continuum of bodily movement, with 
“exercise” being a sub-type representing the higher end of this continuum.62 
 
Prominent organisations such as the American College of Sports Medicine (ACSM) in collaboration 
with the CDC,63 as well as the USA Surgeon General,64 and the National Institutes of Health 
(including the AHA) published seminal articles highlighting the health-associated benefits of PA. 
Findings had already been published as far back as the 1950’s by Morris et al.65 and the 1970’s by 
Paffenbarger et al.66 These publications were integral to the research that followed, with the primary 
objectives to: i) clarify how much PA was enough to derive health-associated benefits; and ii) 
determine what intensity was required to improve an individual’s overall health status. Thus, the 
overall aim was to determine what PA recommendations must be made to the public which would 
result in lowering an individual’s susceptibility of disease morbidity.   
 
In unison with the ongoing development of the evidenced-based US PA recommendations, the 57th  
World Health Assembly (WHA) in 2004, under the auspices of the WHO, endorsed the “Global 
Strategy on Diet, PA, and Health resolution (WHA57.17)”.67 Thus, calling to action the need for all 
member states to develop a national PA action plan, along with supporting policies. For example: i) 
to introduce transport policies that promote active and safe methods of travelling to and from schools 
and workplaces, such as walking or cycling; and ii) to ensure that physical environments support safe 
active commuting, and create space for recreational activity. It was anticipated that these measures 
would increase the PA levels of member country citizens.67 During the 61st WHA in 2008 the 
resolution (WHA61.14) entitled: “Prevention and Control of NCDs: Implementation of the Global 
Strategy and the Action Plan for the Global Strategy for the Prevention and Control of NCDs” was 
endorsed.  
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Although somewhat similar to the individual-specific PA recommendations advocated by the USA, 
the WHO released their own Global Recommendations on Physical Activity for Health in 2010.17 
Similar to the 2008 PA Guidelines for Americans, the dose-response relationship between PA and 
health-derived benefits was taken into consideration and included in the recommendations (e.g. 
frequency, duration, intensity, type and total amount of PA). The WHO Global PA Recommendations 
for Health advocate the following: recreational or leisure-time PA, transportation (e.g. walking or 
cycling), occupational (i.e. work), household chores, play, games, sports or planned exercise, in the 
context of daily, family, and community activities should be performed. In order to improve 
cardiorespiratory and muscular fitness, bone health and reduce the risk of NCDs and depression the 
following are recommended: i) adults aged 18 – 64 yrs should do ≥ 150 minutes of moderate-intensity 
aerobic PA, or activity throughout the week, or do ≥ 75 minutes of vigorous-intensity aerobic PA 
throughout the week, or an equivalent combination of MVPA; ii) aerobic activity should be performed 
in bouts of ≥ 10 minutes duration; iii) for  additional  health  benefits,  adults  should  increase  their  
moderate intensity  aerobic  PA to 300 min/week, or engage in 150 min/week of vigorous intensity 
aerobic PA, or an equivalent combination of MVPA; and iv) muscle-strengthening activities should 
be done involving major muscle groups on ≥ 2 days per week.17 Ongoing investigations of PA level 
using the Global PA Questionnaire (GPAQ), which forms part of the WHO Stepwise approach to 
chronic disease risk factor surveillance (STEPS), continues.68 Its use allows for domain-specific PA 
data specified in the WHA57.17 (i.e. work, transport and leisure time).  
 
Another form of PA and health-related recommendations includes the prescription of daily step 
counts (steps per day [steps/day]) using commercially available step counters (e.g. pedometers and 
accelerometers). The well-publicised ≥ 10 000 steps/day guideline, which seems to be globally 
accepted by various media and commercial entities, originates from several professional 
organisations and/or government agencies from various high-income groups (i.e. USA, Northern 
Ireland, United Kingdom, Japan, and Australia). As far back as 2004, Tudor-Locke and Bassett 
proposed preliminary pedometer-determined PA cut-points for healthy adults based on a large body 
of previously published literature. The following categories were created: i) sedentary (< 5 000 
steps/day); ii) low active (5 000 – 7 499 steps/day); iii) somewhat active (7 500 – 9 999 steps/day); 
iv) active (≥ 10 000 – 12 499 steps/day); and v) highly active (≥ 12 500 steps/day).69 Although it was 
only in 2011, with the use of sufficient and credible scientific evidence, that the same research group 
created a “steps/day” version of the MVPA guidelines.18 Thus,  the need to take more steps, over and 
above those taken in the course of habitual and incidental daily activities; and that these additional 
steps  be taken in bouts of ≥ 10 minutes in duration, were specified.18 At the same time other studies 
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emphasised the importance of intensity-based steps in line with the MVPA guidelines and thus 
recommended the number of steps per minute of ambulation (i.e. step rate or cadence).70,71 As an 
example, 30-minutes of moderate to vigorous-intensity walking was shown to range between 3 100 
and 4 000 steps even after differences in BMI and stride length were considered. In support of these 
preliminary findings, are more recent inferences made by Tudor-Locke et al.72 following a larger 
meta-analysis examining the relationship between the rate of steps taken and intensity level. They 
reported that a step rate or ambulatory cadence value of ≥ 100 steps/min in adults is indicative of 
moderate-intensity PA.72 Overall, the association between the volume of daily step counts and 
average step rate, needs to be examined especially among populations from lower to middle-income 
countries, where evidence suggests that the majority of daily PA is acquired for travel-related 
purposes (e.g. walking).73,74    
 
Despite the numerous PA guidelines/recommendations that have evolved over the past few decades, 
those which currently exist, as well as the increased awareness and understanding of the health-
associated benefits in leading a physically active lifestyle, “physical inactivity” continues to raise 
concern across the globe. This deduction follows the reported and published findings from the Lancet 
Physical Activity Series Working Group released in 2012. One article in particular highlighted 
“physical inactivity” to be one of the four leading four contributors to premature mortality.75 Simply 
described, “physical inactivity” refers to individuals who perform insufficient amounts of MVPA,76 
or equally stated, those who do not meet the WHO Global Recommendations on Physical Activity 
for Health for adults (18 – 64 yrs).17  
 
Sedentary behaviour refers to any waking behaviour while in a seated, reclined or lying posture and 
is characterised by an energy expenditure ≤ 1.5 metabolic equivalents (METs).76,77 Thus, it is 
considered the lowest in energy expenditure when compared to PA and its continuum of increasing 
intensities (i.e. light intensity PA [> 1.5 – 2.9 METs], moderate-intensity [3.0 – 5.9 METs], and 
vigorous-intensity [≥ 6.0 METs]) (Figure 1.13).17,77 Notably so, sedentary behaviour should not be 
confused, nor used reciprocally, with “physical inactivity”.  
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1.4.2 Measurement methodologies: physical activity and sedentary behaviour 
 
Given the complex and multi-dimensional nature of PA, it is considered a challenging entity to 
assess.86 The same inference can be made when characterising and/or measuring sedentary behaviour. 
Thanks to numerous technological advancements a wide spectrum of measurement methodologies 
are used to quantify total energy expenditure. Some of these are illustrated by Ekelund (unpublished) 
(Figure 1.15). A clear inverse relationship exists between degrees of accuracy (precision), cost and 











Figure 1.15 Measures of total energy expenditure (physical activity and sedentary behaviour) 
according to degrees of accuracy, cost and ease of assessment (Ekelund, unpublished). 
 
In terms of PA, the criterion method used is that of whole-room direct calorimetry, which quantifies 
total energy expenditure (TEE) according to kilocalories per day (kCal/day). Conversely, indirect 
calorimetry (e.g. metabolic cart, or mobile calorimeter) allows for an estimation of TEE and physical 
activity-related energy expenditure (PAEE). The disadvantage of these highly sophisticated methods 
is that they are expensive and testing is time-consuming. Thus, objective monitoring devices (e.g. 
combined heart rate and movement sensing, accelerometers, and pedometers), as well as 
subjective/self-report instruments (e.g. questionnaires or PA diaries) offer easy alternatives. All of 
these methods can also be used to predict TEE and PAEE, although with varying degrees of validity 
and reliability. 
 
Given the cost and time implications, opportunities to use both objective monitoring devices (e.g. 
accelerometers), as well as subjective questionnaires (e.g. GPAQ87 or Sedentary Behaviour 
Questionnaire [SBQ]88) are beneficial, especially when trying to capture PAEE in free-living 
conditions (i.e. non-laboratory settings). For example, hip-worn accelerometers (e.g. Triaxial 
ActiGraph GT3X) holds a motion sensor that is able to record the frequency and amplitude of 
accelerations of motion (i.e. counts per minute [counts/min]). Using predetermined cut-points,89, 90, 91 
one is able to quantify activity intensity levels. The cut-points derived by Freedson et al.88 and used 
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in a previous SA study,92 define and divide PA into 4 sub-categories, namely: light-intensity (100 - 
1951 counts/min), moderate-intensity (1952 - 5724 counts/min), vigorous-intensity (5725 - 9498 
counts/min) and very vigorous-intensity (≥ 9499 counts/min). An added benefit of using 
accelerometry includes the capturing of low motion counts (< 100 counts/min), i.e. sedentary 
behaviour. Although this definition by Freedson et al.89 is consistent with that by Troiano et al.91 the 
higher intensity cut-points are different (e.g. light-intensity Freedson89: 100 - 1952 counts/min vs. 
Troiano91: 100 - 2019 counts/min). Comparison of accelerometer-derived data across different studies 
should therefore be done with caution. 
 
The GPAQ, which forms part of the WHO Stepwise approach to chronic disease risk factor 
surveillance (STEPS),87 has been validated68 in numerous countries and thus makes the data captured 
easily comparable. Another advantage includes the description of domain-specific PA time (e.g. 
work, travel and leisure time, respectively), which allows for PA behavioural patterns to be described. 
Similarly, the SBQ88 can be used to assess time spent seated and involved in one of nine different 
sedentary behaviours (e.g. watching television, playing computer/video games, sitting while listening 
to music, sitting and talking on the phone, doing paperwork or office work, sitting and reading, 
playing a musical instrument, doing arts and crafts, sitting and driving/riding in a car, bus, or train). 
Thus, like the GPAQ, the use of the SBQ enables the capturing of behavioural time and help to 
determine patterns of “sedentarism” reported on a typical weekday and weekend day. The major 




1.4.3 Physical activity among South African adult women: levels and patterns   
 
National PA prevalence estimates, reported in 2003, indicate a relatively low proportion of adult 
women to have met the recommended PA level (14%).44 The GPAQ data showed that leisure-time 
PA (54%) was highest among all women (15-65yrs), compared to work- (18%) and travel-domain 
(28%) PA time. On the other hand, PA prevalence revealed that only 12% urban women were 
sufficiently active, compared to 17% rural women. Furthermore, patterns of PA differed between the 
two groups with urban women having reported more leisure-domain PA time (57% vs. 50%) and less 
work- (17% vs. 20%) and travel-domain PA time (26% vs. 30%) compared to their rural counterparts.  
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When comparing PA level across the different population (racial) sub-groups, “Coloured” women 
were the least sufficiently active (8.4%), with 91.6% not meeting the minimum PA level associated 
with health-enhancing benefits (i.e. minimally active: 25.6% and physically inactive: 66.0%) 
compared to their other ethnic counterparts (Figure 1.16).  
 
Figure 1.16 Prevalence (%) of physical activity in a representative sample of SA women according 
to population (racial) sub-group from the SADHS (2003).44  
 
The majority of “Coloured” women reported more leisure-domain (46%) and less work- (27%) and 
travel-domain (27%) PA time, respectively. Thus, domain-specific PA patterns were reported by 



























Sufficiently active (≥ 3 000 MET-min/week)
Minimally active (600 - 2 999 MET-min/week)
Physically inactive (< 600 MET-min/week)
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Figure 1.17 Prevalence (%) of domain-specific physical activity time among the “Coloured” 
women, all women and the urban women sub-group.44  
 
It is important to highlight the relatively lower proportion of leisure-domain PA time among the 
“Coloured” women compared to the other two groups (“Coloured”: 46% vs. all: 54% vs. urban: 57%), 
whereas the opposite exists for work-domain PA time (“Coloured”: 27% vs. all: 18% vs. urban: 17%). 
Although not stated, speculative reasons for these differences may include occupation type and 
moreover, those which require physical labour (e.g. domestic cleaning). Also, the need for active (e.g. 
walking) vs. motorised transport and having to travel longer distances due to home and places of 
purpose (e.g. work, school and shopping centres) not being in close proximity to one another. 
Recently published  data  from two different provinces (Western Cape9  and Gauteng14) highlighted 
that the majority of GPAQ self-report PA time among urban “Black” women (mean age: 26 ± 7 yrs) 
was for travel-related purposes (i.e. walking).9 Gradidge et al.14 also mentioned the negative influence 
of motor vehicle ownership on total walking PA time. Thus, there is scope for more local studies on 

























Leisure domain (% self-report PA time)
Work domain (% self-report PA time)
Travel domain (% self-report PA time)
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Population-based results from the WHO commissioned World Health Survey inclusive of South 
Africa, indicate that more SA women were deemed sufficiently active in 2014100 (58%) than in 200599 
(37%). However, it is important to note that a different set of PA criteria were used, and in particular, 
included the 2010 WHO PA Global Health Recommendations for Health.17 Therefore, these results 
are not entirely comparable with those reported in the 2003 SADHS.44 To my knowledge, national 
PA prevalence estimates from the more recent SANHANES-1 (2012) are non-existent. Nevertheless, 
the collective findings  of the large-scale national surveys34,99,100 highlight that low levels of physical 
activity are very  likely a contributing risk factor for CVD and T2DM among SA women, and even 
more so among sub-groups of urban-dwellers and “Coloured” women. 
 
1.4.4 Physical activity among adult women from other countries: levels and patterns  
 
 
Results from a 22 African country survey73 (excluding South Africa), which formed part of the WHO 
Stepwise approach for Surveillance (STEPS), reported a wide range of physical inactivity prevalence 
estimates among women.73 In particular, women from Mali were reported to be the most inactive 
(67%), while those from Mozambique were the least inactive (7%). The survey also showed that 
leisure time PA was consistently low (5%), compared to work- (49%) and travel-related PA (46%). 
These results were thus in contrast to the SADHS (2003)44 findings among SA women.  Possibly, the 
ongoing and rapid rate of epidemiological transition in South Africa, as compared to the other African 
countries, may explain the difference in findings.  The likelihood of participants misunderstanding 
the description of the GPAQ PA-specific domains is also a plausible reason. Nonetheless, these 
descriptive domain-specific PA findings are in contrast to those from South Africa and thus raises the 
need to investigate PA using objective measurements. It is also conceivable that objectively derived 
PA may indicate different levels to those reported using subjective measures, hence the need for 
studies using more sophisticated and objective measures. 
  
A previous 20 multi-country survey in 2004 underscored the differences in PA patterns between high- 
and low to middle-income countries.74 Notably the majority of leisure PA time performed at high 
intensities (i.e. MVPA) were among high-income adult populations. In contrast, the majority of PA 
time among those from low to middle-income countries was for travel-related purposes (i.e. walking), 
and at relatively lower perceived level of intensity (i.e. moderate).  
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A more recent (2012) global surveillance report, inclusive of low to middle- and high-income 
countries, showed that as many as 31% of adults are physically inactive.75 The Global Observatory 
for Physical Activity (GoPA), which is a joint initiative of the International Society of Physical 
Activity and Health and the Lancet Physical Activity Series Working Group, developed country cards 
on the global status of PA. The results among women from high-income countries (e.g. Australia, 
USA, Canada, Argentina and China), upper to middle-income countries (e.g. Colombia and South 
Africa) and lower to middle-income countries (e.g. India) found that as many as 31% of adults are 
inactive.75 The results per country are depicted in Figure 1.18. 
 
 
Figure 1.18 Prevalence (%) of physical activity among women from different high-, upper to middle- 
and lower to middle-income countries, respectively. * denotes 2018 classification 
Evidently, levels of physical activity among women vary across the different WHO income-
categorised countries. Although the GoPA continues its efforts to document global trends in PA, less 
than a third of the countries, including South Africa, currently engage in ongoing surveillance studies. 
 
Overall, these population-based surveillance studies derived from self-report PA data indicate how 






































of low PA levels in South Africa, as compared to other African countries is worrisome.4,5 The 
influence of technology (e.g. computer games and television), as well as time-based challenges (e.g. 
extended travel time to and from work and/or other purposeful places), the lack of an inclusive PA 
environment (e.g. limited access to exercise facilities and issues of safety), and the lack of social 
(community) networks to promote PA,8 remain significant barriers. Thus, any proposed interventions 
to address the issue of physical inactivity will have to take these factors into consideration.  
 
1.4.5 Sedentary behaviour among South African adult women  
 
To my knowledge, there are data on sedentary behaviour which was gathered during the large national 
SADHS published in 2003,44 however, it has never been reported. More recent GPAQ-derived data 
from the Birth to Twenty (Bt20) cohort study have been published and provide valuable insight on 
sitting time among a large sample of middle-aged urban black women (n = 977).14 There are also  
numerous published findings from small-scale studies among urban92,112,125 and rural “Black 
(African)” women12,116,117 and where  objective measurement instruments were used to quantify 
sedentary behaviour. 
 
Comparing sedentary behaviour data from two separate cross-sectional analyses,  both from the larger 
Bt20 cohort study (Soweto, Johannesburg, Gauteng Province), it transpired that the relatively older  
urban “Black (African)” women  averaged 180 min/day of sitting time per day (mean age: 41 ± 8 
yrs),14 compared to the higher amount of accelerometer-derived sedentary time (median: 575 min/day 
[95% CI: 568 to 597 min/day]) reported among the younger women  (aged: 19 to 20 yrs).125 Having 
also used accelerometer-derived sedentary time,  results from  urban “Black (African)” women  in 
Cape Town (Western Cape Province) showed  similar amounts of time spent sedentary (± 510 
min/day).92 Whether the difference observed between the older and younger women is solely 
attributable to the method of data collection, is unclear. 
 
Comparative findings between urban (n = 16) and rural (n = 263) “Black (African)” women, reported 
by Cook et al.10 provide unique and valuable insight within the SA context. Irrespective of the visible 
difference in sample sizes between the groups (n =16 vs. n = 263), the use of accelerometer-derived 
sedentary time adds strength to the inferences drawn about sedentary behaviour among adult women 
in two different settings. Urban women were significantly younger (30 ± 7 yrs vs. 35 ± 11 yrs, p = 
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0.0168) and more sedentary (842 ± 40 min/day vs. 780 ± 10 min/day, p = 0.0042) compared to their 
older and less sedentary rural counterparts. Interestingly, no statistically significant differences were 
found between normal-weight, overweight and obese women across the two groups (p > 0.05). 
 
In the interpretation of the above data, it should be remembered that the use of different objective 
devices and measurement units used to quantify sedentary behaviour also have their limitations. Not 
only are pedometer-measured step counts and accelerometer-derived motion counts incompatible, but 
so are the definitions used to characterise sedentary level (< 5 000 steps/day18) and time (< 100 
counts/min89,90,91). Thus, the use of different measurement instruments and definitions to describe the 
term sedentary, make any attempts to draw definitive and collective inferences unconvincing.    
 
1.4.6 Sedentary behaviour among adult women from other countries 
 
A growing body of literature describe the adverse health effects of prolonged bouts of time spent 
sedentary.127,128,129 Valuable results from a meta-analysis among adults indicate the significant and 
independent associations between sedentary time and i) CVD incidence (hazard ratio [HR]: 1.143 
[95% CI: 1.002 to 1.729]); ii) T2DM incidence (HR: 1.910 [95% CI: 1.642 to 2.222]); and iii) all-
cause mortality (HR: 1.179 [95% CI:1.106 to 1.257]).130 Most interestingly, the meta-analysis also 
showed that when participants were matched for time spent sedentary, those with relatively higher 
PA levels had a 30% lower all-cause mortality risk compared to those who were less active. Given 
this, the ability to mitigate the adverse health effects of time spent sedentary with increasing PA time 
seems plausible.130 
 
1.4.7 Associations between physical activity and cardiometabolic disease risk for cardiovascular 
disease and type 2 diabetes mellitus among adult women from other countries and South Africa  
 
Recently published findings from a large multi-ethnic women study (The Objective Physical Activity 
and Cardiovascular Health [OPACH])101 highlighted the favourable associations between PA and 
reduced cardiometabolic disease risk. Even after adjusting for differences in age, accelerometer wear 
time, ethnicity and BMI, higher volumes of PA were  statistically significantly associated with 
reduced SBP, DBP, TC, HDL-C, TG and FPG levels (p < 0.01). More importantly, higher volumes 
of light-intensity PA were associated with reduced cardiometabolic disease risk and thus, corroborate 
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previous findings also from the USA. In particular, longitudinal results from the National Health and 
Nutrition Examination Survey (NHANES) among the adult population group (aged: 20 – 84 yrs) 
highlighted the health-related benefits of LPA, even after adjusting for differences in age and 
MVPA.101 
 
Evidence from earlier women cohort studies,103, 104, 105,106 all from high-income countries, also 
revealed the positive association between PA and reduced cardiometabolic disease risk for CVD103,104 
and T2DM.105,106 In particular, results from the multi-ethnic Women’s Health Initiative Observational 
Study (WHI-OS) indicate those who walked ≥ 5 hours per week were 33% less likely to develop 
T2DM compared to those who were non-regular walkers.104,105 Bao et al.106 reported a 9% risk 
reduction in developing T2DM with each 100 minute increment of moderate-intensity PA performed 
per week.106 Most notably, these results were independent of differences in BMI. On the other hand, 
findings from the Australian Longitudinal Study on Women’s Health indicate the equal importance 
of PA and the ability to maintain a healthy weight (i.e. BMI) in association with reduced CVD-risk.103 
Notably, an increase in BMI and decrease in PA were associated with increased risk of hypertension. 
In comparison with healthy weight “high-active” women, hypertensive-risk in the obese “high-
active” women was 3.4 times greater (odds ratio [OR]: 3.43, 95% CI 2.68 to 4.39) and in obese 
“inactive” women 4.9 times greater (OR: 4.91, 95% CI 3.92 to 6.13).103 Thus, PA was shown to 
reduce the risk of hypertension, however, could not remove the negative effect of obesity on risk for 
hypertension.  
 
The debate as to whether high levels of PA counteracts the adverse effect of weight (i.e. BMI) on 
cardiometabolic disease risk for CVD and T2DM remains ongoing and requires further investigation. 
Similarly, whether an increase in total adiposity is the cause or consequence of insufficient PA 
levels.107 The true relationship between body weight and PA levels is equivocal, mainly because of 
methodological issues. For example, the use of BMI, WC and WHR, as proxy measures of obesity 
and central obesity must also be taken into account when reviewing its strength of association with 
PA. Another matter is the tendency to use self-report instruments (e.g. questionnaires) which usually 









Conversely, studies reporting the use of higher precision radiological body composition scanning 
methods (e.g. DXA and computerised tomography [CT]), which include absolute and relative body 
fat measures, as well as its regional distribution measurements (e.g. CFM, AFM and VAT area), may 
help to validate the associations previously reported with BMI, WC and WHR. Furthermore, 
objective measurements will also provide a more accurate representation of body fat and its regional 
distribution among those from different ethnical backgrounds. For example, results from a multi-
country study109 drew attention to the differences in the relationships between DXA-derived %BF 
and BMI, and ethnicity (New Zealand sub-groups: “European”, “Maori”, “Pacific and Asian Indian” 
and South African sub-groups: “European” and “Black (African)”).109 
 
Data from sub-Saharan Africa investigating associations between PA and intermediate 
cardiometabolic disease risk factors for CVD and T2DM are lacking. However, some studies have 
published findings on PA and measures of adiposity (e.g. BMI, WC, WHR and %BF). The majority 
of which report the use of subjectively-derived PA data (i.e. self-report 
questionnaire)24,50,51,52,110,111,112,113 and only two the use of objectively-derived PA measures.112,114 
Cross-sectional findings from a small-scale Cameroonian study115 among  adult women and men 
highlight an inverse association between PAEE and %BF. Although limited in the researcher’s use 
of bioelectrical impedance to quantify %BF a major strength of the study was the use of the 
sophisticated double labelled water technique, to measure TEE and PAEE. In SA, there are data from 
small-scale cross-sectional studies46,92,116,117 and one relatively larger study (Bt20)14 on the 
associations between PA and various intermediate cardiometabolic disease risk factors in women 
from both urban9,14,46,92 and rural46,116,117 settings. These are summarised in Table 1.1. Some of the 
findings therein are adapted from Dickie (MSc dissertation, 2013)118 among urban and rural “Black 
(African)” SA women (15 – 70 yrs).118 The table also  include  earlier (1991 to 1995) and more recent 
(2013 – 2018) data reported among women older than 18 years,  from urban and rural settings and 






Table 1.1 Summary of SA studies investigating physical activity and its association with intermediate cardiometabolic disease risk factors for CVD and 
T2DM in adult women from different settings and racial categories.    
Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  










n = 1042 
25 to 65+ “Black 
(African)”  
Free State  
(urban sample from 
Mangaung and rural 





BMI, WC, WHR, 
SBP, DBP, TC, 
LDL-C, HDL-C, 
TG and FPG 
Prevalence of obesity according to 
BMI (≥ 30 kg/m2) among adult 
women:  
Urban vs. Rural: 43.5% vs. 38.4% 
 
Prevalence of hypertension*:   
Urban vs. Rural: 30.0% vs. 29.0% 
Prevalence of 
hypercholesterolemia*:    
Urban vs. Rural: 6.0% vs. 12.5% 
Prevalence of diabetes mellitus*:    
Urban vs. Rural: 6.0% vs.  4.8% 
(*) denotes age- and sex-adjusted 
prevalence   
Did not report any data on PA 
level or domain-related patterns, 
and thus  associations between 
PA and  any of the measured  
cardiometabolic disease risk were 
not explored 




n = 544 
15 to 64 “Black 
(African)” 
Western Cape 
(urban sample  from 
Khayelitsha,  Nyanga,  
Langa,  Guguletu, and 
Crossroads [all of 




risk factor, PA and 
dietary questionnaire  
(Only PA work-
domain) 
BMI, SBP, DBP, 
TC and HDL-C 
27.3% of women who were 
employed were classified as 
inadequately active at work 
 
Prevalence of obesity according to 
BMI (≥ 30 kg/m2) among urban 
adult women: 44.4%  
 
Did not examine the association 
between PA at work and BMI, 









Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  






Tshabangu et al.,  
200111  
Cross-sectional  
n = 226  
18 to 29 “Black 
(African)” 
Gauteng  





(PA level)  
BMI and WHR  According to BMI  
(≥ 25.0 – 29.9 kg/m2) the majority 
of women were overweight: 61.0% 
 
Mean MVPA reported among the 
adult women: 180 min/day 
 
Did not examine the association 
between PA and BMI, nor PA 
and WHR 
 








n = 530  
15 to 70 “Black 
(African)” 
North West  





(PA index score [PAI])  
BMI, WC, WHR, 
and adiposity 
(sum of 4 
skinfolds [SSF]) 
Fewer women in the highest         
PAI-tertile were obese compared to 
those in the lowest- and middle-PAI 
tertile, respectively   
 
After adjusting for differences in 
age, smoking and total household 
income, inverse associations were 
reported between:  
 
PAI and BMI  
(r = -0.135, p < 0.001)    
 
PAI and WC  
(r = -0.147, p < 0.0001)   
 
PAI and adiposity  


















Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  










n = 530 
39 “Black 
(African)” 
North West  






(PAI score)  
BMI  According to BMI  
(≥ 25.0 – 29.9 kg/m2) the majority 
of women were overweight: 53.8%  
 
Did not examine the association 
between PAI and BMI  
 
Alberts et al.,  
2005119 
Cross-sectional  
n = 1563 










BMI, WHR, TC, 
HDL-C, LDL-C, 
TG,  SBP and 
DBP 
Age-standardised prevalence of 
obesity according to BMI  
(≥ 30 kg/m2): 27.3% 
 
Only 14.4% of women who were 
employed were classified as 
inadequately active at work 
 
Did not examine the association 
between PA work-domain and 
BMI, nor any of the other 
cardiometabolic risk factors 
 
Jennings et al.,  
200851 
Cross-sectional  
n = 223 











derived VAT and 
SAT, SBP, DBP, 
TC, LDL-C, 
HDL-C, TG, FPG 
and fasting serum 
insulin  
 
Did not report on PA level nor 
prevalence of women 
overweight/obese 
 
Did not examine the association 
between PAEE and any of the 
cardiometabolic disease risk 



















Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  






Cook et al.,  
2008116 
Cross-sectional  




n = 151 





(Pedometry, steps/day)  
BMI, WC and 
adiposity (SSF)  
  
Majority of the women were 
overweight according to BMI (≥ 
25.0 kg/m2):  
Mean BMI: 26.6 kg/m2   
Mean WC: 79.4cm 
Mean steps/day: 9 085 
 
Inverse associations were 
reported between:  
 
Steps/day and BMI  
(r = -0.22, p < 0.02) ( remained 
significant even after adjustment 
for age: r = -0.20, p = 0.032) 
 
Steps/day and WC  
 (r = -0.23, p < 0.02)   
 
Only BMI remained significant 
after adjusting for age (p = 0.036) 
 
For every additional  5000 
steps/day increased, BMI was 
shown to decrease by 1.4 kg/m2 
 











(PA, min/day)  
BMI   
Majority of the women were 
overweight however “highly” active  
Mean BMI: 26.6 kg/m2  
Mean MVPA: 224 min/day  
 
86% of the women  met the 
ACSM/CDC physical activity 
guidelines (i.e. ≥ 30 min/day of 
MVPA, at least 5 days per week 
and in ≥ 10-min bouts) 
 
Did not examine the association 








Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  

































n = 138 
(2003/2004) 



























(1997 and 2003/2004)  




















(only 2003/2004)  
(Accelerometry: 
counts/day, steps/day 
and min/day in different 
intensity bands 
(Matthews MVPA cut-




SBP, DBP, TC, 
LDL-C, HDL-C, 



















SBP and DBP 
Linear relationship was reported: 
Self-reported diagnosis with, or 
on medication for, hypertension 
and/or diabetes mellitus with PAI 
(p = 0.0180) 
 
Inverse associations reported 
between: 
PAI and BMI  
(r = -0.24, p = 0.0037) 
 
PAI and WC  
(r = -0.147, p < 0.0001)   
 
PAI and FPG 
(r = -0.47, p < 0.0001) and 
remained even after adjusting for 
difference in BMI  
(r = -0.20, p = 0.0034) 
  
PAI level and adiposity (SSF) and 
remained significant after 
adjusting for age (p < 0.04) 
 
Majority of the women were 
overweight according to BMI  
(≥ 25.0 kg/m2)  
Mean BMI: 26.9 kg/m2  
Mean MVPA: 253 min/day  
 
96.4% of women  met the 
ACSM/CDC physical activity 
guidelines, whereas 69.6% met the 
Institute of Medicine (IOM) 
guidelines (i.e. 60 min/day of 
MVPA, at least 5 days a week and 










Reference  Study design 
(name of 
study/survey)  (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  







Dugas et al.,  
2009114 
Cross-sectional  














(Metabolic chamber)  
(PAEE, kJ/min)  
 






Included lean (< 25.0 kg/m2) vs. 
obese (≥ 30 kg/m2) BMI sub-groups 
Did not examine any association 
between PAEE and BMI, WHR 
and %BF  
 
Did not examine any associations 
between PAEE and BMI, nor 
PAEE and WHR or PAEE and 
%BF  
  
Dugas et al.,  
2009121 
Cross-sectional  




Western Cape  
(urban)  
Objective  
(Double labelled water 
technique)  
(PAEE, kJ/min)  
 
Objective  
(Accelerometry [n = 








Associations  between PAEE and 
BMI, and PAEE and %BF were 
non-significant (p > 0.05) 
 
Did not examine any associations 
between PAEE and BMI, nor 
PAEE and WHR or PAEE and 
%BF 
Goedecke et al.,  
200952 
Cross-sectional  








(PAEE, MET-min/day)  
BMI, WC,  
DXA-derived 
%BF, CT-derived 
VAT and SAT, 
FPG and fasting 
serum insulin 
Did not examine the association 
between PAEE and any of the 
cardiometabolic disease risk 
factors measured 
Goedecke et al.,  
2009122 
Cross-sectional  
n = 28 
26 “Black 
(African)” 




(PAEE, MET-min/day)  
FPG and fasting 
serum insulin 
Did not examine the association 
between PAEE and FPG, nor 
fasting serum insulin 











(Pedometry, steps/day)  
BMI and WC  Inverse associations between 
steps/day and BMI, as well as 
steps/day and WC;  both  
remained significant  after 
adjusting for differences in age  
 
Steps/day and BMI  
(r = -0.08, p < 0.03) 
Steps/day and WC  








Reference  Study design 
(name of 
study/survey)  (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  







Goedecke et al.,  
2010111 
Cross-sectional  








(PAEE, MET/day)  
BMI, WC,  
DXA-derived 
%BF, CT-derived 
VAT and SAT, 
TC, HDL-C, TG, 
LDL-C, total LDL 
particle size as 
well as LDL 
subclass I-IV 
 
Included lean vs. obese BMI sub-
groups 
 
No association between PAEE and 
TG, TC, LDL-C, HDL-C, total 
LDL particle size as well as LDL 
subclass I-IV 
No statistically significant ethnic 
differences or BMI-derived sub-
group differences in PAEE 




n = 180 
 
18 to 45 “Black 
(African)”  
Eastern Cape  
(urban)  







Objective (n = 69) 
(Accelerometry)  
(PAEE [METs/day], 
MVPA [min/day] and 
steps/day)  
 
BMI  Neither the younger age group (18 
to 21 yrs), nor the older age group 
(35 to 45 yrs) were sufficiently 
active as they failed to meet the 
ACSM/CDC PA guidelines   
 
Did not examine associations 
between any of the objective PA 
variables and BMI 
 




n = 707 






(PA, min/week)  
BMI, WC and 
WHR  
Significantly higher proportion of 
physical inactivity amongst those 
who were diabetic (11.6%) 
compared to those who were non-
diabetic (6.1%) (p = 0.035)  
 
Did not examine the association 
between PA and BMI, nor PA 












Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  

















(rural [n = 272] and 




intensity PA, MVPA)  
(Matthews MVPA cut-
points used: ≥ 760 
counts/min 166 and 
compared with 
Freedson MVPA cut-
points used: ≥ 1952 
counts/min) 89 
BMI Higher proportion of rural women  
met the ACSM/CDC PA guidelines 
compared to their urban 
counterparts: 38.2% vs. 27.5%, 
although when using the higher 
Freedson MVPA cut-point the 
proportions decreased: 34.4% vs. 
29.0%  
 
Mean BMI:  
Rural women: 26.8 ± 6.0 kg/m2 
Urban women: 28.5 ± 6.0 kg/m2 
 
Did not examine the association 
between PA and BMI 
 














BMI, WC, WHR, 
%BF, FM, 
FFSTM  (DXA), 
TC, LDL-C, 








67% were classified as active 
according to GPAQ MVPA-criteria 
 
Prevalence of  MetS was 40% 
Prevalence of overweight (29.2%) 
and obesity (48.0%) 
 
Women who  owned a motor 
vehicle reported less travel-related 
PA time and more leisure-related 
PA time (p < 0.01) compared to 
those who did not  own a motor 
vehicle 
 
Women who owned a television 
reported significantly lower total 
MVPA and walking for travel         
(p < 0.01) 
 
An inverse association was 
observed between total MVPA 









Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  







Dickie et al., 
20149 
Part 1:  
Cross-sectional  











Part 2:  
Longitudinal 
observational                   
follow-up (5.5-year) 






























BMI, WC,  
DXA-derived 
%BF, CT-derived 




serum insulin and 
HOMA-IR 
61% were classified as active 
according to GPAQ MVPA-criteria 
 
Active women had significantly 
lower body mass, BMI, FM, %BF, 
WC, CFM, and AFM (p < 0.001),  
measures of insulin resistance 
(fasting serum insulin and HOMA-
IR [p = 0.01]) and higher HDL-C (p 




After adjusting for differences in 
age,  body fat measures were 
significantly increased in both 
groups (p < 0.05) 
 
DBP level was  lower in women 
who were active at baseline, but did 
not change in those who were 
inactive 
 
Meeting WHO Global PA 
Guidelines was associated with 
decreased cardiometabolic risk, but 
did not prevent the increase in body 
fat over a follow-up period of 5.5-
yrs  
 
No associations were examined 
between PA and any of the 














Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  







Dickie et al.,  
201692 
Cross-sectional  
n = 76  








intensity PA, MVPA)  
(Freedson cut-points88: 
light-intensity PA 100 - 
1951 counts/min and 
MVPA: ≥ 1952 
counts/min) 
 
BMI, WC,  
%BF (DXA), 
VAT and SAT 
(CT), TC, LDL-C, 
HDL-C, TG, 
FPG, fasting 
serum insulin and 
HOMA-IR 
 
53.1% were classified as active 
according to GPAQ MVPA-criteria, 
whereas 55.3% reported an average 
of ≥ 10 000 steps/day  
 
Inverse association between light-
intensity PA and trunk FM         
(p < 0.05) 
 
Associations between MVPA and  
cardiometabolic risk outcomes  
were not statistically significant   
 
Manning et al.,  
201624 
Part 1:  
Cross-sectional 
survey   
n = 193 
 
Part 2: Intervention-
study with two 
different groups   















DBP, TC,  
Only 14% were physically active 
 
Proportion of women: 77.7%  
Prevalence of T2DM: 41.5% 




Other cardiometabolic risk markers 
(mean ± SD): 
 
HbA1c: 9.1 ± 2.0% 
SBP: 146 ± 21 mm Hg  
DBP: 85 ± 12 mm Hg 
TC: 5.4 ± 1.2 mmol/L 
 
Did not examine associations 
between PA and cardiometabolic 















Reference  Study design 
(name of 
study/survey)  
 (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  
Measures of  


















35 to 70  “Black 
(African)”  
North West  






score] 166 and the 
International Physical 
Activity Questionnaire 
[IPAQ], PA min/week)  
 
BMI  BMI of the rural women: 27.6±7.4 
kg/m2 (overweight) 
BMI of the urban women: 28.9±8.1 
kg/m2 (overweight) 
Did not examine associations 
between PAI and BMI, or PA and 
BMI 
 




n = 191 











intensity PA, MVPA)  
(Troiano cut-points: 
light-intensity PA 100 – 
2091 counts/min and 








BMI  83% of the young urban women  
met the ACSM/CDC physical 
activity guidelines (i.e. ≥ 30 
min/day of MVPA, at least 5 days 
per week and in ≥ 10-min bouts)  
The proportion was lower when 
using the WHO Global PA 
Recommendation (i.e. ≥ 75 
min/week of vigorous-intensity PA; 
or ≥ 150 min/week of moderate-
intensity PA; or a combination) 
1952 counts/min): 20.0%  
Did not examine association 
between PA and BMI 
Motadi et al.,  
2018113 
Cross-sectional  
n = 65 











BMI, WC and 
BF% (sum of four 
skinfolds), SBP, 
DBP, TC and 
FPG   
64.6% were categorised as 
physically inactive; whereas 36.9% 
were obese according to BMI (≥ 
30.0kg/m2) and 95.4% overweight 
according to %BF (≥31.0%) 
Did not explore examine 
associations between PA and 










1.4.7.1 Summarised findings of Table 1.1 and concluding remarks 
 
Associations between PA and cardiometabolic disease risk outcomes among SA adult women aged 
18 to  65+ yrs were only reported in six of the twenty-six studies summarised in Table 1.1 Results 
from the Transition and Health During Urbanisation of South Africa (THUSA) study46 showed 
significant inverse associations between PA index (PAI) and BMI (r = -0.135, p < 0.001), PAI and 
WC (r = -0.147, p < 0.0001) and PAI and adiposity (r = -0.104, p = 0.03), even after adjustments for 
differences in age, smoking status and household income were taken in account.46 Women in the 
highest PAI tertile were less likely to be obese compared to those in the lowest PAI tertile (OR: 0.38; 
95% CI: 0.22 to 0.26). However, those at greatest risk for obesity were from the higher income 
categories and lowest PA tertile.46 
 
Although using a different PAI, similar results from the DHDSS site reported by Cook et al.10 also 
showed significant inverse associations between PAI and BMI (r = -0.24, p = 0.0037), PAI and WC 
(r = -0.147, p < 0.0001) and, most notably, PAI and FPG (r = -0.47, p < 0.0001). These relationships 
remained statistically significant after adjustment was made for differences in BMI (r = -0.20, p = 
0.0034). A significant linear relationship was also found between PAI and self-report diagnosis of 
hypertension and/or diabetes mellitus (p = 0.0180).  
 
Additional survey findings from the DHDSS site reported by Cook et al.116,117 indicate similar 
associations between objectively-measured PA (i.e. pedometry) and cardiometabolic disease risk. 
Statistically significant inverse associations were shown between steps/day and WC and steps/day 
and BMI (p < 0.05).116,117 Similar to the findings from the THUSA study,46 the inverse association 
between steps/day and BMI remained statistically significant after adjusting for differences in age (p 
< 0.004).116,117 Of greatest importance, however, was the notable reduction in BMI-defined obesity 
risk (≥ 30 kg/m2) with increasing levels of steps/day.116  A measurable decrease in BMI of 1.4 kg/m2  
was observed with every 5 000 steps achieved (p = 0.035). Thus, women who achieved ≥ 12 500 
steps/day, ≥ 10 000 steps/day and ≥ 7 500 steps/day were 62%, 52% and 35%, respectively, less likely 
to be obese compared to women who managed < 5000 steps/day.  
 
Study results reported by Gradidge et al.14 include those from the Bt20 cohort and represent the largest 






between PA and fasting serum insulin (p < 0.05). Unlike the results from the THUSA study46 and 
DHDSS surveys,116,117 none of the obesity (BMI, total FM and %BF) and central obesity measures 
(WC and WHR) were statistically significantly related to PA (p > 0.05). On the contrary, age was 
positively associated with obesity measures (total FM and WC) and other cardiometabolic disease 
risk outcomes (SBP, DBP, FPG, TC, LDL-C, TG, SBP and DBP) (p < 0.05). The credibility of these 
results is quite substantial as the researchers included a large sample size, used DXA-derived 
adiposity measures and descriptive PA data (domains) from the GPAQ. Concerns in their use of 
subjective PA time was acknowledged by Gradidge et al.14 as the authors noted a tendency of PA 
time to be overestimated. 
 
The associations reported by Dickie et al.92 using objective PA time (i.e. accelerometry) and DXA-
derived adiposity measures also among urban women prove useful in eliminating subjective bias, 
albeit in a much smaller study than that of Gradidge et al.14 It also enabled the researchers to examine 
the associations between different PA intensities and cardiometabolic disease risk outcomes (BMI, 
WC, WHR, BP, serum lipid concentrations, FPG, fasting insulin serum and HOMA-IR). The only 
statistically significant inverse association was between LPA and trunk FM (r = -0.25, p < 0.05), 
whereas all the associations between MVPA and the cardiometabolic risk outcomes were not 
statistically significant (p > 0.05). Although PA was objectively measured, the study is limited by a 
small sample and the use of pre-determined accelerometer cut-points.89 The latter prohibits 
comparisons with other SA studies10,13,125 included in Table 1.1 which used different cut-points.90,91 
 
Overall, the summarised findings of these studies and surveys confirm the association between PA 
and obesity as a recognised intermediate risk factor for CVD and T2DM in rural and urban “Black 
(African)” SA adult women10,14,46,92,116,117 To my knowledge,  there are no studies that have 
determined whether the same associations exist among urban “Coloured”  women.  Given the national 
survey data34,35 that pointed to  “Coloured” women as the most inactive and severely obese of  all 
women (racial) sub-groups in SA, it is important to investigate their cardiometabolic risk profiles in 
relation to their engagement in PA. It also remains to be seen whether those who meet PA public 
health recommendations (i.e. sufficiently active) are indeed less likely to be overweight or obese, and 
present with a more favourable cardiometabolic disease risk profile compared to those who are 







Given this background, it is in my view important to profile the PA levels and cardiometabolic disease 
risk factors for CVD and T2DM in a sub-population group in South Africa which are clearly 
understudied, as it cannot be assumed that “Coloured” women present with the same characteristics 
as reported among other SA subgroups.    
 
1.4.8 Associations between sedentary behaviour and cardiometabolic disease risk for 
cardiovascular disease and type 2 diabetes mellitus among adult women from other countries 
and South Africa 
 
Results from both high-income131,132 and low to middle-income133,134 countries consistently report 
inverse associations between self-report sedentary behaviour and cardiometabolic disease risk 
factors. Particularly, it was found that BMI is significantly higher among individuals who report 
higher levels of sitting time.131,132,133,134 However, studies with equally sized samples using 
objectively measured sedentary time, as opposed to subjective data, do not necessarily report the same 
inverse associations.135,136 The equivocal findings could be attributed to the use of different 
accelerometer devices, different cut-points and thus, the greater likelihood of the misclassification of 
sedentary vs. PA time. Furthermore, the additional limitations in using proxy measures of obesity and 
central obesity, as opposed to absolute %BF and regional body fat distribution measures (e.g. CFM 
and VAT), must also be taken into account.   
 
Using both subjective and objective sedentary behaviour data captured from the ProActive cohort 
study among adults aged between 30 to 50 yrs and over a 6-year follow-up period showed that 
sedentary time were significantly inversely associated with cardiometabolic disease risk.137 Most 
notably, more sedentary time (min/day) was associated with larger increases in clustered 
cardiometabolic risk score (CCMRS: β = 0.08 [95% CI: 0.01, 0.15]); with CCMRS when WC was 
removed (i.e. CCMRS no central adiposity: β = 0.08 [95% CI: 0.01, 0.16]) and with; TG (β = 0.15 
[95% CI: 0.01, 0.29]). These associations were independent of baseline sedentary and MVPA times, 
change in MVPA time and other confounding variables. On the other hand, greater increases in 
objectively measured MVPA time (min/day) were associated with larger decreases in WC (β = -3.86 
[95% CI: -7.58, -0.14]) and independent of baseline MVPA and sedentary times, change in sedentary 







Published SA evidence investigating the association between sedentary behaviour, whether self-
report sitting time, pedometry or accelerometer-derived time are sparse. Results 10,14,92,116,117,125 are 






Table 1.2 Summary of SA studies investigating sedentary behaviour and its association with intermediate cardiometabolic disease risk factors for CVD 
and T2DM in women from different settings and racial categories.    
 
Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Race 
categories  
SA Province  
(urban/rural)  






Cook et al.,  
2008116 
Cross-sectional  




n = 151 






(sedentarism defined:              
< 5 000 steps/day)  
BMI, WC and 
adiposity (SSF)  
  
13.2% (n = 151) of the women were 
classified as sedentary  
 
Did not examine any associations 
but did show ambulation 
decreased the risk of obesity, 
while motor vehicle access was 
associated with increased 
adiposity levels  





n = 138 
(2003/2004) 






min/day in different 
intensity bands. Swartz 




SBP and DBP 
Mean (95% CI): 797 min/day (780; 
814) or 13.8 hr/day  
 
Did not examine the association 
between sedentary time and any 
of the cardiometabolic disease 
risk factors 
 














Sedentary defined:       
< 5 000 steps/day)   
BMI and WC  10.9% (n = 56) of the women were 
classified as sedentary  
 
After adjusting for differences in 
age, sex,  pedometry output, 
village and season, the risk of 
obesity was more than twofold 
higher for those in the sedentary 
to low activity zones (5 000 – 7 
499 steps/day)  compared with 
those in  the active (7 500 – 9 999 
steps/day) and  the very active ( 











Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Race 
categories 
SA Province  
(urban/rural)  


















(Sitting time, min/week)  
 
Subjective: Household 





BMI, WC, WHR, 
%BF, FM, 
FFSTM  (DXA), 
TC, LDL-C, 








67% were classified as active 
according to GPAQ MVPA-criteria;  
median (IQR) sitting time of the 
urban women: 1260 min/week 
(840-2100) or equivalent to ±21 
hrs/week or ±3 hrs/day 
 
33% were classified as inactive 
according to GPAQ MVPA-criteria;  
median (IQR) sitting time of the 
urban women: 1260 min/week 
(630-1680) or equivalent to ±21 
hrs/week or ±3 hrs/day 
 
No significant difference in time 
spent sedentary between active vs. 
inactive groups (p > 0.05) 
 
Positive associations reported 
between: 
Sitting time and TG (age 
adjusted) 
(β = 0.12, p < 0.001) 
 
Sitting time and DBP (age & WC 
adjusted) 




















Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Race 
categories 
SA Province  
(urban/rural)  






Dickie et al.,  
201692 
Cross-sectional  
n = 76  








Sedentary time)  
(Freedson cut-point: 
< 100 counts/min)89 
 
 
BMI, WC,  
%BF (DXA), 
VAT and SAT 
(CT), TC, LDL-C, 
HDL-C, TG, 
FPG, fasting 
serum insulin and 
HOMA-IR 
 
Majority of awake-time (59.4%) 
was spent in sedentary behaviour 
(~8.5 hr/day)   
 
Positive associations between:  
 
Sedentary time and TG   
(r = 0.36, p = 0.01);     
 
Sedentary time and TG:HDL-C   
(r = 0.34, p = 0.04). 
 
Both correlations were 
independent of fat mass (kg) 
   




n = 191 










sedentary time)  
(Troiano cut-point: 







BMI  Median (CI) sedentary time of the 
young urban women: 575 min/day 
(568; 597) or equivalent of  
~9.5hr/day  
Did not examine association 
between sedentary behaviour 
























1.4.8.1 Summarised findings of Table 1.2 and concluding remarks  
 
Overall, the summarised findings of these SA cross-sectional studies indicate the beneficial and 
statistically significant associations between sedentary time (subjective and objective) and recognised 
cardiometabolic disease risk factors for CVD and T2DM.14,92,117 For example, rural “Black (African)” 
women who accumulated < 7 499 steps/day had twice the risk for obesity compared to their more 
active rural counterparts (≥ 7 500 steps/day). 117 Among  two separate samples of urban “Black 
(African)” women14,92 high levels of sitting time were associated with raised TG serum 
concentrations14,92 and SBP.14  These associations remained after adjusting for covariates related to 
age and WC,14 and total fat mass.92  
 
Despite the steady increase and availability of sedentary behaviour data in South Africa, the lack of 
a standardised measurement instrument or approach proves to be the current research challenge. 
Gradidge126 proposes that future studies use standardised instruments to investigate the different 
domains of sedentary behaviour.  The reported difference in PA level among urban and rural groups, 
which suggest the possibility of differences in time spent sedentary, also requires thorough 
investigation. Thus, there is scope for studies on women from different residential settings beyond 
the larger metropolitan areas and from all population (racial) sub-groups. Such results will not only 
contribute to the larger picture of sedentary behaviour in South Africa, but also provide valuable 
information on how and where our efforts to combat sedentary behaviour must be concentrated.   
 
1.5 Physical health-related fitness  
 
The section below introduces the definitions pertaining to physical fitness, and in particular health-
related fitness and its components of interest (e.g. body composition, muscular strength and CRF). 
Evidence in support of the health-related benefits among women with higher CRF level and muscular 
strength are presented, as well as those independent of obesity according to the “fat-but-fit” 
paradox.144 Following which methods used to measure each of these components are presented; 
concluding with a summarised table of SA studies (Table 1.3) in which physical health-related fitness 
components were measured among adult women. Notably, only one study reported the association 







1.5.1 Physical health-related fitness: definitions 
 
As described by Pate et al.78 physical fitness relates to a set of attributes that individuals either have, 
or look to achieve, to be categorised as “physically fit”, i.e. “the ability to carry out daily tasks with 
vigour and alertness, without undue fatigue and with ample energy to enjoy leisure-time pursuits and 
to meet unforeseen emergencies”.78 However, as stated by Pate et al.78 the subjective and emotional 
constructs which form part of the overarching physical fitness definition are not easily measurable 
(e.g. vigour and fatigue). In comparison: i) health-related fitness components and ii) skill-related 
fitness components (Figure 1.14) can be objectively measured.  
                      
 
Figure 1.14 The main components of physical fitness, namely health-related and skill-related 
fitness. 62 
 
This dissertation focusses on three measurable components of physical health-related fitness, namely: 























to describe health risk conditions, such as obesity and sarcopnia. Whereas those related to the 
selection for CRF and muscular strength stem from evidence in support of the numerous health-
related benefits associated with regular participation in PA; and specifically common  activities within  
the SA context. Such as occupations associated with manual labour, as well as walking for transport, 
while carrying items, on a daily basis. All of which underpin the components of both CRF and 
muscular strength. In addition, knowledge of muscular strength would also prove advantageous, as 
maintenance or improvement thereof has been shown to  counter the adverse effects associated with 
sarcopenia. It too has an effect on energy expenditure, given the positive relationship between higher 
skeletal muscle mass and a higher resting metabolic rate. Thus, attaining novel baseline data  relative 
to the wide range in age of women tested would aid in identifying possible physical health-related 
components where intervention may impact positive changes in their overall health status.   
  
1.5.1.1 Body composition 
 
Using the basic two-compartment model of body composition, body mass (kg) can be divided into: 
fat-free mass (FFM) and fat mass (FM).79 Fat-free soft tissue mass (FFSTM) forms part of FFM, 
while adipose tissue (or body fat [BF]) is part of FM. All of which can also be expressed relative to 
total body mass (i.e. %FFM, %FFSTM and %BF). 
As a component of health-related fitness, recognition of changes associated with each of these 
compartments are vitally important. Thus, obesity, and in particular central adiposity, as previously 
discussed, is recognised as an intermediate cardiometabolic risk factor for CVD and T2DM. 
Sarcopenia, which refers to the generalised loss of skeletal muscle mass,80 is a sub-compartment of 
FFSTM and is associated with an increased risk for disability and mortality.81 However, an added 
adverse effect of a reduction in FFSTM relates in part to the lowering of daily resting metabolic rate 
(RMR) and total energy expenditure (TEE).82 These, in turn, have been shown to affect body weight 
management, and most notably, weight gain.82 
 
1.5.1.2 Muscular strength  
 
Muscular strength refers to the external force that is either generated by a specific muscle or group of 






focus drawn to maintaining or improving muscular strength can potentially counter the adverse effects 
associated with sarcopenia and the maintenance of, or increase in RMR.84 
 
1.5.1.3 Cardiorespiratory fitness 
 
“The ability to perform large muscle, dynamic, as well as moderate to vigorous-intensity exercise for 
prolonged periods of time,” provides a broad description of CRF.83 Furthermore, it describes the 
ability to perform exercise at higher levels of physical exertion and the integration of numerous 
physiological systems working in unison (i.e. cardiovascular, respiratory, neurological and 
musculoskeletal system, respectively).  Thus, CRF is considered a reflection of total body health85 
and/or physical wellness. 
 
1.5.2 Physical health-related fitness benefits among adult women 
 
Based on an already extensive and still growing body of scientific evidence it is clear that adult 
women with higher levels of CRF have significantly lower all-cause mortality risk, especially 
CVD.140,141 Noticeably, higher CRF levels are also associated with higher habitual PA.83 It is 
important to highlight that PA differs to CRF, as described by Carthenon et al.168 Physical activity is 
described as a behaviour (lifestyle choice), whereas CRF is a physiological measure that reflects a 
combination of PA behaviours, genetic potential and functional health of several organ systems. 168 
Researchers estimate that 40–50% of the variance in CRF is genetically determined (i.e. heritable 
factors),142 whereas improvements in CRF level in response to PA or exercise (i.e. trainability) 
accounts for the remaining proportion (i.e. 45–50%).143 Given this, improvement of CRF level as a 
component of physical health-related fitness maybe considered a beneficial and significant 
influencing factor which attenuates the adverse effects of obesity on cardiometabolic disease risk for 
CVD and T2DM. To this end, the “fat-but-fit” paradox144 and subsequent evidence 21,145 suggest that 
a moderate-high CRF level may in part, counteract the negative consequences associated with obesity. 
In other words, individuals who are obese according to BMI (≥ 30kg/m2) and/or %BF (≥ 30%), but  







1.5.3 Physical health-related fitness: measurement methodologies  
 
1.5.3.1 Body composition 
 
Although the use of BMI, WC and Waist:Hip are cost- and time-effective measurements, they have  
limitations.93,94 The use of scanning equipment, such as dual energy x-ray absorptiometry (DXA), 
allows for whole body composition measurement and includes the use of the basic two-compartment 
model, to determine FFSTM and FM (kg). FFSTM is defined as total body mass minus FM. 
Furthermore, the sophisticated and technical measurement allows for regional body fat distribution 
to be measured, e.g. central fat mass (CFM), appendicular fat mass (AFM) and trunk fat mass (TFM) 
(defined as CFM minus the head).95 However, as with other techniques used to quantify body 
composition, its use is limited in lieu of exposure to low-dose radiation, cost, scanning area, and the 
requirement of a highly trained professional (e.g. radiologist). Nevertheless, advances have been 
made to adjust for those whose body proportions exceed the DXA scanning area,96 as well as the 
measurement of total VAT area97 as an indicator of central adiposity.    
1.5.3.2 Muscular strength 
 
A hand grip dynamometer is commonly used to determine dominant hand grip strength as a proxy 
measure of upper body strength.83 A one repetition maximum (1-RM) supine bench press exercise 
test can also be used,83 however, the risk of incurring a musculoskeletal-related injury is significantly 
higher and requires technical assistance from a trained exercise specialist. Thus, the hand grip test 
remains a convenient field test when testing large groups of individuals who are not familiar with 1-
RM testing. The use of hand grip strength testing using a dynamometer among adult community-
dwellers has been shown to have adequate test-retest reliability (r = 0.981) and reasonable validity (r 
= 0.798).170 Furthermore, results from numerous studies 171, 172 recommend its clinical usage as a 
means to stratify an individual’s risk of all-cause mortality,171 as well as cardiometabolic disease 
specific causes (e.g. CVD171 and T2DM172).  
 
1.5.3.3 Cardiorespiratory fitness 
 
Maximal volume of oxygen (O2) uptake per unit of time (VO2max) or maximal aerobic capacity, is 
accepted as the criterion measure of CRF.83 This physiological variable is generally expressed in 






individuals with differing body masses. Use of indirect calorimetry such as a metabolic cart system 
(e.g. COSMED Quark CPET®), allows for various metabolic variables (i.e. cardiopulmonary 
response) to be measured continuously while exercising to volitional exhaustion. Although the 
equipment and need of a highly-trained exercise physiologist associated with the use of the criterion 
measure is costly, its use eliminates the limitations associated with indirect measurement techniques 
(e.g. graded sub-maximal step-test).98  
 
Data by Hall-López et al.173 indicate an acceptable test-retest reliability (r = 0.907) among apparently 
healthy adults tested on two separate occasions (i.e. exercising to exhaustion on a treadmill). 
Furthermore, results from a large meta-analysis173 confirm the inverse and strong relationships 
between high CRF levels and all-cause mortality among apparently healthy adult women. More 
importantly, the results also indicate that an increase in CRF (i.e. VO2max) to the value of 1 MET, 
which equates to 3.5 mL of O2 per kilogram per minute, is associated with an approximate 10-20% 
reduction in all-cause mortality. 
 
1.5.4 Physical health-related fitness measurements among SA women  
 
Evidence  suggest that body composition vary not only with age and sex, but also with race.138 As 
previously described, the prevalence of severe obesity among “Coloured” and “Black (African)” 
women is of greatest concern (Figure 1.6 and 1.7).35 Of equal concern is the emerging evidence of 
the prevalence of sarcopenia and its associated risk with low levels of PAEE as recently reported by 
Kruger et al.139 among urban and rural “Black (African)” women from the North West Province in 
South Africa. On examination, the DXA-derived body composition data indicated high levels of 
adiposity (%BF) (mean ± SD: 39.6 ± 8.7%) even among those who were diagnosed with sarcopenia 
(%BF: 30.4 ± 5.5%) and among women with low levels of lean body mass (mean age: 57 yrs) (n = 
220).  
 
There is a scarcity of SA data on muscular strength and CRF levels among adult women. The studies 
summarised in Table 1.3 indicate both the measurements and methods used. To my knowledge, only 
one small-scale study92 reported significant associations between high CRF level and reduced central 
adiposity (TFM and VAT) and insulin resistance (i.e. HOMA-IR) among urban “Black” obese 






Table 1.3 Summary of SA studies investigating components of physical health-related fitness with intermediate cardiometabolic disease risk factors for 
CVD and T2DM in women from different settings and racial categories.    
 
Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  










Terblanche et al., 
2005146 
Intervention study  
(n = 26) 
 
(Training group, 




n = 13) 
 
18 to 23  Unknown  Western Cape Estimated VO2max 
measured using a 20-
metre shuttle test 
protocol (before and 
after 6-weeks training 
intervention) 
  
BMI and %BF 
(SSF: 7 skinfolds) 
After 6-weeks of backward 
walk/run training, the trained group 
showed significant decreases in 
%BF (2.4%), skinfold thickness 
(19.7%) (p < 0.01) and a significant 
increase in VO2max (5.2%) 
 
 
Did not examine  associations 
between estimated VO2max and 
BMI, WC or SSF 
  
 





n = 138 
(2003/2004) 











SBP and DBP 
Mean predicted VO2max:  
26.7 mL·kg−1·min−1 
(95% CI: 25.6 to 27.7) 
 
Did not examine associations 
between estimated VO2max and 




















Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  















n = 1 524 
 









(* – too few 
observations to 
record 
reliability)   
All SA provinces 
except the Northern 
Cape*   
 
 
(* – too few observations to 
record reliability)   
Estimated VO2max  
(submaximal 3-minute 
step-test based on the 
Canadian 
Public Health 
Association Project148  
 
BMI, WC, WHR, 
SBP, DBP, TC, 
LDL-C, HDL-C, 
TG and HbA1c 
Total group:  
42% fit, 13% average, 45% unfit  
 
18 to 24 yrs:  
38% fit, 12% average, 50% unfit  
 
 25 to 29 yrs:  
46% fit, 11% average, 43% unfit  
 
30 to 40 yrs:  
45% fit, 15% average, 40% unfit  
 
Race sub-groups:                              
“Black (African)” women –                  
43% fit, 14% average, 43 unfit 
 
“Coloured” women –  
30% fit, 8% average, 62% unfit 
  
Did not examine  associations 
between estimated VO2max and 





















Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  










Dickie et al.,  
201692 
Cross-sectional  







Estimated VO2max  
(submaximal MRC 
step-test, Cambridge, 
United Kingdom149:  
 
BMI, WC,  
DXA-derived 
%BF, CT-derived 




serum insulin and 
HOMA-IR 
 
Median predicted VO2max:  
25.1 mL·kg−1·min−1 
(IQR: 22.8 to 28.4) 
 
Inverse associations between: 
 
Estimated VO2max and DXA-
derived %BF  
(r = -0.34, p = 0.02) 
 
VO2max and trunk FM  
(r = -0.31, p = 0.03) 
 
VO2max and VAT  
(r = -0.47, p < 0.01) 
 
VO2max and HOMA-IR 
(r = -0.41, p = 0.01)  
(remained significant after 
adjusting for differences in body 
fat [kg], but not with VAT. 
 






[PURE] study)  
n = 247 
57 “Black 
(African)” 
North West  




Hand grip strength (kg)  BMI and DXA-
derived %BF 
Mean ± SD: 20.4 ± 6.7 kg  
 
Did not examine  associations 
between hand grip strength and 
















Reference  Study design 
(name of 
study/survey) (n)  
 
Age in yrs 
(range/mean)   
Racial 
categories 
SA Province  
(urban/rural)  














n = 191 
















BMI  BMI: 23.9 kg/m2  
According to BMI category: 12% = 
underweight; 53% = normal weight; 
12% = overweight; 9% = obese 
Mean predicted VO2max:  
32.6  mL·kg−1·min−1 
(95% CI: 31.9 to 33.2) 
 
Estimated VO2max was higher in 
underweight compared to 
overweight and obese women  
(p < 0.0001)  
 
Did not examine any associations 
between estimated VO2max and 
BMI 
 
Goedecke et al., 
2018151 
Intervention study  
(n = 45) 
 
(Exercise group, 
n = 23) 
 
(Control group,  
n = 22) 
 
20 to 35  “Black 
(African)”  
Western Cape  
(urban) 
Estimated VO2peak 
measured using a 
graded exercise 




and after 12-weeks ) 
  
BMI, WC, WHR,   
DXA-derived 
%BF, VAT and 




Baseline VO2peak : 
Exercise group: 24.9 ± 2.9 
mL·kg−1·min−1 vs.  
Control group: 23.9 ± 3.0 
mL·kg−1·min−1 
 
Did not examine any associations 
between estimated VO2peak and 














1.5.4.1 Summarised findings of Table 1.3  
 
In summary, the data extracted from the SANHANES-1 (2012)34 indicates the higher prevalence of 
unfit adult women (45%) compared to those deemed to be fit (42%). Although the use of the 
submaximal step test to estimate CRF level may be seen as a limitation, the survey provides valuable 
data on CRF ratings (i.e. fit vs. unfit) across the four age categories, and indicates the need for 
interventions aimed at increasing CRF level among women aged 20 – 40 yrs. In support of this, are 
the statistically significant inverse associations between CRF level and DXA-derived adiposity 
measures (%BF, trunk FM and VAT) as reported by Dickie et al.92 Such findings highlight the 
potential health benefits associated with higher CRF levels.   
 
Only one study150 reported muscular strength obtained from hand grip strength testing. In comparison 
to the American College of Sport Medicine’s age-specific muscular strength categories for women, 
the group mean of 20.4 ± 6.7 kg falls between the 25th and 30th percentiles for women aged 50 – 57 
yrs, and thus is rated as “poor”.  
 
Given the paucity of physical health-related fitness data on SA women, there is a need for future 
studies and national surveys to include such measures. The results of which may assist in the design 
of context-specific lifestyle interventions aimed specifically at women who are obese, sarcopenic, or 
both, as well as unfit and with low levels of muscular strength.          
 
1.6 Conclusion  
 
In conclusion, it is in my view worthwhile to further explore the prevalence and risk for obesity, 
sarcopenia, and moreover, sarcopenic obesity among SA women. If, at the same time, one can 
objectively measure whole body and central adiposity, muscular strength and CRF levels, time spent 
physically active and sedentary, it would provide valuable information on numerous known 
cardiometabolic disease risk factors and the inter-relationships between these factors. Furthermore, it 
is imperative that we obtain a comprehensive view of the health states of women in SA, as they are 






1.7 Doctoral dissertation overview 
 
1.7.1 Research gap and location of interest 
 
Evaluation of the SA National Demographic and Health survey and examination statistics captured 
since 1998 indicate a significant and steady rise in the prevalence of cardiometabolic disease risk 
associated with CVD and diabetes mellitus among adults.35,44,152 Of major concern is the higher 
prevalence of BMI-defined obesity (≥ 30.0 – 34.9 kg/m2) and moreover, the increasing prevalence of 
severe BMI-defined obesity (≥ 35.0 kg/m2) among women 15 years and older. In accordance with 
more recent national health data, one in every five women are severely obese. Thus, a considerable   
difference exists between women and their male counterparts (20.0% vs. 3.0%, respectively). Overall, 
these statistics underscore women’s potentially higher-risk for CVD and T2DM.   
 
Given the review of SA literature, existing cardiometabolic disease risk data only reflects that of 
urban women living in Cape Town (Western Cape Province). The latter is currently considered the 
second highest population dense metropolitan urban area to that of Johannesburg (Gauteng Province) 











An important factor  is the higher number of  public and private health service facillities in  these 
larger metropolitan urban areas,  compared to those  in surrounding non-metropolitan urban areas. 
Thus, the town of Stellenbosch, and in particular one of its neighbouring residential suburbs, namely 




Figure 1.20 Location of interest: Cloetesville - considered an urban residential suburb neighbouring 
the town of Stellenbosch (Western Cape, South Africa).154  
 
Cloetesville is largely considered a traditional “Coloured” residential area or “township”, which under 
the Apartheid system was used to describe an under-developed urban residential area reserved for 
those who were considered racially non-white.155 To date, Cloetesville’s population approximates 
15 390, of which 81.8% (n = 12 589) are categorised as “Coloured” (women vs. men: 52.6% vs. 
47.4%).156 With only one district public health community clinic and a few privately registered health-
care practitioners, the suburb provides a suitable urban setting for this cross-sectional descriptive 
study.        
 
1.7.2 Problem statement 
 
In response to the SA National Department of Health’s call to action, there is a need to investigate 
key determinants of obesity in specific communities, over and above those already outlined in the 
Strategy for the Prevention and Management of Obesity (2015 – 2020) national policy document.8 
Rapid urbanisation, the lack of quality education and a safe and accessible environment, have been 
identified as contributing factors to the overwhelming prevalence of obesity. Given South Africa’s 






related risk profiles for CVD and T2DM among urban SA women,52,157,158,159 studies investigating 
those from other low socio-economic and under-resourced residential settings, using accurate and 
reliable methods, are required. Additionally, it is important to investigate to what extent 
behavioural/lifestyle risk factors, such as physical inactivity and sedentarism, as well as poor health-
related fitness levels, predict cardiometabolic disease risk outcomes associated with CVD and T2DM 
in the said community.      
 
1.7.3 Potential benefits of the study 
 
A comprehensive and detailed investigation will allow the characterisation of cardiometabolic disease 
risk profiles for CVD and T2DM, including the prevalence of obesity and central adiposity of the 
selected study population. The strength of this study is the use of sophisticated and high-precision 
measurements, including objectively-derived PA variables, sedentary time and physical health-
related fitness measures. This broad examination also allows for the exploration of the association 
between behavioural/lifestyle entities and components of physical health-related fitness, with 
cardiometabolic disease risk in urban-dwelling SA women. All of which is critically important, in 
order to develop context-specific community-based lifestyle interventions, especially in under-
resourced residential areas, aimed at managing and reducing the burden of NCDs.   
 
1.7.4 Primary and secondary aims of the study 
 
The primary aim of this study is to characterise behavioural/lifestyle entities, namely PA levels (time 
and intensities), sedentary behaviour (time) and physical health-related fitness (CRF level and 
muscular strength), using objective methodologies. Furthermore, to characterise cardiometabolic 
disease risk profiles, including the prevalence of obesity and central adiposity, among a sample of 
apparently healthy  women (aged: 18 – 64 yrs) living in Cloetesville,  a low socio-economic and 
under-resourced urban residential area near Stellenbosch (Western Cape, South Africa). 
 
Secondary aims of the study include: i) the use of subjective measurement tools to characterise 
patterns of PA and types of sedentary behaviour; and ii) the investigation of the associations between 
PA time, sedentary time, and health-related fitness components (e.g. CRF level and muscular 







1.7.5 Research study hypotheses 
 
1.7.5.1 Article 1 
 
Using objectively-derived MVPA time, it is hypothesised that urban women from a low-
socioeconomic community who are insufficiently active (< 30 min/day)17 are at higher risk for CVD 
and T2DM compared to those who are sufficiently active (i.e. meet the WHO 2010 Global 
Recommendations on PA for Health).17 
 
1.7.5.2 Article 2 
 
Using objectively-derived PA data, it is hypothesised that, similar to other SA women,92 high PA 
(irrespective of intensity) and CRF levels are independently associated with reduced adiposity and 
cardiometabolic disease risk outcomes for CVD and T2DM in urban-dwelling women. 
 
1.7.5.3 Article 3 
 
We hypothesise that objectively measured high sedentary time (ST), low MVPA and low measures 
of physical health-related fitness (e.g. CRF level and muscular strength), are independently associated 
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Background: Physical inactivity is associated with an increased risk for cardiometabolic diseases such 
as cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Few studies to date have 
described the levels and patterns of physical activity (PA) of urban South African (SA) women from an 
under-resourced and low socio-economic residential area. Aims: To characterise PA levels and patterns 
in urban-dwelling women and to determine if women who are sufficiently active have a more favourable 
cardiometabolic disease risk profile compared to those who are insufficiently active. Methods: Fifty-one 
apparently healthy women (42 ± 13 yrs) underwent the following measurements: PA (GPAQ and 
accelerometry), body composition and regional fat distribution (DXA), resting BP, HbA1c, fasting 
plasma glucose and lipid levels. Results: Less than a third of the women (27.4%, n = 14) met the World 
Health Organisation Global Health Recommendations for moderate to vigorous-intensity PA (MVPA).  
Although overweight, the sufficiently active sub-group had a significantly lower BMI (p = 0.01), FM (p 
= 0.02), AFM (p = 0.01) and hip circumference (p = 0.001), compared to their obese and insufficiently 
active counterparts. Although no statistically significant group differences were found for any of the 
cardiometabolic disease risk outcomes (p > 0.05), clinically significant differences were observed for 
DBP, LDL-C, Lp (a) and FPG. Conclusion: Although overweight, women who accumulated ≥ 30-min 
of MVPA per day presented with more favourable body composition and regional body fat measures, 
compared to those who did not. The cardiometabolic disease risk among the sufficiently active women 
was meaningfully lower than those deemed insufficiently active. In an attempt to combat cardiometabolic 
disease risk for CVD and T2DM among urban and low socio-economic community dwelling women, 
public health interventions should target domains in which women are already physically active, such as 
walking briskly for travel- and/or occupational-related activities. Furthermore, public awareness of the 
health-enhancing benefits associated with meeting MVPA recommendations must be intensified. 
 









Evidence from longitudinal cohort studies conducted in high-income countries [1, 2] highlight the 
positive association between physical activity (PA) and reduced risk for non-communicable disease 
(NCD). Consequently, the World Health Organisation (WHO), the Centers for Disease Control and 
Prevention (CDC), the American College of Sports Medicine (ACSM) and the American Heart 
Association (AHA) established and advocate PA guidelines in an attempt to reduce overall NCD risk [3–
5]. According to the most recent document, the WHO 2010 Global Recommendations on Physical 
Activity for Health [5], adults between 18 – 64 yrs are required to accumulate ≥ 75 min/week of vigorous-
intensity PA; or ≥ 150 min/week of moderate-intensity PA; or an equivalent weekly combination of 
moderate to vigorous-intensity physical activity (MVPA) to be considered sufficiently active. Thus, the 
quantification and accuracy of PA data is crucially important in studies investigating its association with 
cardiometabolic disease risk outcomes for cardiovascular disease (CVD) and/or type 2 diabetes mellitus 
(T2DM). 
 
Presently, a multitude of PA methodologies exist and while the use of subjective instruments (e.g. 
questionnaires and activity logs) are cheaper and easier to administer, the data lacks consistency when 
compared with data obtained from objective instruments (e.g. accelerometers and pedometers). Given 
the variability in methodological effectiveness [6], opportunities to examine both PA levels and patterns 
(i.e. time, intensity, and domain) using both instrumentation types, allow for an in-depth understanding 
of population sub-groups (e.g. obese individuals) [7]. The Global PA Questionnaire (GPAQ), which 
forms part of the WHO Stepwise approach to chronic disease risk factor surveillance (STEPS), includes 
work-, travel- and leisure-specified PA domains. Given its validity in a South African (SA) setting [8], 
results from the last comprehensive national demographic survey (2003) revealed that 86% of adult 
women (88% urban vs. 83% rural) are insufficiently active (< 3000 MET-min/week) [9]. Even though 
total PA time among the urban sub-group was insufficient for health-enhancing benefits, leisure-domain 
PA time (54%) was proportionally higher compared to work- (18%) and travel-domain PA time (28%) 
[9]. 
 
The predominance of insufficient PA levels among SA adult women is concerning, however, the steady 







cardiometabolic disease over the same period of time among adult women (CVD: 5–30% and diabetes 
mellitus: 4–8%) is even more alarming [9,10]. One in five SA adult women are categorised as severely 
obese, with higher proportions among urban vs. rural adult women (22.3% vs. 17.0%, respectively) [10]. 
 
Evidence from large women cohort studies consistently show an inverse relationship between PA and 
cardiometabolic disease risk [1, 2, 11]. Notably, the Objective Physical Activity and Cardiovascular 
Health  study (OPACH) report that accelerometer-derived PA time is positively associated with reduced 
cardiometabolic disease risk among a diverse ethnic group of adult women (i.e. “White”, “Black” and 
“Hispanic”) [11]. In line with this finding are those from a small-scale SA cross-sectional study in which 
higher levels of accelerometer-derived PA time was shown to associate with reduced cardiometabolic 
disease risk, although limited to only urban “Black (African)” women [12]. Moreover, the national survey 
results highlighted that “Coloured” women (92%) are the most insufficiently active among all racial sub-
categories (“White” 89%, urban “Black (African)” 88%, “Indian” 83% and rural “Black (African)” 82%) 
[9]. Thus, the need to profile PA and cardiometabolic disease risk, especially among women from other 
low socio-economic urban settings who are already obese and prediabetic, is warranted [13]. 
 
Therefore, the aim of this study was two-fold: (i) to characterise PA levels and patterns in  women from 
an under-developed urban residential setting; and (ii) to determine whether those who are sufficiently 
active have a more favourable cardiometabolic disease risk profile compared to those who are 
insufficiently active. We hypothesised that urban and low socio-economic dwelling women who are 
insufficiently active are at higher risk for CVD and T2DM compared to those who meet the WHO Global 
Health Recommendations for MVPA [5].  
 
2.3 Materials and methods 
 
2.3.1 Location of interest   
 
Located on the outskirts of Cape Town is the town of Stellenbosch, which neighbours the urban suburb 
of Cloetesville. According to the Bureau for Economic Research [14], Cloetesville is classified as a low 







highest  level  of  education  and  access  to  basic  services. Furthermore, its population approximates   
15 390 of which 31% are women (≥ 20 yrs) [15]. 
 
2.3.2 Study participants 
 
A convenience sample of 73 apparently healthy women volunteered to participate in this cross-sectional 
study. Women were recruited from local church groups, the public health clinic and community centre, 
and via “word of mouth” (Figure 2.1).  
 
An Afrikaans-speaking health champion, living in Cloetesville, assisted with the participant recruitment. 
Participants were included if they were: i) 18–64 yrs old; ii) had no known diseases and were not taking 
medications for T2DM, human immunodeficiency virus (HIV) or acquired immune deficiency 
syndrome, or any other metabolic diseases; iii) not pregnant or lactating; and iv) had any known 
musculoskeletal problems that prevented them from being physically active. Rapid HIV screening tests 
were not performed, however, women were asked if they were receiving treatment for HIV. Study 
procedures and potential risks were explained to each participant in their preferred language (Afrikaans 
or English) following which written informed consent was received. Approval of the study was granted 
































































n = 73 women living in Cloetesville were recruited via "word of mouth" 
 
12 women were excluded during pre-screening: 
 Pregnancy (n = 1) 
 Angina (n = 1 ) 
 Using prescribed medication for T2DM (n = 10) 
n = 14 sufficiently active women and n = 37 insufficiently active women 
10 participants’ entire data sets were excluded from the final analysis 
due to invalid accelerometer-derived PA data  
  
n = 61 women were inducted into the cross-sectional study 
n = 51 women included in the final analysis 
 
The following data points were missing in the final analysis:  
 
Sufficiently active sub-group 
 Systolic blood pressure and diastolic blood pressure (n = 1) 
 Body composition and regional body fat distribution measures 
(n = 1)  
 
Insufficiently active sub-group  
 Systolic blood pressure and diastolic blood pressure (n = 2) 
 Fasting plasma glucose (n = 1) 
  
 
According to the WHO Global PA Health Recommendations [5], 
women who accumulated an average of 30-min of MVPA per day 
were considered sufficiently active, whereas those who did not were 










2.3.3 Physical activity 
 
PA was measured for 7 consecutive days using the triaxial ActiGraph GT3X accelerometer (ActiGraph 
LLC, Pensacola, Florida). Recording began on the first day of testing, 2-hours after the monitor was 
received, and was completed when returned 8-days later. Participants were instructed to wear the 
accelerometer on their right hip, attached by an elastic belt during waking hours. As the monitors were 
not waterproof, the women were asked to remove the belt while bathing, showering or swimming. The 
time sampling interval was set at 60-sec epochs. The original ActiGraph data files (*.agd) were 
downloaded onto a personalised computer and processed using Microsoft® Excel using a custom-written 
program (‘ACTILIFE’, http://actigraphcorp.com/products-showcase/software/actilife/). Data from 
participants were included if they met the minimum requirement of ≥ 600-min of monitor wear time on 
≥ 3-days of the week) [16]. Wear time was determined by subtracting non-wear time from 24-hours, 
where non-wear time was defined as an interval of ≥ 60 consecutive min with zero activity counts 
allowing for intervals of 1 to 2-min of relatively low activity counts per minute (counts/min) (i.e. < 100) 
[16]. Ten participants were excluded from the whole group analysis due to invalid accelerometer data. 
Sedentary time was defined as < 100 counts/min, whereas total PA time (≥ 100 counts/min) was divided 
into light-intensity PA (LPA) (100–1,951 counts/min) and MVPA (≥ 1,952 counts/min) [17]. In 
accordance with the WHO 2010 Global Recommendations on Physical Activity for Health [5], women 
who accumulated an average of 30-min of MVPA per day were considered sufficiently active, whereas 
those who did not were grouped as insufficiently active. The GPAQ provided descriptive PA data 
(min/week) according to the work-, travel- and leisure-domains [18]. One participant was excluded from 
this data set due to invalid data. 
 
2.3.4 Socio-economic status and behavioural/lifestyle factors 
 
Measures of socio-economic status (SES), including level of education (completion of grade 12) and 
employment status, were recorded using the WHO STEPS instrument [19]. Participants were categorised 
as employed or unemployed, while students, homemakers and retirees were grouped together in a 
separate category. Women were categorised as either smokers or non-smokers, whereas those who 







An additional proxy measure of SES, an asset index score, was calculated and based on the 14-items 
used by Jennings et al. [20] and other researchers among urban SA women [21,22]. Ownership of items 
which are said to reflect individual and household wealth, as well as access to resources were determined. 
These included electricity in the home, ownership of a television, radio, motor vehicle, fridge, stove and 
oven, washing machine, telephone, DVD player, microwave, computer/laptop, cellular telephone and 
paid television channels. 
 
2.3.5 Body composition assessment 
 
Standing height and body mass, in lightweight clothing and without shoes, were measured using a sliding 
steel anthropometer (Seca® 711, Hamburg, Germany) and calibrated digital scale (Seca® 813, Hamburg, 
Germany), respectively. Hip circumference at the greatest protuberance of the buttocks and waist 
circumference (WC) at the level of the umbilicus, were both measured.  
 
Whole body composition, including fat-free soft tissue mass (FFSTM) and fat mass (FM), were measured 
by dual-energy x-ray absorptiometry (DXA) (Discovery-W®, software version 13.4.1, Hologic, Bedford, 
MA) according to standard procedures. The DXA scan region was 195 × 65 cm and the DXA system 
weight limit was 310 kg. Those participants whose body proportions exceeded the DXA scanning area 
(n = 11) were analysed using the arm-replacement method which replaces the data obtained for the left 
arm with the data obtained for the right arm [23]. FFSTM was defined as total body mass minus FM. 
Regional body fat distribution was characterised as central fat mass (CFM) and appendicular fat mass 
(AFM) [24]. Visceral adipose tissue (VAT) area was determined using the DXA-VAT derived 
methodology [25]. Due to a technical computer software error, one participant’s body composition data 
was reported missing.    
 
2.3.6 Cardiometabolic disease risk outcomes 
 
Blood pressure (BP) was measured after at least 5 min of seated rest, and three times in succession at 1 







Healthcare, Mannheim, Germany). An average of the last two readings were used for the analysis. Three 
data sets were incomplete due to participants’ refusal to have their BP measured more than once.       
 
Participants were asked to fast overnight for a minimum period of 8 hours. On arrival at the testing site, 
blood samples were drawn by a trained nurse. The samples were analysed by a local commercial 
pathology laboratory (PathCare, Stellenbosch, South Africa). Using enzymatic colorimetric assays, 
serum total cholesterol (TC) (intra-assay CV: 0.72%), low-density lipoprotein cholesterol (LDL-C) 
(intra-assay CV: 1.3%), high-density lipoprotein cholesterol (HDL-C) (intra-assay CV: 0.62%),  
triglyceride (TG) (intra-assay CV: 0.72%) concentrations, and fasting plasma glucose (FPG) level (intra-
assay CV: 0.54%) were measured using the Beckman AU5800 instrument (Beckman Coulter Inc., 
Fullerton, California, USA). Plasma lipoprotein (a) [Lp (a)] was measured using an IMMAGE 800 
Immunochemistry System (Beckman Coulter Inc., Fullerton, California, USA). glycated haemoglobin 
(HbA1c) was performed on a Biorad Variant™ II Turbo (Bio-Rad Laboratories, Inc., Hercules, California, 
USA) (intra-assay CV: 1.2%). Only one participant’s FPG level was missing due to an inadequate plasma 
concentration.    
 
2.3.7 Statistical analysis 
 
Data were analysed using STATISTICA version 13.3 (StatSoft Inc. Tulsa, OK, USA). Descriptive data 
are presented as means ± standard deviation (SD) or percentages. Non-gaussian distributed data 
(accelerometry, GPAQ, FPG and HbA1c) are presented as medians and interquartile range (IQR) and 
were normalised by log transformation for parametric statistical analyses. Chi-squared tests for 
independent groups were used to examine differences in categorical data (i.e. SES, behavioural/lifestyle 
factors and cardiometabolic disease risk factors and sub-categories). One-way analysis of variance 
(ANOVA) was used to compare age, asset index, body composition and regional body fat distribution 
measures between sub-groups. A two-way analysis of covariance (ANCOVA) adjusting for: i) body 
mass; and ii) fat mass (kg), was used to compare cardiometabolic disease risk measures between sub-








Additionally, Cohen’s d effect size (ES) and 90% confidence intervals (CI) were calculated to assess the 
magnitude of the differences between the sub-groups [26, 27]. A published spreadsheet was used to make 
qualitative probabilistic inferences about the “true” differences which were classified as either small, 
moderate or large clinically significant differences between sub-groups [28]. Quantitative likelihoods of 
the true differences between sub-groups were assessed as follows: 0–0.5% (most unlikely); > 0.5–5% 
(very unlikely); > 5–25% (unlikely); > 25–75%, (possibly); > 75–95% (likely); > 95–99.5% (very likely); 
> 99.5–100% (most likely) [28]. Threshold values for Cohen’s d ES were: < 0.2 (trivial), ≥ 0.2 (small), 




2.4.1 Physical activity levels and patterns 
 
Total PA time (min/week) for the whole group and sub-groups according to intensity bands (LPA and 









Table 2.1 Physical activity time measured using accelerometry for the whole group and comparison between sub-groups. 
Accelerometry 
All 












ES (90% CI) 
for the difference in log 
transformed mean values 
Magnitude-based inferences 
 
Number of activity days measured 5 (5 - 6) 6 (5 - 6) 6 (5 - 6) 0.547 -0.02 (-0.5; 0.4) trivial difference 
Non-wear time (min/day) 611 (542 - 636) 573 (542 - 612) 622 (546 - 667) 0.053 -0.63 (-1.1; -0.1) 78% (likely) moderate difference 
Wear time (min/day) 829 (801 - 898) 866 (827 - 898) 817 (772 - 893) 0.040 0.68 (0.1; 1.2) 34% (possibly) moderate difference 
Sedentary time (min/day) 475 (442 - 514) 485 (438 - 527) 470 (443 - 510) 0.813 0.08 (-0.4; 0.5) trivial difference 
Total PA time  (min/day) 365 (308 - 404) 386 (364 - 429) 345 (301 - 381) 0.171 0.44 (-0.1; 0.9)  76% (likely) moderate difference 
LPA time (min/day) 340 (282 - 374) 351 (286 - 382) 338 (279 - 370) 0.983 -0.01 (-0.5; 0.5) trivial difference 
MVPA time (min/day) 22 (12 - 30) 42 (34 - 59) 18 (8 - 23)   < 0.001* 2.07 (1.4; 2.6) 96% (very likely) large difference 
Steps per day 
 
8 232 
(6 032 - 9 871) 
 
 
11 686                    
(9 788 - 13 245) 
 
 
6 296                               
(5 375 - 8 556) 
 
< 0.001* 1.65 (1.0; 2.2) 88% (likely) large difference 
Values are medians with interquartile ranges in parenthesis (n). All values were normalised by log transformation for parametric analyses (ANOVA). P-values 
highlighted in bold indicate statistically significant differences (p < 0.05) between sub-groups (*). Sufficiently active women accumulated an average of 30-min/day of 
accelerometer-derived moderate to vigorous-intensity physical activity (MVPA). min/day, minutes per day; PA, physical activity; LPA, light-intensity physical activity; 








Using the accelerometer-derived PA data, 27.4% (n = 14) of the women were classified as sufficiently 
active [5]. The sufficiently active sub-group recorded significantly greater MVPA (median: 42 min/day 
vs. 18 min/day; ES = 2.07; p < 0.001) and accumulated more steps/day (median: 11,686 steps/day vs. 
6,296 steps/day; ES = 1.65; p < 0.001) compared to women who were insufficiently active. Moderate 
practical worthwhile differences were observed for all other accelerometer-derived variables, except 
sedentary and LPA time (trivial differences). The proportion of awake time spent sedentary and at the 





Figure 2.2 The proportion of awake time spent sedentary and at different physical activity intensities 
among the whole group and sub-groups. 
 
According to the GPAQ analysis, the majority of PA time reported by the women was work-related 
(74.2%) and performed at moderate-intensity (median: 150 min/week; IQR: 0–360 min/week) (Table 
2.2), whereas travel (20.0%) and leisure PA time (5.8%) were proportionally less. The sufficiently active 
sub-group reported significantly higher leisure PA time (median: 52 min/day vs. 0 min/day; ES = 0.73; 














































in total work (ES = 0.25; p = 0.429) and total travel (ES = 0.20; p = 0.538) PA time were observed 







Table 2.2 Domain-specific subjective physical activity time (GPAQ) for the whole group and comparison between sub-groups. 
Physical activity time 
All 













ES (90% CI) for 








Total vigorous (min/week) 0 (0 - 0) 0 (0 - 0) 0 (0 - 0) - - - 
Total moderate (min/week) 352 (190 - 840) 427 (345 - 1400) 285 (165 - 470) 0.164 0.44 (-0.1; 0.9) 78% (likely) small difference 
Total MVPA (min/week) 352 (190 - 900) 465 (345 - 1400) 285 (165 - 470) 0.162 0.45 (-0.1; 0.9) 78% (likely) small difference 
Work domain        
Total work (min/week) 150 (0 - 360) 165 (0 - 1200) 142 (0 - 300) 0.429 0.25 (-0.2; 0.7) 56% (possibly) small difference 
Travel domain       
Total travel (min/week)  90 (0 - 150) 82 (50 - 225) 90 (0 - 150) 0.538 0.20 (-0.3; 0.7) 50% (possibly) small difference 
Leisure domain       
Total leisure (min/week) 0 (0 - 80) 52 (0 - 90) 0 (0 - 35) 0.042* 0.73 (0.1; 1.2) 65% (possibly) moderate difference 
Values are medians with interquartile ranges in parenthesis. All values were normalised by log transformation for parametric analyses (ANOVA). P-values highlighted 
in bold indicate statistically significant differences (p < 0.05) between sub-groups (*). Sufficiently active women accumulated an average of 30-min/day of accelerometer-







2.4.2 Socio-economic and behavioural/lifestyle characteristics 
 
Of the 51 participants who were interviewed, 17 reported their completion of grade 12 (33.3%) and there 
was no difference in the level of education between sub-groups (sufficiently active vs. insufficiently 
active: 35.7% vs. 32.2%; p = 0.824). After excluding homemakers and retirees (n = 5), as well as those 
still attending secondary school (n = 3), the majority of women were employed (60.8%), with no 
statistically significant difference in employment status between the sufficiently active and insufficiently 
active sub-groups (78.5% vs. 54.0%; p = 0.228).  
 
Women who were smokers (21.6%) were in the minority, as were those who consumed alcohol (25.5%). 
No sub-group differences were found for smoking (sufficiently active: 35.7% vs. insufficiently active: 
16.2%; p = 0.130) or alcohol consumption (sufficiently active: 28.5% vs. insufficiently active: 24.2%; p 
= 0.110). 
 
The majority of women reported ownership of 12 of the 14 items (12 ± 2 items) used to characterise 
individual and household wealth, with the insufficiently active group significantly better off than the 
sufficiently active group (12 ± 2 vs. 10 ± 2 items; p = 0.036). A significantly higher proportion of 
insufficiently active women (62.1%) compared to their sufficiently active counterparts (28.5%), had 
access to a motor vehicle (p = 0.050). 
 
2.4.3 Age, body composition and body fat distribution characteristics 
 
Table 2.3 depicts the age, body composition and regional body fat results of the participants. The mean 
age of the whole group was 42 ± 13 yrs, with no significant difference between the sub-groups (p = 
0.825). Although the sufficiently active sub-group was overweight (BMI: 27.3 ± 4.0 kg/m2), they had 
statistically significantly lower body mass (ES = -0.78; p = 0.017) and total FM (ES = -0.72; p = 0.029) 
compared to their insufficiently active and obese counterparts (BMI: 32.8 ± 7.6 kg/m2; ES = -0.80; p = 
0.015). Although FFSTM (kg) was not significantly lower in the sufficiently active versus insufficiently 
active sub-group, a moderate practical worthwhile group difference was found (ES = -0.63; p = 0.063). 







lower in the sufficiently active versus insufficiently active sub-group, whereas small to moderate 
practical worthwhile group differences were shown for body composition (%BF) and regional body fat 







Table 2.3 Age, body composition and body fat distribution measurements of the whole group and comparison between sub-groups. 
 




P-value ES (90% CI) Magnitude-based inference 
Age (yrs) (n = 51) 42 ± 13 (18 - 64) 14 41 ± 14 37 42 ± 13 0.825 -0.07 (-0.5; 0.4) trivial difference 
Body composition         
Height (m) (n = 51) 1.56 ± 0.1 (1.37 - 1.69) 14 1.55 ± 0.1 37 1.56 ± 0.1 0.691 -0.08 (-0.5; 0.4) trivial difference 
Body mass (kg) (n = 51) 76.2 ± 18.8 (37.7 - 127.0) 14 66.2 ± 11.5 37 80.1 ± 19.7 0.017* -0.78 (-1.3; -0.2) 72% (possibly) moderate difference 
BMI (kg/m2) (n = 51) 31.3 ± 7.2 (15.1 - 53.1) 14 27.3 ± 4.0 37 32.8 ± 7.6  0.015* -0.80 (-1.3; -0.2) 74% (possibly) moderate difference 
FFSTM (kg) (n = 50)  33.8 ± 6.5 (21.8 - 57.9) 13 30.9 ± 4.3 37 34.9 ± 6.9 0.063 -0.63 (-1.1; -0.1) 54% (possibly) moderate difference 
FFSTM (%) (n = 50)   45.8 ± 6.0 (33.4 - 64.3) 13 47.6 ± 4.4 37 45.2 ± 6.4  0.204 0.40 (-0.1; 0.9) 74% (likely) small difference 
Fat mass (kg) (n = 50)  35.6 ± 12.9 (8.2 - 67.3) 13 29.9 ± 8.1 37 39.0 ± 13.6  0.029* -0.72 (-1.2; -0.1) 65% (possibly) moderate difference 
Body fat (%) (n = 50) 47.2 ± 7.0 (24.3 - 61.1) 13 44.9 ± 5.1 37 48.0 ± 7.4  0.175 -0.45 (-0.9; 0.1) 78% (possibly) small difference 
Regional fat distribution 
     
 
  
Waist (cm) (n = 51) 88.7 ± 16.2 (57.4 - 138.3) 14 82.3 ± 11.1 37 91.1 ± 17.3 0.082 -0.55 (-1.0; -0.0) 87% (likely) small difference 
Hip (cm) (n = 51) 110.5 ± 15.1 (78.5 - 153.5) 14 104.1 ± 15.2 35 113.5 ± 14.3  0.001* -0.83 (-1.3; -0.2) 77% (likely) moderate difference 
Waist:Hip (n = 51) 0.80 ± 0.1 (0.64 - 0.97) 14 0.80 ± 0.1 37 0.80 ± 0.1     0.681 0.00 (0.0; 0.0) trivial difference 
CFM (kg) (n = 50) 18.9 ± 7.0 (4.2 - 39.3) 13 15.8 ± 4.8 37 20.0 ± 7.3 0.063 -0.62 (-1.1; -0.1) 53% (possibly) moderate difference 
CFM (% FM) (n = 50) 53.1 ± 4.8 (41.2 - 63.0) 13 54.2 ± 3.9 37 52.6 ± 5.0 0.314 0.36 (-0.1; 0.8) 67% (possibly) small difference 
AFM (kg) (n = 50) 17.7 ± 6.5 (4.8 - 36.2) 13 14.1 ± 3.5 37 18.9 ± 6.9  0.019* -0.77 (-1.3; -0.2) 70% (possibly) moderate difference 
AFM (% FM) (n = 50) 50.0 ± 5.1 (39.4 - 60.5) 13 49.0 ± 4.3 37 50.4 ± 5.4 0.429 -0.19 (-0.7; 0.3) trivial difference 
VAT area (cm2) (n = 50) 152.7 ± 66.4 (19.2 - 418.0) 13 128.7 ± 38.5 37 161.1 ± 72.3 0.131 -0.49 (-1.0; 0.0) 75% (possibly) small difference 
Values are means ± standard deviations. P-values highlighted in bold indicate statistically significant differences (p < 0.05) between sub-groups (*). Sufficiently active 
women accumulated an average of 30-min/day of accelerometer-derived moderate to vigorous-intensity physical activity (MVPA). ES, effect size; CI, confidence interval; 
yrs, years; m, metres; kg, kilograms; BMI, body mass index; kg/m2, kilograms per metre squared; %, FFSTM, fat-free soft tissue mass; percentage; cm, centimetres; 







2.4.4 Cardiometabolic disease risk outcomes 
 
Cardiometabolic disease risk outcomes of the whole group, as well as the sub-groups are presented in 
Table 2.4. In accordance with the 2017 American College of Cardiology/American Heart Association 
(ACC/AHA) Task Force on Clinical Practice Guidelines for the Prevention, Detection, Evaluation, and 
Management of High Blood Pressure (BP) [29], only 3 of the 13 women (23.0%) who were previously 
diagnosed with hypertension and reported use of anti-hypertensive medication, presented with normal 
BP levels on the day of investigation.  
 
On average, the whole group presented with unfavourable BP levels. The sufficiently active sub-group 
had elevated systolic BP (SBP) levels (≥ 120 mm Hg), of which six women were hypertensive (i.e. stage 
1 [n = 2] and stage 2 [n = 4]). In comparison, 23 women in the insufficiently active sub-group were 
hypertensive (i.e. stage 1 [n = 6] and stage 2 [n = 17]). For both SBP and diastolic (DBP) levels, body 
mass and fat mass adjusted differences between sub-groups were not statistically significant, although a 
small clinically significant difference was observed for DBP levels (ES = -0.25; p = 0.147).   
 
No statistically significant group differences were observed for any of the serum lipid concentrations, 
even after adjusting for: i) body mass and ii) fat mass (kg). On average, TC, LDL-C and TG 
concentrations for the whole group were categorised as “desirable” (TC: < 5.0 mmol/L, LDL-C: < 3.0 
mmol/L and TG: < 1.7 mmol/L) according to the National Cholesterol Education Program Adult 
Treatment Panel III (NCEP ATP III) criteria [30]. Notably, a small clinically significant difference 
between the sufficiently active and insufficiently active sub-groups was observed for LDL-C (ES = -
0.22; p = 0.979). Mean HDL-C concentration fell below the “desirable” value (< 1.3 mmol/L) for both 
the whole group and insufficiently active sub-group. The difference between the sub-groups for HDL-C 
was trivial (ES = 0.21; p = 0.263). Lipoprotein (a) was higher than the “desirable” cut-off value for the 
whole group and both sub-groups (Lp (a) > 50 mg/dL) according to the European Consensus Statement 
of the European Atherosclerosis Society [31]. Although not statistically significantly, a small clinically 















 Body mass 
adjusted 
P-value 
ES (90% CI) Magnitude-based inference 
 
Blood pressure           
SBP (mm Hg) (n = 48) < 120ǂ 128.0 ± 20.0 (93.3 - 183.0) 14 127.0 ± 19.6 34 128.7 ± 20.5 0.255 -0.08 (-0.6; 0.4) trivial difference 
DBP (mm Hg) (n = 48) < 80ǂ 84.4 ± 14.8 (54.6 - 133.0) 14 81.8 ± 11.6 34 85.5 ± 15.9 0.147 -0.25 (-0.7; 0.2) 56% (possibly) small difference 
Serum lipid concentrations          
Total cholesterol (mmol/L) (n = 51) < 5.0^ 4.9 ± 1.1 (2.2 - 8.1) 14 4.9 ± 1.3 37 4.9 ± 1.1 0.809 0.00 (-0.5; 0.5) trivial difference 
LDL-C (mmol/L) (n = 51) < 3.0^ 2.9 ± 0.9 (0.8 - 5.5) 14 2.8 ± 1.0 37 3.0 ± 0.9 0.592 -0.22 (-0.7; 0.3) 50% (possibly) small difference 
HDL-C (mmol/L) (n = 51) ≥ 1.3^  1.2 ± 0.3 (0.7 - 1.9) 14 1.3 ± 0.3 37 1.2 ± 0.3 0.091 0.21 (-0.3; 0.7) trivial difference 
Triglycerides (mmol/L) (n = 51) < 1.7^ 1.3 ± 0.7 (0.3 - 3.6) 14 1.2 ± 0.5 37 1.3 ± 0.8 0.141 0.00 (-0.5; 0.5) trivial difference 





All (Range) n Active n Inactive  Body mass 
adjusted  
P-value 
ES (90% CI) for 






        
Prediabetes indicators          
FPG (mmol/L) (n = 50) < 5.6α 4.9 (4.5 - 5.6) 14 4.6 (4.3 - 5.1) 36 5.0 (4.6 - 5.7) 0.421 -0.44 (-0.9; 0.0) 78% (likely) moderate difference 
HbA1c (%) (n = 51) < 5.7Δ 5.7 (5.4 -5.9) 14 5.7 (5.5 - 5.8) 37 5.8 (5.3 - 5.9) 0.460 -0.05 (-0.5; 0.4) trivial difference 
Values are unadjusted means ± standard deviations (range), except FPG (fasting plasma glucose) and HbA1c (glycated haemoglobin) which are medians with interquartile range in 
parenthesis. Body mass adjusted P-values highlighted in bold indicate statistically significant differences (p < 0.05) between sub-groups (*). Sufficiently active women accumulated 
an average of 30-min/day of accelerometer-derived moderate to vigorous-intensity physical activity (MVPA). ES, effect size; CI, confidence interval; SBP, systolic blood pressure; 
mm Hg, millilitre of mercury; DBP, diastolic blood pressure; mmol/L, millimoles per litre; LDL-C, low-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; mg/dL, 
milligrams per decilitre; %, percentage. Ideal range values highlighted according to the ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High 
Blood Pressure in Adults (ǂ) [29], the NCEP ATP III criteria (^) [30], the European Atherosclerosis Society Consensus Panel (¥) [31], the International Diabetes Federation (α) [32] 








As a prediabetes indicator, the median FPG value for the whole group and sub-groups fell below the 
impaired FPG cut-off value of ≥ 5.6 mmol/L set by the International Diabetes Federation (IDF) [32] and 
the Harmonised Guidelines [33]. Even after adjusting for differences in body mass and fat mass (kg) no 
statistically significant group differences were observed. A statistically significantly higher proportion 
of women in the insufficiently active sub-group presented with impaired FPG levels (insufficiently 
active: 27.0% vs. sufficiently active: 21.4%; p = 0.044) (Table 2.5), however, the proportion of women 
with impaired HbA1c levels [34, 35] were similar (insufficiently active: 51.3% vs. sufficiently active: 
50.0%; p = 0.711). Fifteen women (40.5%) in the insufficiently active sub-group could be considered 
prediabetic and another four (10.8%) as having undiagnosed T2DM (≥ 6.5%), while five women (35.7%) 
in the sufficiently active sub-group were prediabetic and two presented with undiagnosed T2DM 
(14.2%). Although no statistically significant differences in impaired FPG and HbA1c were shown 
between the sub-groups, a moderate clinically significant difference was observed for FPG level (ES = -







Table 2.5 Frequency of cardiometabolic disease risk factors among sub-groups. 
Cardiometabolic disease risk factor International 
authority 











































Central obesity (%) (n) 
 
IDF and Harmonised 
Guidelines 








Elevated SBP (%) (n) 
 
IDF and Harmonised 
Guidelines 








Elevated DBP (%) (n) 
 
IDF and Harmonised 
Guidelines 








Elevated LDL-C (%) (n) 
 
NCEP ATP III 
 








Low HDL-C (%) (n) 
IDF and Harmonised 
Guideline 
< 1.3 mmol/L 28 (4/14) 54 (20/37) 0.123 
Elevated TG (%) (n) 
ID F and Harmonised 
Guideline 
≥ 1.7 mmol/L 14 (2/14) 27 (10/37) 0.338 
 
Elevated lipoprotein (a) (%) (n) 
 
 
NCEP ATP III 
 
 











Impaired FPG (%) (n) 
 
IDF and Harmonised 
Guidelines 




















(ⱡ) indicates missing data points. Sufficiently active women accumulated an average of 30-min/day of accelerometer-derived 
moderate to vigorous-intensity physical activity (MVPA). %, percentage; WHO, World Health Organisation; BMI, body mass 
index; kg/m2, kilograms per metre squared; IDF, International Diabetes Federation; WC, waist circumference; cm, centimetre; 
SBP, systolic blood pressure; mm Hg, millilitre of mercury; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein; 
NCEP ATP III, National Cholesterol Education Program Adult Treatment Panel III; mmol/L, millimoles per decilitre; HDL-
C, high-density lipoprotein; TG, triglycerides; FPG, fasting plasma glucose; mg/dL, milligrams per decilitre; HbA1c, glycated 











Table 2.6 compares the proportions of women from the sub-groups according to four cardiometabolic 
disease risk factor sub-categories (0–2; 3–5; 6–8 and ≥ 9). The distribution of women in these categories 
were not statistically significantly different between the sub-groups (p > 0.05).  
 
Table 2.6 A comparison of the proportions of women in each activity sub-group with increasing 
numbers of cardiometabolic disease risk factors. 
Number of cardiometabolic 
disease risk factors 





% of insufficiently active 
women (n) 
P-value 
0 - 2 29 (4/14) 16 (6/37) 0.321 
3 - 5 36 (5/14) 27 (10/37) 0.543 
6 - 8 35 (5/14) 51 (19/37) 0.318 
≥ 9  0 (0/14) 5 (2/37) 0.374 
Maximum possible number of cardiometabolic disease risk factors is 12. Sufficiently active women accumulated an average 




Using objectively-derived MVPA time, this small-scale cross-sectional study showed that less than a 
third of the urban dwelling women were sufficiently active, and although overweight according to BMI, 
presented with more favourable body composition and regional body fat measures compared to their 
insufficiently active counterparts. Sufficiently active women also presented with lower DBP and FPG 
levels, and reduced serum lipid concentrations (LDL-C and Lp (a)). Although not statistically significant, 
the proportion of women who presented with ≤ 2 cardiometabolic disease risk factors was higher among 
the sufficiently vs. insufficiently active sub-group (29% vs. 16%, respectively). The opposite was true 
when comparing women with ≥ 6 risk factors (insufficiently active: 51% vs. sufficiently active: 35%). 
The majority of self-reported PA time was work-related, however, the sufficiently active sub-group 
reported significantly more leisure-time PA compared to the insufficiently active sub-group. 
 
Although only a minority of women (27.4%) who took part in this study met the WHO 2010 Global 
Recommendations on Physical Activity for Health [5], observable differences in BMI and total adiposity 
in comparison to those who failed to meet the guideline, were shown. These results are consistent with 







associated benefit of reduced adiposity with higher daily volumes of total activity counts including all 
intensities, and reduced cardiometabolic disease risk measures [36]. Given the positive and strong 
relationship between activity counts and steps measured per day (adjusted R2 = 0.87) [37], the sufficiently 
active sub-group accumulated a significantly greater amount of MVPA (min/day) and steps/day 
compared to their insufficiently active counterparts. This finding is in agreement with another SA study 
where a dose-dependent relationship between the number of steps/day and obesity-risk reduction among 
rural women was observed [38]. Following adjustment for age and other potential confounders (i.e. motor 
vehicle access, education level and smoking), BMI was 1.4 kg/m2 lower per 5,000 steps/day. It is thus 
plausible to suggest that the higher volume of PA (i.e. steps/day) recorded by the sufficiently active sub-
group may also, in part, explain their significantly lower levels of total and central adiposity, and in 
particular, their lower VAT area, which is a recognised pathogenic fat depot. In the Modeling the 
Epidemiologic Transition Study (METS) among a community-based sample of “African-American” 
adult women (n = 161), statistically significant inverse correlations were shown between DXA-derived 
VAT volume and accelerometer-derived MVPA (r = -0.25; p = 0.001) and, VAT volume and activity 
counts (r = -0.24; p = 0.002) [39]. Both measures remained significant after adjusting for differences in 
age and smoking status. Therefore, our results reinforces the beneficial effects of higher MVPA and daily 
PA volume (i.e. steps/day) on central obesity measures and cardiometabolic disease risk. 
 
Although none of the body- and fat-mass adjusted group differences for the other cardiometabolic disease 
risk factors were statistically significant, clinically significant differences were observed for DBP and 
FPG levels, and serum lipid concentrations (LDL-C and Lp (a)) between the sub-groups. Inferences from 
the Framingham Heart Study [40] indicate that high DBP is a main determinant of hypertension-
associated CVD risk [40]. The Australian Longitudinal Women’s Health Study [41] also reported that ≥ 
150 min/week of moderate-intensity PA is associated with a reduction in hypertension-risk. Thus, 
consistent with these findings, women in our study who met the WHO MVPA guideline presented with 
a more favourable cardiometabolic disease risk profile [5]. Conversely, moderate-intensity PA does not 
appear to lower elevated Lp (a) concentrations [42], which is known to raise CVD-risk due to its pro-
thrombotic and anti-fibrinolytic effects, or acceleration in atherosclerosis [31]. Diet-induced changes, 
specifically carbohydrate restriction and multivitamin supplementation, have been associated with a 12% 
decrease in absolute Lp (a) concentrations and it also correlated with reductions in LDL-C (r = 0.436; p 
< 0.05) and total adiposity (FM: r = 0.385; p < 0.05) [43]. Thus, it seems plausible that the high 







and insufficiently active: 74%) are largely driven by their dietary intake. Similarly, the prevalence of 
prediabetes (HbA1c: ≥ 5.7%) among the sub-groups (50% vs. 51%, respectively), may also partially be 
attributed to their dietary intake. A 24-week diet-intervention trial in which 93 T2DM patients were 
randomly assigned to either a very low-carbohydrate (LC) group or high-unrefined carbohydrate (HC) 
group resulted in a greater reduction in HbA1c among the LC group (-2.6 ± 1.0% vs. -1.9 ± 1.2%; p = 
0.002) [44]. Thus, the assessment of habitual dietary intake of low socio-economic urban dwelling SA 
women, independent of total activity level, is required. This information will help to inform future 
lifestyle intervention studies aimed at reducing cardiometabolic disease risk for CVD and T2DM.  
 
Domain-specific PA time (%) reported among the whole group in our study differed greatly from those 
previously reported among women at national level [9]. Most notably, the group in this study only 
reported 6% of leisure time PA, compared to 54% among the national representative sample. Travel-
domain PA time was comparably lower (20% vs. 28%, respectively), whereas work-domain PA time 
considerably higher (74% vs. 18%) compared to the national sample. A plausible explanation for these 
differences may relate, in part, to the ongoing and rapid epidemiological transition in SA [45, 46], which 
negatively affects daily activity level. For example, a significantly higher proportion of insufficiently 
active women (62% vs. 31%) had access to a motor vehicle compared to women who were sufficiently 
active. These results are in support of those by Gradidge et al. [47] from a different SA location and in 
which the GPAQ was used to characterise PA level among urban adult women. Thus, the current study 
results re-emphasise the collective importance of work- and travel-related PA time, and most likely 
performed at light- and moderate-intensities given our additional use of objectively measured PA time. 
Given the combination of these inferences, future SA studies are needed to examine the association 
between varying intensity levels of objectively measured PA and cardiometabolic disease risk. In 
addition, descriptive studies identifying factors influencing changes in PA patterns are also required. All 
of which, will help to inform future intervention studies aimed at increasing PA level or the intensity of 
time already spent physically active, especially among low socio-economic urban dwelling SA adult 
women who are already obese and either prediabetic or diagnosed with T2DM [13].   
 
Our results emphasise the clinical health benefits associated with being sufficiently active and thus the 
importance of meeting global MVPA recommendations [5]. Even though the majority of PA time was 







vigorous intensity, time spent moderately active was sufficient to reduce overall cardiometabolic disease 
risk. However, despite their current PA status, the sufficiently active sub-group’s future health cannot be 
predicted. Nevertheless, it does not deter from the fact that the entire sample, on average, spent the 
majority of awake time sedentary. According to Ploeg et al. [48], sedentary behaviour is more deleterious 
to one’s health than physical inactivity and it minimises the “benefits” associated with ≥30 min/day of 
MVPA [5]. Given the challenge to reduce time spent sedentary, while increasing time spent physically 
active, it is important to understand the context in which the women from the current study reside. 
Notably, the lack of an inclusive PA environment (e.g. limited access to exercise facilities and issues of 
safety) and the lack of social/community networks to promote PA, as well as time-based challenges, such 
as the extended travel time to and from work and/or other purposeful places. Notably, any proposed 
interventions to address issues of physical inactivity and sedentarism will have to take these factors into 
consideration. 
 
The strengths of the present study include the use of sophisticated measurement equipment, namely the 
DXA-scanner and accelerometry, to characterise body composition and regional fat distribution, as well 
as PA level. This especially among a sample of urban women which, to our knowledge, little is currently 
known about. Potential limitations include the cross-sectional study design, sample of convenience, as 
well as the small sample size, especially when categorised into the two activity sub-groups. In addition, 
the loss of data due to non-compliance in wearing the activity monitors should also be considered. Thus, 
the findings should be considered exploratory, with limited generalisability to the entire urban adult 
women population in SA. Another limiting factor is the omission of measuring fasting serum insulin 
level, and thus our inability to assess beta cell function and insulin resistance using the Homeostatic 
Model Assessment of Insulin Resistance [49]. Future studies should include its measurement, as it may 
help to explain the underlying reason for the high number of prediabetic women among this sample of 




Unique to this study was the presentation of both accelerometer and subjective PA data. Thus, allowing 
for PA time to be objectively quantified and the domains described. Notably, the majority of women did 







favourable body composition and regional body fat measures, as well as reduced cardiometabolic disease 
risk. In an attempt to combat cardiometabolic disease risk for CVD and T2DM among urban and low 
socio-economic community dwelling women, public health interventions should target domains in which 
time is already spent physically active. For example, walking briskly for travel- and/or occupational-
related activities, while also aiming to increase awareness of the health-enhancing benefits associated 
with meeting MVPA recommendations. Nonetheless, the success of interventions are dependent on our 
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Background: Few South African (SA) studies have examined the association between objectively-
derived physical activity (PA) time in different intensities and daily volume, with cardiorespiratory 
fitness (CRF) level. The aim of this study was to investigate these associations among women living in 
an under-resourced urban setting, and to examine each in relation to i) body composition, ii) regional 
body fat measures and, iii) cardiometabolic disease risk outcomes. Methods: Sixty-one apparently 
healthy women (42 ± 13 yrs) completed a socio-demographic questionnaire followed by the measurement 
of resting blood pressure, fasting plasma glucose level and serum lipid concentrations. Dual-energy x-
ray absorptiometry was used to measure body composition and accelerometry to measure PA time 
(intensities) and volume (steps/day), respectively. A graded exercise test to exhaustion was performed to 
determine CRF level. Results: Although the associations between PA (intensities and volume) and CRF 
level were not statistically significant, all were clinically important and positive associations. 
Independent of steps/day, higher CRF level was associated with women who were younger and with 
reduced measures of total and central adiposity (BMI, fat mass, waist circumference and visceral adipose 
tissue area) (p < .001). Independent of steps/day, higher CRF level was associated with women who were 
younger and with reduced measures of total and central adiposity (BMI, fat mass, waist circumference 
and visceral adipose tissue area) (p < .001). Both steps/day and CRF level were also inversely associated 
with fat-free soft tissue mass and skeletal mass index (p < .050). Even though the associations between 
PA intensities with each cardiometabolic risk outcome were statistically non-significant, small clinically 
important associations were observed. Conclusion: The study highlights the health-related benefits of 
higher daily PA volume and CRF level, with reduced total adiposity and central obesity among both 
young and older women residing in an under-resourced urban setting. The challenge to design healthy 
lifestyle-based interventions for women of all ages and fitness levels requires immediate action. In the 
interim, content from a focus group of self-nominated community leaders with a vested interest in 
personal and public health can provide the foundation for such interventions. Most notably, those aimed 
at behavioural/lifestyle modification to reduce cardiometabolic disease risk.                                                                                              
 











The World Health Organization (WHO) expects the burden of non-communicable disease (NCD) 
morbidity and mortality to increase further, from already high levels, among women residing in low- and 
middle-income countries, such as South Africa [7]. A well-established body of evidence highlights the 
unequivocal health-related benefits of high cardiorespiratory fitness (CRF) levels which, independent of 
total adiposity [1], associate with reduced all-cause mortality risk [2-4]. Notably, CRF is described as a 
physiological measure that reflects a combination of physical activity (PA) behaviour and innate genetic 
potential [1]. Thus, the WHO 2010 Global Recommendations on PA for Health [8] aligns itself to 
increasing PA in an attempt to decrease NCD, however, these guidelines draw explicit reference to 
moderate to vigorous-intensity physical activity (MVPA) and not light-intensity physical activity (LPA). 
Even when using the steps·day−1 version of these guidelines [9], the intensity determined by duration 
and step frequency (i.e. cadence) includes only MVPA. Tudor-Locke et al. [9] stated: “An appropriate 
translation, specifically allowing for minimal amounts of time in MVPA, implied that steps should be 
taken over and above those taken in the course of habitual and incidental daily activities; and also should 
be taken in bouts of at least 10-minutes in duration.” Although, they too purport the notion that any PA 
is better than none, and that increased levels of PA should be progressively approached. Interestingly, 
some research propose that LPA also hold significant health benefits [5,6]. Therefore the investigation of 
LPA as a separate entity to MVPA and total daily volume (i.e. steps·day−1), in relation to risk factors 
associated with NCD, namely cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM), is 
warranted.  
 
Results from a large cross-sectional analysis, the Objective Physical Activity and Cardiovascular Health 
study (OPACH), inclusive of three diverse ethnic groups (“White”, “Black” and “Hispanic”), show 
objectively-derived LPA is associated with lower CVD risk [10]. After adjusting for differences in age 
and monitor wear time, favourable associations were shown between low- and high-LPA and 
cardiometabolic disease risk factors (body mass index [BMI], waist circumference [WC], resting systolic 
blood pressure [SBP] and diastolic blood pressure [DBP], triglyceride [TG] and fasting plasma glucose 
[FPG]) (p < .01). Of practical importance is the ≥ 5 hrs per person per day of LPA reported in the OPACH 
study, and thus in support of other studies reporting the health-related associations with: i) higher daily 







Few South African (SA) studies examined the associations of PA and CRF with body composition 
measures and cardiometabolic disease risk outcomes. Results from a number of small-scale cross-
sectional studies have shown favourable associations between PA measured subjectively (questionnaire-
based PA level index scores) [11,12] and objectively (pedometers [13,14] and accelerometers [12]), with 
lower measures of adiposity (BMI, WC and, % body fat [%BF]). However, to our knowledge, only one 
SA study has explored relationships between LPA and body composition [15]. Similar to the objectively-
derived PA results indicative of MVPA [12] and steps·day−1 [13,14], Dickie et al. [15] showed an inverse 
association between LPA and trunk fat mass (TFM) (r = -0.25, p = .03), measured using high-precision 
dual-energy x-ray absorptiometry (DXA) among 76 apparently healthy urban SA women. Although none 
of the other cardiometabolic risk factors (i.e. SBP, DBP, serum lipid concentrations, FPG and fasting 
serum insulin) were associated with LPA, higher CRF levels (indirect assessment) were inversely 
associated with %BF (r = -0.34, p = .02), central fat mass (CFM) (kg) (r = -0.31, p = .03), visceral adipose 
tissue (VAT) area (cm2) (r = -0.47, p < .01) and insulin resistance  (r = -0.41, p = .03). When adjusting 
for differences in fat mass (FM), the association between CRF and insulin resistance remained, however, 
not when VAT area was adjusted for (p > .05).  
 
These findings are important, as PA and CRF play a significant role in influencing health outcomes, 
especially among SA communities undergoing epidemiological transition [16], and moreover, among 
child-bearing women. What’s more are the noticeable differences in the prevalence of severe obesity 
(BMI: ≥ 35 kg·m2) among “Coloured” and “Black (African)” SA adult women (26% and 20%, 
respectively) compared to “Asian/Indian” and “White” SA adult women (18% and 15%, respectively) 
[17]. Given South Africa’s historical past these differences, as well as the prevalence of NCD among 
these groups [18], may in part, be attributed to social inequalities (e.g. education level, access to 
healthcare and earning capacity) [16]. Findings from the Bellville-South community cohort study (Cape 
Town, South Africa) provide further insight into the presence of obesity (53.7%) and diabetes mellitus 
(28.6%) among urban-dwelling and previously disadvantaged adults (mean age: 54 yrs) [19]. Although 
sex-specific results were not reported, the sample comprised mostly of women (73.5%) and showed an 
equal frequency of cardiometabolic disease risk among normal weight, overweight and obese BMI-
categories [19]. A further outcome of this study was the description and prevalence of two distinct obese 
phenotypes, i) metabolically healthy and obese (31%) and; ii) metabolically unhealthy and normal weight 
(29%) [20]. These findings corroborate with the results from the extensively published HERITAGE 







Previous studies have mostly used subjective and indirect methods to characterise PA [11, 12] and CRF 
[15], which may over- or underestimate their relative role in cardiometabolic disease risk for CVD and 
T2DM. Thus, there is a compelling need to characterise modifiable behavioural/lifestyle factors such as 
PA, as well as CRF, while also exploring its associations with obesity and cardiometabolic disease risk 
outcomes among low socio-economic urban-dwelling women using objectively-derived methodologies 
and high precision measurement techniques. 
 
Therefore, the aims of this cross-sectional study were two-fold: i) to investigate the association between 
PA (LPA, MVPA and steps·day−1) and CRF; and ii) to examine both PA and CRF in relation to body 
composition, regional body fat measures, and cardiometabolic disease risk outcomes. We hypothesise 
that similar to other SA women [15] both high PA (irrespective of intensity) and CRF levels are 
independently associated with reduced adiposity and cardiometabolic disease risk outcomes for CVD 
and T2DM in urban-dwelling SA adult women.  
 
3.3 Materials and methods 
 
3.3.1 Cloetesville (Stellenbosch, Western Cape, South Africa) 
   
Cloetesville is considered a low socio-economic residential urban suburb neighbouring the university 
town of Stellenbosch in the Western Cape Province of South Africa [22]. Its population approximates 
15 390, of which 31% are adult women [23]. 
 
3.3.2 Study participants 
 
Women were recruited from local church groups, the public health clinic, community centre, and via 
“word of mouth” (i.e. snowball sampling). An Afrikaans-speaking health champion, living in Cloetesville, 
assisted with the participant recruitment. All the procedures and potential risks were explained to each 
participant in her preferred language (Afrikaans or English) and everyone provided written informed 







Participants were included in the study if they were: i) 18 – 64 yrs old; ii) had no known diseases and 
were not taking medications for T2DM, human immunodeficiency virus (HIV) or acquired immune 
deficiency syndrome, or any other metabolic diseases; iii) not pregnant or lactating; and iv) free of any 
known musculoskeletal problems that prevented them from being physically active. Rapid HIV screening 
tests were not performed, although women were asked if they were receiving anti-retroviral treatment 
for HIV. Twelve women, who underwent pre-screening, were excluded from the study. One woman tested 
positive to the compulsory urine pregnancy test, another presented with angina, whilst 10 were excluded 
as they reported the use of prescribed T2DM medication. Thus, a convenience sample of 61 apparently 
healthy women underwent testing on two separate days, approximately seven days apart. On completion 
of testing, 10 participants were excluded from the final group analysis due to invalid accelerometer data 
(Figure 3.1). The study proposal was approved by the Human Research (Humanities) Ethics Committee 

















































Figure 3.1 Flow chart of participant recruitment and testing of the whole group (n = 51) and sub-group 







12 women were excluded during pre-screening, i.e. 
 One woman was pregnant 
 One woman presented with angina 
 Ten women were using prescribed medication/s for T2DM 
Sub-group (n = 46)   
10 participants’ entire datasets were excluded from the whole group 
analysis due to invalid objective physical activity data  
  
61 women were inducted into the cross-sectional study 
Whole group (n = 51)  
5 participants’ data for the following outcome measures were reported 
missing: 
 Body composition and regional body fat distribution measures 
(n  = 1)  
 Systolic blood pressure and diastolic blood pressure (n = 3)  
 Fasting plasma glucose (n = 1) 
  
 
5 participants chose not to participate in the graded treadmill exercise 












3.3.3 Socio-economic status and behavioural/lifestyle factors 
 
Using the WHO STEPwise approach to chronic disease risk factor surveillance (STEPS) instrument [24], 
each participant underwent an individualised interview. Questions pertaining to proxy measures of socio-
economic status (SES) were asked including: i) the highest level of education completed and; ii) 
employment status over the previous 12-month period. Behavioural/lifestyle factors included current 
tobacco smoking status and alcohol consumption. Women were categorised as either smokers or non-
smokers; whereas those who reported alcohol consumption based on an average monthly intake (≥ 4 
drinks per month) were categorised as consumers of alcohol.  
 
An asset index score was also used as a proxy measure of SES and based on the 14-item asset list used 
by Jennings et al. [25], and since reported by other research groups among urban adult SA women [26,27]. 
The items included reflect measures of individual and/or household wealth plus accessibility to basic 
resources, namely, electricity in the home, ownership of a television, radio, motor vehicle, fridge, stove 
and oven, washing machine, telephone, DVD player, microwave, computer/laptop, cellular telephone 
and paid television channels (e.g., DSTV®). 
 
3.3.4 Body composition and regional fat distribution assessment 
 
Standard anthropometric measures (standing height, body mass, waist and hip circumferences) were 
determined according to the International Society for the Advancement of Kinanthropometry (ISAK) 
guidelines [28]. DXA (Discovery-W®, software version 13.4.1; Hologic, Bedford, MA) was used to 
determine whole body composition and regional body fat distribution. The latter included CFM, 
appendicular fat mass (AFM) and TFM defined as CFM minus the head [29].  
 
In accordance with the guidelines set by the European Working Group on Sarcopenia in Older People 
(EWGSOP) [30] skeletal muscle index (SMI) was calculated using appendicular skeletal muscle (ASM) 
mass (i.e. the sum of the muscle masses of all four limbs) divided by height measured in metres squared. 
Using the DXA, visceral adipose tissue (VAT) area (cm2) was derived using the methodology described 







3.3.5 Cardiometabolic disease risk outcomes 
 
Three successive blood pressure (BP) measurements were taken after at least 5-min of seated rest, using 
an appropriate-sized cuff and an automated BP monitor (Omron® HBP-1100, Omron Healthcare, 
Mannheim, Germany). The average of the last two readings were noted for analysis. Three participants 
were excluded from the group BP data set as only one measure was recorded.     
 
Participants were asked to fast overnight for a minimum of 8-hours. On arrival at the testing venue, 
venous blood samples were drawn by a trained nurse. The samples were analysed by a local commercial 
pathology laboratory (PathCare, Stellenbosch, South Africa). Due to an inadequate serum concentration 
one participant’s FPG was reported missing.     
 
3.3.6 Physical activity (time, intensities and steps·day−1) 
 
Physical activity time was measured during waking hours for 7 consecutive days using the triaxial 
ActiGraph™ GT3X accelerometer (ActiGraph™ LLC, Pensacola, Florida). Time sampling intervals were 
set at 60-sec epochs. Each original ActiGraph™ data file (*.agd) was downloaded onto a personalised 
computer and processed on a Microsoft Excel spreadsheet using a custom-written program (‘ACTILIFE’, 
http://actigraphcorp.com/products-showcase/software/actilife/). Data from each participant was included 
if they met the minimum requirement of ≥ 600-min of monitor wear time on ≥ 3-days of the week [32]. 
Wear time was determined by subtracting non-wear time from 24-hours, where non-wear time was 
defined as an interval of ≥ 60 consecutive minutes with zero activity counts allowing for intervals of 1 
to 2-min of relatively low activity counts per minute (< 100) [32]. Freedson cut-points were used to 
convert the accelerometer counts measured per minute (counts·min−1) into intensity bands [33]. 
Sedentary time was defined as < 100 counts·min−1. Physical activity (≥ 100 counts·min−1) was divided 
into two sub-categories according to intensity level namely: light (100 – 951 counts·min−1) and moderate 
to vigorous (≥ 1952 counts·min−1) [33]. Average daily time in minutes per day (min·day−1) was used to 
summarise both sedentary and physical activity time according to LPA and MVPA. Steps·day−1 were also 








3.3.7 Cardiorespiratory fitness 
 
A graded exercise test to exhaustion was performed on the h/p/Cosmos Saturn® treadmill (Nussdorf-
Traunstein, Germany) to determine maximal aerobic capacity (VO2max). The COSMED Quark CPET 
metabolic system (Rome, Italy) was used to monitor metabolic variables continuously throughout the 
exercise test. The gas analysers were calibrated prior to each test with atmospheric gas and known 
concentrations of O2 (16%), CO2 (5%) and balance N2.  The turbine flow meter was calibrated using a 3-
L calibration syringe. Each participant was fitted with a heart rate monitor, as well as a treadmill safety 
harness. To ensure that each participant achieved maximal exertion, at least two of the following five 
criteria needed to be met: i)  oxygen consumption (V̇O2) did not increase by > 150 mL per successive 
workload; ii) a respiratory quotient (RQ) value of ≥ 1.15 was reached; iii) heart rate (HR) reached > 90% 
of age-predicted maximal HR, calculated as 220 - age (yrs); iv) rating of perceived exertion (RPE) was 
reported as > 19 on the 6 to 20 Borg scale [34] and; v) the participant indicated she was exhausted. Five 
women did not do the test, thus a sub-group of 46 women were included in the final group analysis 
(Figure 1). Relative VO2max (mL·kg
−1·min−1) was used as the criterion measure of CRF level. 
 
3.3.8 Statistical analysis 
 
Based on a power (1 - β) of 80% and α = 0.05 and assuming a medium to large effect size for four 
independent variables in a multiple regression analysis, the required sample size was between 38 and 68 
participants [36] and the variance inflation factor (< 3) was assessed for multicollinearity. Statistica 
version 13.3 (StatSoft Inc. Tulsa, OK, USA) was used to perform the descriptive data analysis and null-
hypothesis testing [35]. The level of statistical significance was set at p < .05.  
 
The distribution of each variable was examined with the Shapiro-Wilk normality test. Parametric data 
are presented as means ± standard deviations (SD) or percentages. Non-Gaussian distributed variables 
(PA data, sedentary time, FPG and HbA1c) were normalised by log transformation for parametric 
analyses and presented as medians and interquartile range (IQR). One-way analysis of variance 
(ANOVA) was used to determine if PA and CRF differed according to categorical variables used to 







body composition, regional fat distribution measures, and cardiometabolic outcome measures) were used 
to determine if there were differences between the whole group (n = 51) and the CRF sub-group (n = 46).  
 
To evaluate the univariate associations between PA and CRF level, Pearson’s product-moment correlation 
coefficients (r) were calculated. The same was done for associations between PA, body composition, 
CRF level and cardiometabolic disease risk outcome measurements (unadjusted and adjusted for 
confounding variables: i) FM [kg], and ii) VAT area [cm2]). These were then used to determine which 
variables to include in the forward stepwise multiple regression analyses, which were calculated to 
investigate the independent associations between PA and CRF level, and all body composition, regional 
body fat distribution, and cardiometabolic risk outcome measurements.  
 
The Pearson’s r ( 90% CI) were interpreted using the magnitude-based inference methodology [37]. 
Qualitative probabilistic inferences about the true or clinically important correlation were determined 
according to the following thresholds: < 0.1, trivial; > 0.1 – 0.3, small; > 0.3 – 0.5, moderate; > 0.5 – 0.7, 
large; > 0.7 – 0.9, very large [38]. If the 90% CI overlapped small positive and negative values, the 




3.4.1 Socio-economic and behavioural/lifestyle characteristics 
 
The majority women (66.7%, n = 34) had completed primary school (grade 7). Of those who had 
completed high/secondary school (grade 12) (33.3%, n = 17), only two (3.9%) reported completion of a 
tertiary/college undergraduate degree. Women were classified as either: employed (58.8%, n = 30), 
unemployed (25.4%, n = 13), retired/homemaker (9.8%, n = 5) or grade 12 students (5.8%, n = 3).  
 
Eleven women reported cigarette smoking (21.5%) and thirteen women reported consumption of alcohol 
(25.4%). The majority of women reported ownership of 12 of the 14-items (mean ± SD: 12 ± 2) used to 








3.4.2 Age, body composition and body fat distribution characteristics 
 
The mean age of the whole group was 42 ± 13 yrs (Table 3.1). The majority were obese (56.9%, n = 29) 
and overweight (25.5%, n = 13), whereas only seven (13.7%) were normal weight and two underweight 
(3.9%). When compared to the age-specific percentiles of the American College of Sports Medicine 
(ACSM) [39] the women’s %BF (mean ± SD: 47.2 ± 7.0%) fell below the 1st percentile for ages 40 – 49 
yrs and thus rated as “very poor”.  
 
According to the EWGSOP international SMI cut-off of ≤ 5.76 kg·m2 [30], 13 of the women (26.0%) 
were diagnosed with sarcopenia. None of these women were obese, but were relatively younger 
compared to the whole group (mean ± SD [range]: 37 ± 14 [18 – 47 yrs] vs. 42 ± 13 yrs [18 – 64 yrs]). 
When using the more recently published SA-specific SMI cut-off (≤ 4.94 kg·m2) [40], the proportion of 





















Table 3.1. Age, body composition and regional body fat distribution measurements.  
 n Mean ± SD Range 
Age (yrs) 51 42 ± 13 (18 - 64) 
Body composition    
Height (m) 51 1.56 ± 0.1        (1.37 - 1.69) 
Body mass (kg) 51 76.2 ± 18.8       (37.7 - 127.0) 
BMI (kg·m2) 51 31.3 ± 7.2        (15.1 - 53.1) 
Fat-free soft tissue mass (kg) 50 33.8 ± 6.5         (21.8 - 57.9) 
Fat-free soft tissue mass (%) 50 45.8 ± 6.0         (33.4 - 64.3) 
SMI (kg·m2) 50 6.5 ± 1.0          (4.4 - 9.4) 
Fat mass (kg)  50 35.6 ± 12.9          (8.2 - 67.3) 
Body fat (%) 50 47.2 ± 7.0         (24.3 - 61.1) 
Regional body fat distribution    
Waist (cm) 51 88.7 ± 16.2         (57.4 - 138.3) 
Hip (cm) 51 110.5 ± 15.1         (78.5 - 153.5) 
Waist:Hip 51 0.80 ± 0.1         (0.64 - 0.97) 
CFM (kg) 50 18.9 ± 7.0          (4.2 - 39.3) 
CFM (% FM) 50 53.1 ± 4.8         (41.2 - 63.0) 
AFM (kg) 50 17.7 ± 6.5           (4.8 - 36.2) 
AFM (% FM) 50 50.0 ± 5.1            (39.4 - 60.5) 
TFM (kg) 50 17.9 ± 6.8            (34.1 - 37.2) 
TFM (% FM) 50 47.4 ± 8.0            (20.0 - 63.7) 
VAT area (cm2) 50 152.7 ± 66.4           (19.2 - 418.0) 
Values are unadjusted mean ± standard deviation (n). yrs, years; m, metres; kg, kilograms; BMI, body mass index; kg·m2, 
kilogram per metre squared; %, percentage; SMI, skeletal mass index; cm, centimetre; Waist:Hip; waist to hip ratio; CFM, 
central fat mass; AFM, appendicular fat mass; TFM, trunk fat mass; VAT, visceral adipose tissue; cm2, centimetre squared. 
 
3.4.3 Characteristics of cardiometabolic disease risk outcomes 
 
Cardiometabolic disease risk outcomes are presented in Table 3.2. Thirteen women reported their use of 
anti-hypertensive medication, with only three being normotensive when assessed. Mean DBP level of 
the whole group was > 80 mm Hg (mean ± SD: 84.4 ± 14.8 mm Hg) and thus categorised as stage 1 








In line with the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) [42], 
mean lipid serum concentrations fell below the upper limit value (TC: < 5.0 mmol·L−1; LDL-C: < 3.0 
mmol·L−1 and TG < 1.7 mmol·L−1). Mean HDL-C fell below the desired value (≥ 1.3 mmol·L−1) and, in 
accordance with the European Consensus Statement of the European Atherosclerosis Society [43] 
lipoprotein (a) (Lp (a) > 50 mg·dL−1) exceeded the desired mean cut-off value of < 30 mg·dL−1.  
 
According to both the International Diabetes Federation (IDF) [44] and the Harmonised Guidelines [45], 
most of the women (74.0%, n = 37/50) were normoglycemic (FPG: < 5.6 mmol·L−1), whereas the 
minority presented either with prediabetes (n = 11) or T2DM (n = 2) (26.0%, n = 13/50). Using the 
American Diabetes Association (ADA) Hb1Ac cut-off value of ≥ 5.7% [46,47] as another indicator of 
prediabetes, 51.0% (n = 26/51) of the women presented with prediabetes and 6 with undiagnosed T2DM 






















Table 3.2. Cardiometabolic disease risk outcomes. 
Blood pressure n Mean ± SD     Range 
SBP (mm Hg) 48 128.0 ± 20.0 (93.3 - 183.0) 
DBP (mm Hg) 48 84.4 ± 14.8 (54.6 - 133.0) 
Lipid profile n Mean ± SD     Range 
Total cholesterol (mmol·L−1) 51 4.9 ± 1.1 (2.2 - 8.1) 
LDL-C (mmol·L−1) 51 2.9 ± 0.9 (0.8 - 5.5) 
HDL-C (mmol·L−1) 51 1.2 ± 0.3 (0.7 - 1.9) 
Triglycerides (mmol·L−1) 51 1.3 ± 0.7 (0.3 - 3.6) 
TG:HDL-C 51 1.0 ± 0.6 (0.2 - 2.9) 
Lipoprotein (a) (mg·dL−1 ) 51 54.5 ± 49.4  (2.0 - 232.0) 
Apolipoprotein A1 (g·L−1) 51 1.4 ± 0.2 (0.9 - 1.8) 
Apolipoprotein B (g·L−1)  51 0.9 ± 0.3 (0.4 - 1.8) 
Apo B:Apo A 51 0.6 ± 0.2 (0.3 - 1.2) 
Diabetes indicators n Median    IQR 
FPG (mmol·L−1) 50 4.9  (4.5 - 5.6) 
HbA1c (%) 51 5.7 (5.4 - 5.9) 
Values are mean ± standard deviation, except for fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c) which 
are reported as median and interquartile range (IQR). SBP, systolic blood pressure; mm Hg, millilitre of mercury; DBP, 
diastolic blood pressure; TC, total cholesterol; mmol·L−1, millimoles per litre; LDL-C, low-density lipoprotein; HDL-C, high-
density lipoprotein cholesterol; TC:HDL-C, total cholesterol to high-density lipoprotein cholesterol ratio; TG:HDL-C, 
triglyceride to high-density lipoprotein cholesterol ratio; mg·dL−1, milligrams per decilitre; g·L−1, grams per litre; Apo B:Apo 
A, Apolipoprotein B to Apolipoprotein A1 ratio; %, percentage. 
 
3.4.4 Accelerometer-derived physical activity (intensity and volume)    
 
Objectively-derived PA time (LPA and MVPA) reported in min·day−1 and steps·day−1 are presented in 
Table 3.3. A larger proportion of awake time was spent in sedentary behaviour (57.3% of daily wear-time 
[median: 7-hr and 55-min]) compared to time spent physically active. The majority of PA time was 
performed in the light-intensity band, the minority in the moderate-intensity band and none in the 
vigorous-intensity band. Only 27.4% of the whole group (n = 14) met the WHO 2010 Global 
Recommendations on PA for Health [8], with an even smaller proportion (23.5%) achieving the 








Table 3.3 Accelerometer-derived physical activity data of the whole group and cardiorespiratory fitness 
of the sub-group. 
Accelerometry (n = 51)  Median (IQR) 
Number of activity days measured 5 (5 - 6) 
Non-wear time (min·day−1) 611 (542 - 662) 
Wear time (min·day−1) 829 (801 - 898) 
Sedentary time (min·day−1) 475 (442 - 514) 
Total PA (min·day−1) 365 (308 - 404) 
Intensity bands   
          LPA (min·day−1) 340 (282 - 374) 
          MVPA (min·day−1) 22 (12 - 30) 
Steps·day−1 8 232 (6 032 - 9 871) 
International PA health recommendations (n = 51) % (n) 
Sufficiently active women (≥ 150 min·week−1 MVPA) [8] 27.4 (14) 
Insufficiently active women (< 150 min·week−1 MVPA) [8] 72.6 (37) 
Sufficiently active women (≥ 10 000 steps·day−1) [9] 23.5 (12) 
Insufficiently active women (< 10 000 steps·day−1) [9] 76.5 (39) 
Cardiorespiratory fitness (relative VO2max)  Mean ± SD (Range) 
All women (mL·kg−1·min−1) (n =46) 23.2 ± 5.4 (11.5 - 35.1) 
Sufficiently active women (≥ 150 min·week−1 MVPA) [8] (mL·kg−1·min−1) (n =14) 24.8 ± 6.3 (11.5 - 34.5) 
Insufficiently active women (< 150 min·week−1 MVPA) [8] (mL·kg−1·min−1) (n = 32) 22.6 ± 4.9 (14.2 - 35.1) 
Sufficiently active women (≥ 10 000 steps·day−1) [9] (mL·kg−1·min−1) (n =12) 26.3 ± 4.8 (19.0 - 34.5) 
Insufficiently active women (≥ 10 000 steps·day−1) [9] (mL·kg−1·min−1) (n = 39) 22.1 ± 5.2 (11.5 - 35.1) 
Accelerometry values are medians with interquartile range (IQR) in parenthesis. min·day−1, minutes per day; PA, physical 
activity; LPA, light-intensity physical activity; MVPA, moderate to vigorous-intensity physical activity; steps·day−1; 
VO2max, maximal aerobic capacity; mL·kg−1·min−1, millilitres per kilogram per minute. International PA health 
recommendations according to the WHO 2010 Global Recommendations on PA for Health [8] and PA volume measured 
in steps·day−1 [9]. 
 
 
3.4.5 Cardiorespiratory fitness  
 
The mean relative VO2max (mL·kg
−1·min−1) of the sub-group of 46 women is presented in Table 3.3. In 
comparison to the ACSM’s age-specific relative VO2max (CRF) categories for women, the group mean 







(22.1 – 23.3 mL·kg−1·min−1), and is thus rated as “poor” [39]. Noticeably, the difference in relative 
VO2max (CRF) between the sufficiently and insufficiently active sub-categories according to the WHO 
guideline of meeting ≥ 150 min·week−1 of MVPA, was not statistically significant (p = .202) (Figure 3.2). 
However, the comparison according to the ≥ 10 000 steps·day−1 recommendation [9], was statistically 





Figure 3.2 Differences in mean relative VO2max (CRF) levels for all women, sufficiently and 
insufficiently active women according to the WHO 2010 Global Recommendations on PA for Health [8] 
and sufficiently and insufficiently active women according to the ≥ 10 000 steps·day−1 recommendation 
[9].*, p < .05; statistically significant difference between sub-categories. 
 
When comparing the sub-group of women (n = 46) who completed the graded exercise test to the whole 
group (n = 51), there were no statistically significant differences in age, SES, behavioural/lifestyle factors, 
body composition measures (body mass [BM], BMI, FM and %BF), or body fat regional distribution 
measurements (WC, hip circumference and VAT area), cardiometabolic disease risk outcomes and PA 
variables (LPA, MVPA and steps·day−1) (all, p > .05).   
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3.4.6 Associations between physical activity, socio-economic status and behavioural/lifestyle factors 
 
No differences were found for LPA (min·day−1) when comparing women who had completed 
high/secondary school to those who had completed primary school (327 ± 76 min·day−1 vs. 346 ± 75 
min·day−1, p = .406). The same result was shown for MVPA (25 ± 18 min·day−1 vs. 23 ± 17 min·day−1, 
p = .711) and steps·day−1 (7 458 ± 4 188 vs. 7 724 ± 3 001, p = .816). Women who were employed 
accumulated significantly more LPA (361 ± 79 min·day−1 vs. 295 ± 51 min·day−1, p = .001), as well as 
steps·day−1 (8 871 ± 3 289 vs. 5 655 ± 3 756, p = .002), whereas no statistically significant difference 
was shown for MVPA (26 ± 16 min·day−1 vs. 22 ± 19 min·day−1, p = .351). None of the 
behavioural/lifestyle factors were statistically significantly associated with PA (p > .05).  
 
3.4.7 Associations between physical activity and cardiorespiratory fitness, and body composition 
and regional fat distribution measures 
 
Although the magnitude of the associations between LPA, MVPA, steps·day−1 and CRF were of small 
clinical importance, they were not statistically significant (r = 0.17, r = 0.18, r = 0.26, respectively; p > 
0.05). Similarly, none of the associations between LPA and body composition, nor those with regional 
body fat measurements, were statistically significant (p > .05). Although, small clinically important 
associations between LPA and body composition measures, except for FFSTM (kg), were observed 
(Figure 3.3a). 
 
Both higher steps·day−1 and CRF were associated with reduced body mass, BMI and total adiposity (kg) 
(p < .05), as well as reduced central obesity measures (WC, CFM [kg] and VAT) (Figure 3.3c and d) and 
absolute measures of regional body fat (AFM and TFM) (p < .05) (Figure 3.4c and d). Although CRF 
and FFSTM (kg) was inversely associated (p < .05), a positive association was found with %FFSTM 
(Figure 3.3c and d). The magnitude of the correlations varied between small (-0.2) and very large (-0.8) 













Figure 3.3 Correlation coefficient and 90% confidence intervals in relation to body composition variables and a) light-intensity physical 





























































































































































































































Figure 3.4 Correlation coefficient and 90% confidence intervals in relation to regional fat distribution variables and a) light-intensity physical 


















































































































































































































3.4.8 Associations between physical activity, cardiorespiratory fitness, and cardiometabolic risk 
outcomes 
 
None of the univariate associations between the PA variables, and CRF, and each of the cardiometabolic 
disease risk outcomes were statistically significant (p > .05), even after the adjustment for total FM (kg) 
(Additional file 1). However, after adjusting for differences in VAT area, serum concentrations of TG 
and TG:HDL-C were both inversely associated with all PA variables and CRF level (p < .05). 
 
Most notably, the magnitude of the unadjusted correlation coefficient (r) between LPA and HDL-C (r = 
0.17), and between CRF and HDL-C (r = 0.18), were deemed clinically significant (Additional file 1). 
The same were observed for MVPA and SBP (r = -0.13), MVPA and DBP (r = -0.16), steps·day−1 and 
SBP (r = -0.13), steps·day−1 and DBP (r = -0.14), CRF and SBP (r = -0.22), and CRF and DBP (r = -
0.27). When adjusted for total FM (kg) and VAT area, these correlations were trivial (r < 0.1). 
 
3.4.9 Multiple regression analysis  
 
Exploration of independent associations of PA (steps·day−1) and CRF (relative VO2max) with body 
composition were determined using multiple regression analysis (Table 3.4). All models were adjusted 
for age (yrs) as it was shown to be inversely associated with CRF (r = -0.38, p = .008). Both steps·day−1 
and CRF level were inversely associated with BMI (steps·day−1: β =-0.25, p = .038) (CRF: β =-0.64, p < 
.001), whereas only CRF was negatively associated with absolute FM (β = -0.53, p = .002). CRF was 
also positively associated with %FFSTM (β = 0.69, p < .001). 
 
None of the PA variables were independently associated with any of the regional body fat distribution 
measures. However, CRF was inversely associated with WC (β = -0.63, p < .001) and VAT area (β = -









Table 3.4 Independent associations (partial correlation coefficients) between physical activity variables 
and cardiorespiratory fitness level, with body composition and regional body fat distribution 
measurements.     
BMI (kg·m2)       p-value 
n = 46 r =  0.751 R2 = 0.565 SEE = 4.90 < .001 
  β B SEE  
Relative VO2max (mL·kg−1·min−) -0.648 -0.847 0.165 < .001 
Steps·day−1 -0.252 -9.889 4.600 0.038 
Age (yrs) -0.097 -0.054 0.066 0.415 
     
FM (kg)       p-value 
n = 46 r =  0.515 R2 = 0.265 SEE = 14.32 < .007 
  β B SEE  
Relative VO2max (mL·kg−1·min−) -0.534 -1.569 0.484 0.002 
Steps·day−1 -0.021 -2.632 13.449 0.845 
Age (yrs) -0.090 -0.114 0.194 0.559 
     
%FFSTM        p-value 
n = 46 r = 0.478 R2 = 0.228 SEE = 9.09 < .018 
 β B SEE  
Relative VO2max (mL·kg−1·min−) 0.466 0.848 0.307 0.008 
Steps·day−1 0.116 6.391 8.538 0.458 
Age (yrs) 0.254 0.200 0.123 0.114 
     
WC (cm)        p-value 
n = 46     r = 0.697 R2 = 0.487 SEE = 12.08 < .001 
 β B SEE  
Relative VO2max (mL·kg−1·min−) -0.635 -1.883 0.408 0.001 
Steps·day−1 -0.160 -14.238 11.340 0.216 
Age (yrs) -0.046 -0.060 0.164 0.716 
     
VAT area (cm2)         p-value 
n = 46 r = 0.692 R2 = 0.480 SEE = 50.03 < .001 
  β B SEE  
Relative VO2max (mL·kg−1·min−) -0.566 -6.902 1.691 < .001 
Steps·day−1 -0.212 -77.597 46.960 0.106 
Age (yrs) 0.026 0.142 0.680 0.835 
BMI, body mass index; kg·m2, kilograms per metred squared; r, correlation coefficient; R2, coefficient of determination; SEE, 
standard error of estimate; β, partial correlation coefficient; B, parameter estimate; FM, fat mass, kg, kilograms; VO2max, 
maximal aerobic capacity; mL·kg−1·min−1, millilitres per kilogram per minute; steps·day−1, steps per day; yrs, years; 
%FFSTM, percentage fat-free soft tissue mass; WC, waist circumference; cm, centimetre; VAT, visceral adipose tissue; cm2, 










The principal finding of this small-scale cross-sectional study was the clinically significant and positive 
associations found between PA intensity time (LPA and MVPA) and daily volume (steps·day−1) with 
CRF. Irrespective of PA intensity, statistically significant inverse associations between higher 
steps·day−1, as well as CRF, with total adiposity, measures of regional body fat (AFM and TFM) and 
central obesity (WC, CFM and VAT area) were observed. However, both steps·day−1 and CRF were also 
inversely associated with FFSTM (kg) and SMI. Independent of VAT area, higher PA time (both LPA 
and MVPA), volume (steps·day−1) and CRF were all associated with reduced TG and TG:HDL-C serum 
levels, suggestive of reduced cardiometabolic disease risk among the more active and/or fitter women. 
Most notably, higher CRF was associated with women who were younger and with reduced total and 
central adiposity (BMI, FM, WC and VAT area); all of which were independent of PA (steps·day−1).     
 
Although less than a third of the women in the present study met the daily step count recommendation 
(≥ 10 000 steps·day−1) [9], our results showed that higher steps·day−1 was associated with lower total and 
central adiposity. Similar to these results, although among a larger (n = 151) rural SA sample of women 
(aged: 15 – 55 yrs), Cook et al. [13] reported a dose-dependent association between BMI and steps·day−1. 
After adjusting for potential confounders (age, access to a motor vehicle, education, tobacco use and 
comorbidities) the study showed that for every 5 000 steps·day−1, BMI was 1.4 kg·m2 lower. The same 
authors also reported that women (n = 138) (age range: 19 – 56 yrs) with the highest CRF levels had 
significantly lower %BF [12]. Similar results were shown among a smaller sample of urban SA women 
(n = 46) (age range: 18 – 45 yrs) [15]. Irrespective of the different methods used to determine CRF level 
(indirect [12, 15] vs. direct assessment) and %BF (sum of skinfolds [12] vs. DXA [15]), all these findings, 
including those of the present study, signify the measurable health-related benefits associated with being 
more active and having a higher CRF level. Having stated this, however, our study revealed that, on 
average, urban women presented with “very poor” CRF levels [39] which was also lower than previously 
reported data from a rural (~ 26.7 mL·kg−1·min−1) [12] and an urban SA sample (~ 25.1 mL·kg−1·min−1 
) [15]. Thus, even though the more active and fitter women presented with more favourable health 
outcomes, their aerobic fitness, similar to other SA women were rated  as “very poor” according to the 
ACSM’s age-specific reference data for women [39]. Thus, it could be postulated that higher CRF levels 







Possible reasons for the low aerobic fitness levels found in the present study; may in part, be explained 
by the lack of vigorous-intensity PA time and the relatively lower FFSTM% to higher BF% (45.8% vs. 
47.2%, respectively) among those who took part. Higher PA intensities ( 6 METs) require an increase 
in the number of motor units recruited by the central nervous system resulting in higher oxygen demand 
and thus cardiac output [49]. However, other factors, e.g. genetics and dietary intake, which fall beyond 
the scope of the present study, may also contribute to a “very poor” CRF-grading [48]. 
 
Even though the majority of awake time (43.7%) spent physically active was performed at LPA (~ 5.5 
hours per day), our results failed to show statistically significant associations between LPA and any of 
the body composition, regional body fat measures and cardiometabolic risk factors for CVD and T2DM. 
General findings from the literature based on accelerometer data [33], also among SA women [15], 
provided our motivation for the Freedson cut-points in the present study [33]. However, numerous 
accelerometer-based cut-points exist, specifically among adult populations, and they vary in terms of the 
number of activity counts·min−1 (e.g. light-intensity, Freedson: 100 - 1952 counts·min−1 vs. Troiano: 100 
- 2019 counts·min−1) [32]. Using these cut-point values, the differences in our data set are apparent, 
namely: 340 vs. 314 min·day−1 of LPA and 22 vs. 14 min·day−1 of MVPA. Thus, it is possible that a 
failure to identify pertinent predictors of cardiometabolic risk, as in the present study, may be attributed 
to the application of various PA intensity thresholds. 
 
In the presence of visceral obesity, numerous alterations in serum biochemical parameters exist, e.g. 
impaired fasting glucose, abnormal liver function and dyslipidaemia [50-52]. This is confirmed by the 
correlation between an excess accumulation of VAT and an increased risk for CVD [51] and/or T2DM 
[52]. However, our study showed that independent of VAT area, but not total FM, CRF level and each 
of the PA variables (time in different intensity bands and steps·day−1) are associated with an improved 
lipid profile (reduced serum TG and TG:HDL-C concentrations, respectively). Thus, total FM, as 
opposed to VAT area, seem to play a mediating role between the independent variable (CRF level) and 
each of the dependent variables (TG and TG:HDL-C). When the effect of total FM was removed, none 
of the relationships were statistically significant, whereas the opposite was true for VAT area. To our 
knowledge, this is the first study to measure, and examine DXA-derived VAT area in SA women in 
relation to behavioural/lifestyle factors such as PA (intensity and volume) and CRF level. Furthermore, 







urban  women with higher CRF levels (predicted VO2max)  have reduced HOMA-IR ( r = -0.41, p = .01), 
both before and after adjusting for differences in total FM [48]. Collectively, this body of evidence 
underlines the cardiometabolic health-related benefits associated with higher PA volume and higher CRF 
levels among overweight and obese women. 
 
Evidence is suggestive that lifestyle intervention programmes aimed exclusively at weight loss goals, 
should also focus on increasing CRF level [48] while monitoring changes in absolute FM and FFSTM. 
Given the positive effects of controlled exercise and dietary intake on improving  cardiometablic health 
and adiposity, our challenge is to devise innovative and sustainable health and exercise promotion 
programmes within communities, while taking into account their personal circumstances and daily 
challenges. This may require partnerships with government (both national and provincial), universities, 
non-profit organisations and/or private enterprises to develop and present such programmes. Importantly, 
volunteers within communities, so-called health champions, should be empowered to lead and manage 
these programmes themselves and ultimately assume responsibility for the sustainability of such 
programmes.  
 
Limitations of the present study include the use of a potentially biased sampling method, the small size 
of the study group, as well as even smaller sub-group of women who completed the maximal incremental 
exercise test. However, the use of objectively-derived PA variables, VO2max criterion method and DXA-
scanning techniques, can all be regarded as strengths of the study. The findings of the present study are 
preliminary, and thus hypothesis generating. Nevertheless, the study provides valuable insight into the 
overall health status of women living in an under-resourced urban community in South Africa. It 
underscores the need to introduce comprehensive lifestyle programmes for women from a young age to 




The study highlights the health-related benefits of higher daily PA volume and CRF level, with reduced 
total adiposity and central obesity among both young and older women residing in an under-resourced 
urban setting. The challenge to design and implement healthy lifestyle-based interventions for women of 







programmes, focus groups, comprising self-nominated community leaders with a vested interest in 







Additional file 1. Associations between physical activity, cardiorespiratory fitness, and cardiometabolic disease risk outcomes. 






0.05 0.03 0.26 0.26 0.17 -0.01 -0.09 
Adjusted for FM (kg) 
 
0.01 0.04 0.03 0.03 -0.01 -0.02 -0.01 
Adjusted for VAT (cm2) 
 





-0.13 -0.16 -0.05 -0.04 -0.02 -0.02 -0.04 
Adjusted for FM (kg) 
 
0.01 0.07 -0.03 -0.03 -0.03 -0.02 -0.02 
Adjusted for VAT (cm2) 
 
0.01 0.01 -0.03 -0.03 -0.01 -0.35* -0.39* 
Steps·day−1 Unadjusted 
 
-0.13 -0.14 0.02 0.03 0.11 -0.19 -0.23 
Adjusted for FM (kg) 
 
-0.01 0.04 -0.01 -0.01 0.01 -0.01 0.01 
Adjusted for VAT (cm2) 
 
0.01 -0.02 -0.01 -0.01 0.03 -0.35* -0.39* 




-0.22 -0.27 -0.01 -0.06 0.18 -0.06 -0.10 
Adjusted for FM (kg) 
 
0.01 0.04 -0.04 -0.04 -0.01 -0.02 -0.01 
Adjusted for VAT (cm2) 
 
0.01 0.05 -0.04 -0.04 0.01 -0.43* -0.46** 
Values are Pearson product-moment correlation coefficients (top row, unadjusted values) and partial correlation coefficients (middle row; values adjusted for fat mass (FM) 
in kilograms (kg); bottom row, values adjusted for visceral adipose tissue area (VAT) in centimetre squared (cm2). min·day−1, minutes per day; LPA, light-intensity physical 
activity; MVPA, moderate to vigorous-intensity physical activity; steps·day−1, steps per day; max.; maximal; VO2max, maximal aerobic capacity; mL·kg−1·min−1, millilitres 
per kilogram per minute; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol, HDL-C, high-density 









Associations between physical activity, cardiorespiratory fitness, and cardiometabolic disease risk outcomes (continued). 






-0.03 0.01 0.20 0.18 0.15 0.13 
Adjusted for FM (kg) 
 
-0.03 -0.03 0.01 0.01 -0.01 -0.03 
Adjusted for VAT (cm2) 
 





-0.01 -0.17 -0.03 0.03 0.06 0.12 
Adjusted for FM (kg) 
 
-0.03 -0.04 -0.01 -0.01 -0.04 -0.02 
Adjusted for VAT (cm2) 
 
-0.02 -0.02 -0.01 -0.01 0.04 0.05 
Steps·day−1 Unadjusted 
 
-0.11 -0.12 -0.07 -0.03 -0.07 0.02 
Adjusted for FM (kg) 
 
-0.02 -0.01 -0.01 0.01 -0.04 -0.04 
Adjusted for VAT (cm2) 
 
0.01 -0.04 0.01 0.01 0.04 0.06 




0.03 0.03 -0.10 -0.12 -0.07 -0.06 
Adjusted for FM (kg) 
 
-0.03 -0.04 -0.03 -0.02 -0.02 -0.04 
Adjusted for VAT (cm2) 
 
0.01 -0.03 -0.02 0.01 0.04 0.02 
Values are Pearson product-moment correlation coefficients (top row, unadjusted values) and partial correlation coefficients (middle row, values adjusted for fat mass [FM] 
in kilograms [kg]); bottom row, values adjusted for visceral adipose tissue area [VAT] in centimetre squared [cm2]). min·day−1, minutes per day; LPA, light-intensity physical 
activity; MVPA, moderate to vigorous-intensity physical activity; steps·day−1, steps per day; max., maximal; VO2max, maximal aerobic capacity; mL·kg−1·min−1, millilitres 
per kilogram per minute; Apo A, Apolipoprotein A1; Apo B, Apolipoprotein B; Apo B:Apo A, Apolipoprotein B to Apolipoprotein A1 ratio; FPG, fasting plasma glucose; 
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Background: The purpose of this study was to characterise sedentary time (ST) and type, and to examine 
the independent associations between objectively measured ST, moderate to vigorous-intensity physical 
activity (MVPA) and physical health-related fitness, with cardiometabolic risk. Methods: Fifty-one 
South African (SA) women (42 ± 13 yrs) completed interviewer-administered lifestyle questionnaires 
and laboratory-based tests to determine cardiometabolic disease risk profiles. Accelerometers (GT3X 
ActiGraph) were fitted and worn for ± 5 days. Multivariate linear regression was used to characterise the 
relationships between ST, MVPA and physical health-related fitness, with cardiometabolic risk. Results: 
No discernible associations between ST and MVPA, nor ST and CRF level, were observed. A moderately 
strong, inverse association was found between ST and muscular strength (r = -0.35; p = 0.011). Only 
physical health-related fitness and neither ST, nor MVPA, was independently associated with 
cardiometabolic risk, though potentially mediated by total and central adiposity. Conclusions: Lower 
CRF and muscular strength, as opposed to ST and MVPA, pose greater cardiometabolic disease risk in 
women from an under-resourced urban community. Low CRF and muscular strength, as opposed to ST 
and MVPA, pose greater cardiometabolic disease risk in women from an under-resourced urban 
community. Although there is somewhat of a minor truth in the “some physical activity is better than 
nothing” notion, our findings suggest that low levels of physical activity are not sufficient to impact 
fitness levels to the extent that it would provide some protection against women’s risk for future 
cardiometabolic disease. Furthermore, efforts to improve the overall fitness status of women in under-
resourced communities may be ineffective if their dietary habits are not simultaneously addressed, as 
exercise alone cannot solve the overweight and obesity problem that is prevalent among these women. 
 
 













Physical inactivity, an unhealthy diet, and tobacco and alcohol use, are described by the World Health 
Organization (WHO) as behavioural/lifestyle factors associated with increased risk for non-
communicable disease (NCD).1 The effects of such behaviours may result in obesity, hypertension, 
dyslipidaemia and glucose intolerance, and when clustered together are referred to as the metabolic 
syndrome (MetS).2 Similarly, prolonged bouts of sedentary time (ST) characterised by an energy 
expenditure of ≤ 1.5 metabolic equivalents3 are also linked to deleterious health effects.4,5,6 Of particular 
interest are the findings from a meta-analysis among adults, highlighting the independent and positive 
association between higher ST and increased cardiometabolic risk for cardiovascular disease (CVD) and 
type 2 diabetes mellitus (T2DM), which remained even after adjusting for differences in moderate to 
vigorous-intensity physical activity (MVPA) time.7 Such findings indicate the health-related benefits in 
targeting the reduction of ST. The latter differs in definition to physical inactivity which refers to 
individuals who perform insufficient amounts of MVPA.3 In light of this, targeting ST as an additional 
public health strategy to the current MVPA behavioural recommendations (i.e. ≥ 150 min/week of 
MVPA),24 in managing NCD-risk, warrants further investigation. 
 
Recognised as modifiable behaviours, ST and MVPA are important predictors of cardiometabolic risk.40 
Cardiorespiratory fitness (CRF), considered a physiological entity comprised of an individual’s genetic 
potential and physical activity behaviour, is an equally important predictor of cardiometabolic health. 
Results from a large adult population-based study39 indicated statistically significant associations 
between low MVPA and CRF levels, and high clustered cardiometabolic risk. Notably, even after 
adjustment for MVPA and ST, CRF remained the most important predictor for clustered cardiometabolic 
risk. The continuous clustered cardiometabolic risk score (CCMRS), as opposed to the traditional binary 
MetS criteria, is beneficial as it portrays an individual’s progressive increase in risk better when more 
risk factors are present. 
 
To our knowledge, little is known about sedentary behaviour among South Africans.8 Only two studies9,10 
highlighted the negative impact of ST on cardiometabolic health of urban-dwelling obese women. Of 






(SA) women as compared to their male counterparts (20.0% vs. 3.0%, respectively),11 and moreover, the 
irrefutable negative health implications associated with excess adiposity.12 Recent evidence suggests that 
a moderate-high cardiorespiratory fitness (CRF) level, may in part, counteract the negative consequences 
associated with obesity.13 In addition, the importance of increased muscular strength and reduced 
cardiometabolic risk for CVD.38 As components of physical-health related fitness, there remains a 
scarcity of data on CRF and muscular strength among adults in SA. Therefore, there is a compelling need 
to characterise ST and physical health-related fitness among women who are already obese. Furthermore, 
it should be determined whether high levels of ST and low levels of CRF and muscular strength relate to 
higher levels of total and central adiposity. Collectively, all these factors have the propensity to 
negatively impact overall  cardiometabolic risk for CVD and T2DM, as well as  health-related quality of 
life.   
 
Thus, the aim of this study was two-fold: i) to characterise ST (time and type) in urban women; and ii) 
to examine the independent associations between ST, MVPA and physical health-related fitness (CRF 
level and muscular strength), with cardiometabolic risk. We hypothesise that objectively measured high 
ST, low MVPA, and low measures of physical health-related fitness, are independently associated with 




4.3.1 Study design, participants, and sampling method  
 
This cross-sectional study included a convenience sample of residents from Cloetesville (Stellenbosch, 
Western Cape, South Africa), regarded an under-resourced urban living area.14 Using the chain sampling 
approach and assistance from a community representative, 73 women were recruited from the local 
community centre, health clinic and faith groups. Inclusion criteria were women aged between 18–64 yrs 
who were not pregnant or lactating, had no apparent physical and psychological diseases and were not 
using T2DM medication. Although rapid HIV-testing was not performed, participants were asked if they 






pregnancy and T2DM medication use, 10 women were excluded due to invalid accelerometer data and 
5 women chose not to complete the maximal exercise test. Approval of the study was granted by the 





Lifestyle-questionnaires included the WHO STEPwise approach to chronic disease risk factor 
surveillance instrument and the Sedentary Behaviour Questionnaire (SBQ), the latter shown to be a valid 
and reliable adult assessment tool.15 Both questionnaires were explained to each participant in their 
preferred language (Afrikaans or English) on the first day of testing. Resting blood pressure (BP) was 
measured in three successive intervals (Omron® HBP-1100, Omron Healthcare, Mannheim, Germany) 
and a fasting blood sample drawn to determine plasma glucose level (FPG), glycated haemoglobin 
(HbA1c) and serum lipid concentrations. Body mass (BM) and standing height, were measured using a 
calibrated electronic scale (Seca® 813, Hamburg, Germany) and sliding steel anthropometer (Seca® 711, 
Hamburg, Germany). Waist circumference (WC) at the level of the umbilicus was also recorded, whereas 
DXA (Discovery-W®, software version 13.4.1; Hologic, Bedford, MA) was used to measure whole body 
composition (fat-free soft tissue mass [FFSTM] and fat mass [FM]), as well as regional body fat 
distribution (central, appendicular, and trunk).16 Skeletal muscle index (SMI = ASM/height2) according 
to the guidelines set by the European Working Group on Sarcopenia in Older People (EWGSOP)17 and 
VAT area (cm2)18 were also determined.  
 
Each participant was instructed to wear an ActiGraph GT3X accelerometer (ActiGraph LLC, Pensacola, 
Florida) on their right hip attached to an elastic belt during waking hours for 7-days. Due to the monitor 
being non-water resistant, participants were instructed not to wear it when bathing or swimming. 
Recording of activity counts commenced 2-hrs after the monitor was fitted with time sampling intervals 
set at 60-sec epochs. Each ActiGraph data file (*.agd) was downloaded onto a personalised computer and 
processed in Microsoft Excel® using a custom-written program (‘ACTILIFE’, 
http://actigraphcorp.com/products-showcase/software/actilife/). Data was included only if participants 
met the minimum requirement of ≥ 600-min of monitor wear time on ≥ 3-days.19 Wear time was 






of ≥ 60 consecutive min with zero activity counts allowing for intervals of 1–2-min of relatively low 
activity counts/min (i.e. < 100). According to Freedson20 cut-points, ST reported in min/day was defined 
as < 100 counts/min, whereas MVPA as ≥ 1952 counts/min.  
 
Physical health-related fitness components included muscular strength (kg) determined using a hand grip 
dynamometer (Takei Digital Hand Grip 5401, Niigata City, Japan) and CRF level (relative VO2max) 
determined using an incremental exercise test performed to exhaustion on the h/p/Cosmos Saturn® 
treadmill (Nussdorf-Traunstein, Germany) along with the COSMED Quark CPET metabolic system 
(Rome, Italy).  
 
Informed by the International Diabetes Federation (IDF) MetS criteria21 a clustered cardiometabolic risk 
score (CCMRS), indicative of additional risk over and above the sum of the risk associated with each 
aberration,21 was generated by standardising each individual risk factor (i.e. subtracting the sample mean 
from the participant’s mean value and then dividing by the standard deviation of the sample [z-score]). 
Consequently, the standardised values for BP, WC, TG, log FPG, and the inverse of HDL-C, were added 
and the total divided by the denominator equal to the number of risk factors included (i.e. x = 5). A 
positive CCMRS meant a less preferable cardiometabolic disease risk profile.  
 
4.3.3 Statistical analyses 
 
Using STATISTICA version 13.3 (StatSoft Inc. Tulsa, OK, USA) the descriptive data are presented as 
means ± standard deviations or percentages. Non-gaussian distributed data (ST type, accelerometer-data, 
FPG, and HbA1c) are presented as medians with interquartile range and normalised by log-
transformation for parametric analyses. Differences in weekday vs. weekend day ST behavioural types 
were determined using Student t-tests. Group differences between the 51 vs. 46 participants who 
completed the CRF test, were assessed using Chi-squared tests (categorical variables) and Student t-tests 
(age and asset index). One-way analysis of variance (ANOVA) was used to determine if there were any 
differences between ST type, accelerometer data, muscular strength and cardiometabolic risk between 
the whole group (n = 51) and the sub-group (n = 46). The level of statistical significance was set at p < 
0.05. 






To explore the univariate associations between objectively measured ST in relation to i) MVPA, and ii) 
physical health-related fitness (muscular strength and CRF level), Pearson product-moment correlation 
coefficients (r) and 90% confidence intervals were calculated. Qualitative inferences for the probability 
of each “true” or “clinically significant” association using prescribed threshold values (< 0.1, trivial; 0.1–
0.3, small; > 0.3–0.5, moderate; > 0.5–0.7, large; > 0.7–0.9, very large) were also determined.22 The same 
analysis was completed between ST and body composition, regional fat, individual cardiometabolic risk 
outcomes and CCMRS, both before and after adjusting for fat mass [kg] and VAT area [cm2]). These 
results informed the forward stepwise multiple regression analyses to detect the presence of independent 
associations between ST, MVPA, and physical health-related fitness, with individual cardiometabolic 
risk outcomes and CCMRS.  
 
According to Cohen,23 and at a power of 80% and statistical significance of 5%, a sample size of 38–68 
participants was required to detect medium to large effect sizes for a maximum of four predictor variables 
in each multiple regression analysis. A variance inflation factor (< 3) was used to assess for multi-




4.4.1 Socio-demographics, socio-economic status, behavioural/lifestyle factors and physical health-
related fitness 
 
Socio-demographics, socio-economic status (SES) and behavioural/lifestyle factors are shown in Table 
4.1. Even though the majority of women were employed, little over a third had completed secondary 
school (grade 12). Few consumed alcohol (≥ 4 drinks/month), with even fewer reporting habitual 
smoking. On average, women possessed 86% of the personal and household wealth items listed in the 
questionnaire. Internet connectivity (88.2%; n = 45) and ownership of a motor vehicle (47.1%; n = 24) 









Table 4.1 Socio-demographics, socio-economic status and behavioural/lifestyle factors. 
 
Socio-demographics n = 51 
Age (yrs) 42 ± 13 (18 - 64) 
Education  n = 51 
Completed grade 7 (%) (n)  66.7 (34) 
Completed grade 12 and/or tertiary education (%) (n)   33.3 (17) 
Employment   n = 51 
Employed (%) (n) 60.8 (31) 
Unemployed (%) (n) 23.5 (13) 
Retirees/ Homemakers (%) (n) 9.8 (5) 
Students (%) (n) 5.9 (3) 
Behavioural/lifestyle factors n = 51 
Consumers of alcohol (%) (n) 25.5 (13) 
Smokers (%) (n) 21.6 (11) 
Asset index (number of assets out of a possible 14) 12 ± 2 (6 - 13) 
  Values for age and asset index are mean ± standard deviations with range in parenthesis.  
 
Self-report sedentary behaviours (type) on a typical weekday and weekend day are presented in Table 
4.2. Irrespective of week vs. weekend day, time spent watching television was the highest of the self-
reported sedentary behaviours (Figure 4.1). Likewise, and specifically during a typical weekday, time 
spent seated while listening to music, talking on the phone, driving/riding a car, bus or train, and reading, 
also ranked high (median: 180 min/day). Less time was spent in the remainder of sedentary behaviours 
(i.e. playing computer/video games, doing paperwork/office work, playing a musical instrument, and 
doing arts/crafts). Only one sedentary behaviour, namely time spent doing paperwork/office work, was 











Table 4.2 Self-report sedentary behaviours (type) on a typical weekday and weekend day. 
 
Time spent siting (min/day)   Weekday (n = 51)  Weekend day (n = 51)   p-value 
Watching television  300 (240 - 360) 300 (240 - 360) 0.223 
Listening to music 180 (60 - 240) 240 (120 - 300) 0.219 
Talking on the phone 180 (120 - 240) 180 (120 - 240) 0.448 
Diving/riding in a car, bus, or train 180 (120 - 240) 180 (120 - 300) 0.498 
Reading 180 (120 - 240) 120 (60 - 240) 0.085 
Playing computer/video games 120 (60 - 240) 60 (60 - 240) 0.740 
Doing paperwork/ office work 60 (60 - 240) 60 (60 - 60) 0.020* 
Playing a musical instrument 60 (60 - 60) 60 (60 - 60) 0.842 
Doing arts and crafts  60 (60 - 60) 60 (60 - 60) 0.484 
Values are medians with interquartile range in parenthesis. min/day, minutes per day. All values were normalised by                            
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Objectively measured ST and MVPA (min/day) are presented in Table 4.3. While wearing the 
accelerometer, women spent a larger proportion of awake time sedentary (57.3%; ~7.8 hr/day) vs. 
physically active (2.7%; ~22 min/day). Thus, most of the women (72.6%) fail to meet the MVPA WHO 
global health recommendations.24 In comparison to international age- and sex-specific CRF 
classifications, their relative VO2max (23.2 ± 5.4 mL·kg
−1·min−) was rated as “poor” and fell between the 
25th and 30th percentiles (22.1 – 23.3 mL·kg−1·min−1).26 Similarly, muscular strength was also rated 
“poorly” (26.5 ± 5.1 kg) and considerably lower than ≥ 54.0 kg which is rated as “good”.25 
 
Table 4.3 Accelerometer-derived sedentary and moderate to vigorous-intensity physical activity time, 
cardiorespiratory fitness and muscular strength. 
 
Accelerometry n = 51 
Number of activity days measured 5 (5 - 6) 
Non-wear time (min/day) 611 (542 - 636) 
Wear time (min/day) 829 (801 - 898) 
Sedentary time (min/day) 475 (442 - 514) 
MVPA (min/day) 22 (12 - 30) 
Cardiorespiratory fitness n = 46  
Relative VO2max (mL·kg−1·min−1) 23.2 ± 5.4 (11.5 - 35.1) 
Muscular strength n = 51  
Dominant hand grip strength (kg) 26.5 ± 5.1 (13.6 - 38.8) 
Values for accelerometry data are medians with inter-quartile range in parenthesis. min/day, minute per day; MVPA, 
moderate to vigorous-intensity physical activity; %, percentage. Cardiorespiratory fitness and muscular strength values are 
mean ± standard deviation with range in parenthesis. VO2max, maximal aerobic capacity; mL·kg−1·min−1, millilitres per 
kilogram per minute; kg, kilogram.  
 
 
No statistically significant differences in age, SES, height, any of the body composition measures (BM, 
BMI, FM, %BF, WC and VAT area), or any of the individual cardiometabolic risk outcomes and CCMRS 
were found between the whole group and the sub-group of women who completed the CRF test (all, p > 
0.05). In accordance with BMI categories, the majority of women were either obese or overweight (56.9% 






DXA-derived mean %BF was just below 50% of total BM (47.2 ± 7.2%), thus rated as “very poor” and 
shown to fall below the 1st percentile (> 39.1%) of age- and sex-related classifications.25 Although 26.0% 
of the women were sarcopenic according to the international EWGSOP standards (SMI: ≤ 5.76 kg/m2), 
none were considered BMI-obese.17 However, when using the lower SA sarcopenia-specific cut-point 
(SMI: ≤ 4.94 kg/m2), the proportion was lower (22.0%; n = 11) and included both younger and older 
women (age range: 18 – 52 yrs).26  
 
Table 4.4 Body composition and regional body fat distribution measurements. 
 
Body composition n Mean ± SD                                    Range 
Height (m) 51 1.56 ± 0.1 1.37 - 1.69 
Body mass (kg) 51 76.2 ± 18.8 37.7 - 127.0 
BMI (kg/m2) 51 31.3 ± 7.2 15.1 - 53.1 
Fat-free soft tissue mass (kg) 50 33.8 ± 6.5 21.8 - 57.9 
Fat-free soft tissue mass (%)  50 45.8 ± 6.0 33.4 - 64.3 
SMI (kg/m2) 50 6.5 ± 1.0 4.4 - 9.4 
Fat mass (kg)  50 36.6 ± 13.0 9.0 - 68.6 
Body fat (%) 50 47.2 ± 7.0 24.3 - 61.1 
Regional body fat distribution n Mean ± SD                                    Range 
Waist circumference (cm) 51 88.7 ± 16.2 57.4 - 138.3 
CFM (kg) 50 18.9 ± 7.0 4.2 - 39.3 
CFM (% FM) 50 53.1 ± 4.8 41.2 - 63.0 
AFM (kg) 50 17.7 ± 6.5 4.8 - 36.2 
AFM (% FM) 50 50.0 ± 5.1 39.4 - 60.5 
VAT area (cm2) 51 151.7 ± 66.2 19.2 - 418.0 
 Values are mean ± standard deviation (SD). m, metres; kg, kilograms; BMI, body mass index; SMI, skeletal muscle mass; 
%, percentage; CFM, central fat mass; AFM, appendicular fat mass; VAT, visceral adipose tissue; cm2, centimetres squared.   
 
 
In accordance with the IDF risk cut-off criteria for WC (≥ 80 cm),21 the group presented with high 
cardiometabolic risk (88.7 ± 16.2 cm). %CFM was higher than %AFM (53.1% vs. 50.0%, respectively), 






4.4.2 Cardiometabolic risk outcomes and clustered cardiometabolic risk score 
 
The individual cardiometabolic risk outcomes are presented in Table 4.5, with frequency distributions of 
the individual and CCMRS depicted in Figure 4.2 and 4.3, respectively. According to international 
diagnostic criteria, mean DBP (84.4 ± 14.8 mm Hg) was indicative of stage 1 hypertension,27 whereas 
HbA1c (≥ 5.7%) that of prediabetes.28 Mean serum HDL-C was below and plasma Lp (a) above their 
respective ideal values.29,30 
 
Table 4.5 Individual cardiometabolic risk outcomes. 
Blood pressure  Ideal value Mean ± SD Range 
SBP (mm Hg) (n = 48) < 120 128.0 ± 20.0 93.3 - 183.0 
DBP (mm Hg) (n = 48) < 80 84.4 ± 14.8 54.6 - 133.0 
Lipid profile Ideal value  Mean ± SD Range 
TC (mmol/L) (n = 51) < 5.0 4.9 ± 1.1 2.2 - 8.1 
LDL-C (mmol/L) (n = 51) < 3.0 2.9 ± 0.9 0.8 - 5.5 
HDL-C (mmol/L) (n = 51) ≥ 1.3 1.2 ± 0.3 0.7 - 1.9 
TG (mmol/L) (n = 51) < 1.7 1.3 ± 0.7 0.3 - 3.6 
TG:HDL-C (n = 51) < 2.0 1.0 ± 0.6 0.2 - 2.9 
Lp (a) (mg/dL) (n = 51) < 50.0  54.5 ± 49.4 2.0 - 232.0 
Diabetes indicators Ideal value Median  Interquartile range 
FPG (mmol/L) (n = 50) < 5.6 4.9 4.5 - 5.6 
HbA1c (%)(n = 51) < 5.7  5.7 5.4 - 5.9 
Values for blood pressure and lipid profile are unadjusted means ± standard deviation (SD), whereas values for indicators for 
diabetes are medians and interquartile range. SBP, systolic blood pressure; mm Hg, millilitres of mercury; DBP, diastolic 
blood pressure; TC, total cholesterol; mmol.L, millimoles per litre; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-
density lipoprotein cholesterol;TG, triglyceride; TG:HDL-C, triglycerides to high-density lipoprotein cholesterol ratio; Lp (a), 













Figure 4.3 A frequency distribution of positive (red) vs. negative (green) clustered cardiometabolic risk 
scores (CCMRS) of all the women. A positive CCMRS implies a less preferable cardiometabolic disease 
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4.4.3 Associations between sedentary time, socio-demographics, socio-economic status, and 
behavioural/lifestyle factors 
 
Objectively measured ST and age were not related (r = 0.07; p = 0.588). Women who were employed 
accumulated less ST per day compared to the unemployed women (463 ± 12 min/day vs. 505 ± 14 
min/day; p = 0.051). None of the other SES or behavioural/lifestyle factors were statistically significantly 
associated with ST (p > 0.05).  
 
4.4.4 Associations between sedentary time, MVPA and physical health-related fitness  
 
Neither MVPA, nor CRF correlated with objectively measured ST (Table 4.6). However, muscular 




Figure 4.4 The inverse association between objectively measured sedentary time and muscular strength 


































4.4.5 Associations between sedentary time, body composition, and regional body fat distribution 
measures 
 
None of the univariate associations between any of the body composition distribution measures were 
significantly correlated with ST (all, p > 0.05) (Table 4.6). Small clinically significant inverse 








Table 4.6 Correlation coefficients between objectively measured sedentary time and behavioural/lifestyle measures, body composition and 
regional body fat distribution measures. 
 
 n Correlation coefficient (90% CI) Magnitude-based inference                                         
Behavioural/lifestyle measures    
MVPA (min/day) 51 -0.02 (-0.25; 0.21)   Trivial  
Cardiorespiratory fitness (mL·kg−1·min−1) 46 -0.04 (-0.27; 0.19) Trivial  
Muscular strength (kg) 51 -0.35*(-0.54; -0.13) Small  
Body composition    
Body mass (kg) 51 -0.08 (-0.31; 0.16) Trivial  
BMI (kg/m2) 51 -0.07 (-0.30; 0.17) Trivial  
Fat-free soft tissue mass (kg) 50 -0.18 (-0.40; 0.06) Small  
Fat-free soft tissue mass (%) 50 -0.02 (-0.25; 0.21) Trivial  
SMI (kg/m2) 50 -0.16 (-0.38; 0.08) Small 
Fat mass (kg) 50 -0.07 (-0.30; 0.17) Trivial  
Body fat (%) 50 0.01 (-0.22; 0.24) Trivial  
Regional body fat distribution measures    
Waist circumference (cm) 51 -0.07 (-0.30; 0.17) Trivial  
CFM (kg) 50 -0.08 (-0.31; 0.16) Trivial  
CFM (%) 50 -0.06 (-0.29; 0.18) Trivial  
AFM (kg) 50 -0.05 (-0.28; 0.19) Trivial  
AFM (%) 50 0.08 (-0.16; 0.31) Trivial  
TFM (kg) 50 -0.08 (-0.31; 0.16) Trivial  
TFM (%) 50 -0.03 (-0.26; 0.23) Trivial  
VAT area (cm2) 50 -0.06 (-0.29; 0.18) Trivial  
min/day, minute per day; moderate to vigorous-intensity physical activity; mL·kg−1·min−1, millilitres per kilogram per minute; kg, kilogram; BMI, body mass index; kg/m2, 
kilogram per metre squared; %, percentage; SMI, skeletal mass index; CFM, central fat mass; AFM, appendicular fat mass; TFM, trunk fat mass; VAT, visceral adipose 






4.4.6 Associations between sedentary time, individual cardiometabolic risk outcomes, and 
clustered cardiometabolic risk 
 
None of the univariate associations between ST and any of the individual cardiometabolic risk outcomes 
presented in Table 4.7 were statistically significantly correlated (all, p > 0.05). However, after adjusting 
for differences in VAT area (cm2), ST correlated positively with serum TG (r = 0.36; p = 0.048), 
TG:HDL-C (r = 0.41; p = 0.020) and also with CCMRS (r = 0.65; p < 0.001). When adjusting for 
differences in total FM (kg) and VAT area (cm2), CCMRS was strongly correlated with ST (r = 0.46 and 






Table 4.7 Associations between objectively measured sedentary time with individual cardiometabolic risk outcomes and clustered 









Adjusted for  





Adjusted for  





SBP (n = 48) -0.11 (-0.34; 0.13) Small -0.01 (-0.25; 0.23) Trivial 0.02 (-0.22; 0.26) Trivial 
DBP (n = 48) -0.18 (-0.40; 0.06) Small -0.01 (-0.25; 0.23) Trivial 0.02 (-0.22; 0.26) Trivial 
TC (n = 51) -0.18 (-0.40; 0.06) Small -0.01 (-0.25; 0.23) Trivial -0.01 (-0.25; 0.23) Trivial 
LDL-C (n = 51) -0.20 (-0.41; 0.03) Small  0.02 (-0.21; 0.25) Trivial 0.01 (-0.22; 0.24) Trivial 
HDL-C (n = 51) -0.08 (-0.31; 0.16) Trivial  0.01 (-0.22; 0.24) Trivial 0.01 (-0.22; 0.24) Trivial 
TG (n = 51) 0.01 (-0.22; 0.24) Trivial -0.02 (-0.25; 0.21) Trivial 0.36* (0.14; 0.55)  Moderate 
TG:HDL-C (n = 51) 0.01 (-0.22; 0.24) Trivial -0.01 (-0.25; 0.23) Trivial 0.41* (0.20; 0.59) Moderate  
Lp (a) (n = 51) -0.04 (-0.27; 0.19) Trivial -0.04 (-0.27; 0.19) Trivial -0.03 (-0.26; 0.20) Trivial 
FPG (n = 50) -0.03 (-0.26; 0.20) Trivial -0.04 (-0.27; 0.20) Trivial 0.01 (-0.22; 0.24) Trivial 
HbA1c (n = 51) -0.02 (-0.25; 0.21) Trivial -0.03 (-0.26; 0.20) Trivial 0.03 (-0.20; 0.26) Trivial 
Clustered cardiometabolic 
 risk score (n = 47) 
-0.07 (-0.30; 0.17) Trivial 0.46** (0.24; 0.63) Moderate 0.65** (0.48; 0.77) Large  
Values are Pearson product-moment correlation coefficients with 90% confidence interval in brackets (second column) & Partial correlation coefficients with 90% 
confidence interval in brackets (fourth column, values adjusted for fat mass [FM] in kilograms [kg]; sixth column, values adjusted for visceral adipose tissue [VAT] area 
in centimetres squared [cm2]). SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol, HDL-C, 
high-density lipoprotein cholesterol; TG, triglyceride; TG:HDL-C, triglyceride to high-density lipoprotein cholesterol ratio; Lp (a), lipoprotein (a); FPG, fasting plasma 












4.4.7 Multiple regression analysis 
 
Separate multivariate regression models were used to explore the independent associations of ST, MVPA 
and physical health-related fitness (CRF level and muscular strength), with the following dependent 
variables: i) serum TG and TG:HDL-C concentrations as individual markers of cardiometabolic risk; and 
ii) CCMRS (Table 4.8). Only muscular strength was independently associated with serum TG 
concentration (β = -0.34; p = 0.033), however, after adjusting for VAT area (cm2) the association was no 
longer statistically significant (p > 0.05). CRF level was independently associated with CCMRS (β = -






Table 4.8 Correlation coefficients of independent associations between physical health-related fitness 
(muscular strength and cardiorespiratory fitness) with serum triglyceride and clustered cardiometabolic 
risk score.     
 
TG (mmol/L)          
n = 46 r = 0.315 R2 = 0.099 S.E.E = 0.759 p = 0.033 
  Β B S.E.E p-value 
Dominant hand grip strength (kg) -0.347 0.055 0.025 0.033 
Relative VO2max (mL·kg−1·min−1) -0.024 -0.003 0.021 0.873 
Sedentary time (min/day) 0.098 0.932 1.493 0.536 
 
 
Clustered cardiometabolic risk score         
n = 46 r = 0.486 R2 = 0.236 S.E.E = 0.520 p = 0.010 
  Β B S.E.E p-value 
Relative VO2max (mL·kg−1·min−1) -0.377 -0.039 0.614 0.008 
Dominant hand grip strength (kg) 0.252 0.029 0.016 0.092 
Sedentary time (min/day) -0.058 -0.402 1.006 0.691 
TG, triglyceride; mmol.L, millimoles per litre; r, correlation coefficient; R2, coefficient of determination; SEE, standard error 
of estimate; β, partial correlation coefficient; B, parameter estimate; kg, kilogram; VO2max, maximal aerobic capacity; 
mL·kg−1·min−1, millilitres per kilogram per minute; min/day, minutes per day. p-values highlighted in bold are statistically 





The main findings of this cross-sectional study indicate that the women spent the majority of their time 
awake in sedentary mode (± 7.8 hr/day) with as much as ± 5 hr/day spent watching television. 
Subsequently, the women presented with poor CRF and muscle strength, which were independently 
associated with increased cardiometabolic risk for CVD and T2DM. Contrary to our research hypothesis, 
ST and MVPA were not associated with cardiometabolic risk.  
 
To our knowledge this is the first SA cross-sectional study to characterise sedentary behaviour both 
subjectively and objectively among urban-dwelling women. Although national prevalence estimates 
exist, these relate to “physical inactivity”1 which differs in definition to sedentary behaviour.3 Given that 






of SA-specific data is concerning, especially given the 14% NCD-related mortality estimate attributed to 
physical inactivity.1 Our results provide insight as to the types of sedentary behaviours, most importantly 
television viewing as the most prominent, as well as the high proportion of sedentarism among the 
women living in a low socio-economic urban setting. These findings are in agreement with previous 
reports on accelerometer-derived ST (± 8.5 hr/day) and self-report sitting time (± 3 hr/day) among other 
adult women from under-resourced urban settings.10,11 
 
Even though the majority of women who took part in the present study were mostly sedentary, 
insufficiently active and unfit, no discernible associations between ST and MVPA, nor ST and CRF level 
were observed. A reason for this finding may, in part, relate to the narrow ranges of time spent sedentary 
and moderately active. Alternatively, both physical-health fitness measures presented with larger data 
ranges. Such that an inverse and moderately strong association between ST and muscular strength (r = -
0.35; p = 0.011) along with small clinically significant inverse associations between ST and FFSTM (kg) 
and, ST and SMI (kg/m2) were found. These results indicate that high ST is an independent risk factor 
for low muscle mass, and thus offers a reasonable explanation underpinning the “poor” muscular strength 
rating achieved by most women in the study.   
 
The high proportion of physical inactivity (72.6%) in the present study differed greatly from previous 
SA studies which reported high levels of self-report MVPA among urban women (61.0% and 75.0%).9,31 
Most likely, this divergence can be ascribed to our objective measurements opposed to self-report 
estimates. Importantly, low levels of physical activity are associated with higher risk for sarcopenia. Most 
unexpectedly, it was younger women in our study with suspected sarcopenia which is contrary to the 
generalised deficits in skeletal muscle mass and strength associated with ageing.32 Although we cannot 
infer cause and effect, the younger women had statistically significantly higher %BF and lower CRF in 
comparison to those who were sufficiently active and of similar age. There is strong evidence in the 
literature that an increase in skeletal muscle mass as a result of muscular strength (resistance) exercise 
training contributes towards the maintenance or increase in resting energy expenditure, as well as 
improvement in glucose tolerance among prediabetics.33 Thus, it is important to introduce resistance 
training from a young age, especially given the risks associated with sarcopenic obesity. At the same 
time  the importance of high CRF levels must be emphasised, as recent findings indicated that moderate-






≥ 25 kg/m2) who also present with impaired fasting insulin or undiagnosed T2DM.36 Also characterised 
as the “Fat-but-Fit” paradigm,37 this inference is not aimed at diminishing the importance of preventing 
obesity but rather aims to offer a practical means to improving cardiometabolic health among women 
who are highly unfit, and thus have the potential to show significant improvements in CRF given 
exposure to aerobic exercise programmes.  
 
Despite most of the women being BMI-obese (56.9%, n = 29) and presenting with high total adiposity 
(%BF: 47.2 ± 7.0%), objectively-measured ST did not associate with any of the adiposity measures (all, 
p > 0.05). However, when adjusting for differences in adiposity, higher serum lipid concentrations (TG 
and TG:HDL-C) and CCMRS correlated positively with ST (all, p < 0.05). This finding highlights the 
potential mediating role of adiposity between high ST and raised cardiometabolic disease risk. Our results 
are in agreement with previous large-scale international studies,34,35 as well as a small-scale SA study,9 
which hypothesised that the mediation effects are partly associated with a reduction in lipoprotein lipase 
activity during extended bouts of sedentary time. However, given the low socio-economic status of the 
women in our study we cannot negate the potential influence of dietary intake on serum lipid 
concentrations. For example, a cheaper high-carbohydrate low-fat diet is negatively associated with 
reduced HDL-C and higher TG serum concentrations.41     
 
The strengths of the present study include the use of high precision measurement techniques (DXA 
scanner, accelerometry and maximal exercise treadmill test). Moreover, the inclusion of the CCMRS 
strengthens the study, as the use of a continuous score as opposed to cut-points used by the IDF21, is a 
truer reflection of the overall risk of an individual. Its use also accounts for the progressive CVD and 
T2DM risk increase with increasing MetS risk factors. However, limitations in its use include the lack 
of consensus that exists with regards to which risk factors to include, as well as the definition of women 
who are “high risk.” In general, the attributed risk is specific to only the study sample being studied, and 
thus not based on any specific biological measure. Other limitations include our use of a small sample of 
convenience, which was further reduced due to the non-adherence of accelerometer data specifications 
(n = 10) and those who refused the maximal exercise test (n = 5), as well the inability to estimate insulin 
resistance. Nevertheless, the small sample size was deemed adequate according to the power calculation. 
Furthermore, the cross-sectional design of the study limited any causal conclusions to be drawn which 






the present study, our inability to characterise other equally important behavioural/lifestyle factors, e.g. 




Low CRF and muscular strength, as opposed to ST and MVPA, pose greater cardiometabolic disease risk 
in women from an under-resourced urban community. Although there is somewhat of a minor truth in 
the “some physical activity is better than nothing” notion, our findings suggest that low levels of physical 
activity are not sufficient to impact fitness levels to the extent that it would provide some protection 
against women’s risk for future cardiometabolic disease. Furthermore, efforts to improve the overall 
fitness status of women in under-resourced communities may be ineffective if their dietary habits are not 
simultaneously addressed, as exercise alone cannot solve the overweight and obesity problem that is 
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5.1 Introduction   
                                      
Under the supervision of Prof Elmarie Terblanche, Bradley Fryer, a previous Stellenbosch University 
Sport Science doctoral student (2014 – 2016) identified the high proportion of obesity, hypertension, and 
particularly T2DM among residents residing in Cloetesville - a neighbouring and low-resourced suburb 
to the University town of Stellenbosch (Western Cape Province, South Africa). Data captured by the local 
public health community clinic task force indicated as much as 65.0% of the adult day clinic patients 
having at least one NCD (2013). Given this observation, as well as Bradley’s professional interests as an 
allied health professional (i.e. biokineticist), he implemented a community-based lifestyle intervention 
and assessed its effects on physiological, psychological and health-related outcomes in adults living with 
T2DM in this community. The outcomes  revealed the effectiveness of a structured community-based 
intervention in assisting T2DM individuals to better manage themselves and reduce their overall health 
risk for other NCDs, e.g. cardiovascular disease (CVD) (Fryer, 2016).174   
 
Following on from Bradley’s project, the SUNWELL Community Health Programme was established in 
June 2015 and is run by students and staff in the Department of Sport Science. The programme offers an 
equal opportunity for all community members to participate in weekly exercise classes and learn about 
leading a healthy, active, and safe lifestyle. The mission of the SUNWELL Community Health 
Programme is consistent with the United Nations 3rd Sustainable Developmental Goal, which states: “To 
ensure healthy lives and promote well-being at all ages”. 
 
Our involvement in this community over the last 4 years made us acutely aware of the general poor health 
and physical conditioning of the adults, as well as their dire need for more and proper health care services. 
Though, we also realised that we need more in-depth knowledge about the individuals we want to serve, 
before we can implement interventions and hopefully make a meaningful difference in this community. 
This in keeping with the sentiments spoken by Prof Jimmy Volmink, the Dean of our Faculty of Medicine 
and Health Sciences who said: “To have an impact (e.g. in a community) - one must first generate 
knowledge (e.g. about that specific community)” (FMHD, 17 Oct 2019). Thus, conceptualisation of the 
larger research project, which includes the present doctoral study, began early in 2016. The expectation 






appropriate community-based interventions, as well as guide the aims and objectives of the SUNWELL 
Community Health Programme. 
 
5.2 Motivation for the cross-sectional study 
 
Research on the health status of populations can be done via large, community-based, cohort and 
epidemiological studies, or with smaller, cross-sectional studies. In case of the former, one attempts to 
gather as much information as possible, in as large samples as possible. The advantage of these types of 
studies is that they usually have high external validity, in other words, the findings can be generalised to 
the larger population. However, these studies are time- and resource dependent, which, among other, can 
exclude the use of gold standard tests and measurements. Cross-sectional studies, usually done on a 
smaller scale than cohort and epidemiological studies, includes individuals, in a particular setting (e.g. 
clinical, hospital, school, community, etc.), who meet a set of inclusion and exclusion criteria. Cross-
sectional studies can be completed in a shorter period of time, is usually less time- and money dependent 
and are often conducted when planning a cohort study, or as a baseline in a cohort study.  The major 
advantage of this type of study is that one can implement more elaborate and gold standard tests and 
measurements (i.e. high internal validity) and gain in-depth knowledge about a specific group of 
individuals; the downside is that this study design lacks external validity.  
 
Therefore, the decision to embark on a small-scale cross-sectional study in a specific community outside 
Stellenbosch, was primarily motivated by the mission of the SUNWELL Community Health Programme, 
as explained in the previous section. This study design afforded us the opportunity to use sophisticated 
and high-precision objective measurements to determine body composition and regional fat distribution 
(e.g. DXA-scan), PA variables and ST (accelerometry), as well as CRF and muscular strength (e.g. 
VO2max and hand grip strength test, respectively). An advantage of using “direct” measures was our ability 
to exclude potential participant bias which is evident in previously published epidemiological studies 
using “indirect” and subjective behavioural/lifestyle data (e.g. self-report PA questionnaires108, 176). 
Furthermore, the use of “proxy” indices for obesity (e.g BMI and WC) are also confounded by the 







Although the use of the “direct” measures limited the sample size of this doctoral study, it provided us 
with a rich data set and comprehensive picture of the overall health status of women from a low-resourced 
urban community. Furthermore, the study was purposely limited to women, as they fulfil vital roles in 
the community as income-earners, child-bearers and minders. Moreover, the main findings presented in 
this dissertation contribute to the knowledge base of the general health of urban women in SA and focuses 
specifically on a (previously) under-studied sub-population. 
 
5.3 Combined findings of the doctoral dissertation 
 
This study aimed to characterise modifiable behavioural/lifestyle factors namely, PA and sedentary 
behaviour, as well as physical health-related fitness components (CRF and muscular strength) in relation 
to cardiometabolic disease risk for CVD and T2DM in urban-dwelling women from an under-resourced 
community (Cloetesville, Stellenbosch) in the Western Cape. In addition, we determined which of 
physical activity, sedentarism and health-related fitness levels are predictors of obesity and other 
cardiometabolic disease risk outcomes associated with CVD and T2DM. The main objectives of this 









Table 5.1 The main objectives of this dissertation and primary findings. 
 
 No. Objective Ch. Cross-sectional research findings  
1 To characterise PA levels and 
patterns in women from an 
under-developed urban 
residential setting. 
2 - Less than a third of the women (27.4%) met the WHO Global Health Recommendations for MVPA 
using accelerometry. 
 
- The majority of PA time reported by all the women was work-related (74.2%) and performed at 
moderate-intensity, whereas travel (20.0%) and leisure PA time (5.8%) were proportionally less. 
 
- Sufficiently active women reported significantly higher leisure PA time compared to those who were 
insufficiently active. 
 
2 To determine whether women 
who are sufficiently active have 
a more favourable 
cardiometabolic disease risk 
profile compared to those who 
are insufficiently active. 
 
 
2 - Although overweight, sufficiently active women had a significantly lower BMI, FM, AFM and hip 
circumference, compared to their obese and insufficiently active counterparts. 
 
- Although no statistically significant group differences were found for any of the cardiometabolic 
disease risk outcomes, clinically significant differences were observed for DBP, FPG levels, as well 
as serum LDL-C and Lp (a) concentrations.  
 
- Overall, cardiometabolic disease risk among the sufficiently active women was lower than those 
demmed insufficiently active. 
 
3 To investigate the associations 
between different PA intensities 
(LPA and MVPA) and volume 
(steps/day) with CRF. 
3 - Irrespective of PA intensity and volume, the associations with CRF were positive and clinically 








No. Objective Ch. Cross-sectional research findings 
4 To examine both PA (intensities 
and volume) and CRF in relation 
to body composition, regional 
body fat measures, and 
cardiometabolic disease risk 
outcomes for CVD and T2DM in 
urban-dwelling women.  
 
3 - Clinically significant associations between PA intensities and cardiometabolic risk outcomes were 
observed.  
 
- Independent of PA volume, higher CRF was associated with younger women who also presented with 
reduced measures of total (BMI and FM) and central adiposity (WC and VAT area). 
 
- Steps/day and CRF were inversely associated with FFSTM and SMI. 
5 To characterise sedentary 
behaviour (time and type) in 
urban-dwelling women. 
 
4 - An average of 7.8 hr/day of objectively measured awake time was spent sedentary (57.3% of awake 
time). 
 
- Irrespective of weekday vs. weekend day, an average of 5 hr/day was reportedly spent sedentary while 
watching television. 
6 To examine the independent 
associations between objective 
ST, MVPA and physical health-
related fitness (CRF and 
muscular strength), with 
cardiometabolic risk. 
 
4 - No significant association was detected between ST and MVPA, or ST and CRF, however, a 
moderately strong and inverse association was observed between ST and muscular strength. 
 
- Only physical health-related fitness and neither ST, nor MVPA, was independently associated with 
cardiometabolic risk; this association is potentially mediated by total (FM) and central (VAT area) 
adiposity. 
No.; number; Ch.; chapter; PA, physical activity; SA, South African; %, percentage; WHO, World Health Organization; MVPA, moderate to vigorous-intensity physical activity; BMI, body 
mass index; FM, fat mass; AFM, appendicular fat mass; DBP, diastolic blood pressure; FPG, fasting plasma glucose; LDL-C, low-density lipoprotein; Lp (a), lipoprotein a; LPA, light-intensity 
physical activity; steps/day, steps per day; CRF, cardiorespiratory fitness; CVD, cardiovascular disease; T2DM, type 2 diabetes mellitus; WC, waist circumference; VAT, visceral adipose tissue; 
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5.4 The presence of obesity and other cardiometabolic disease risk factors for cardiovascular 
disease and type 2 diabetes mellitus in women from a low socio-economic urban community 
 
The descriptive data presented in this dissertation indicates the high proportion of obesity (56.9%; n = 
29/51) among urban-dwelling women residing in Cloetesville. Our novel use of highly sophisticated and 
more reliable measures (e.g. DXA-derived adiposity measures) confirmed the high levels of both obesity 
(%BF: 47.2% ± 7.0%) and central adiposity (%CFM: 53.1% ± 4.8%) among women in this study.  
 
In addition to obesity-related risk for CVD and T2DM, a relatively high proportion of women were 
hypertensive (60.4%; n = 29/48). More importantly, only 23.0% (n = 3/13) of those already diagnosed 
with hypertension and reporting their use of anti-hypertensive medication were normotensive on 
examination. This finding is in agreement with Manning et al.24 who reported on urban-dwelling women 
in the larger metropolitan area of Cape Town. The majority (83.4%) of their women were hypertensive 
while receiving anti-hypertensive pharmacological treatment. Yet, on the day of investigation their mean 
BP levels were high (SBP: 145.6 ± 21.0 mm Hg and DBP: 84.5 ± 12.0 mm Hg). As speculated by 
Manning et al.24, our findings (Table 5.2) support their notion that weight status, poor compliance of anti-
hypertensive treatment regimes and insufficient PA levels, may have contributed to the overall high 
proportion of poor BP control. All these factors raise overall CVD and T2DM risk among women who 
are already obese and hypertensive. 
 
Table 5.2 Potential factors contributing to poor blood pressure control in women in the present study. 
 
Factors Chapter Main finding 
Weight status  Chapter 2 High level of obesity among the women                                                         
(i.e. %BF: 47.2% ± 7.0%). 
Insufficient PA 
levels 
Chapter 2 Insufficiently active women (i.e. ≤ 30 min/day of MVPA) had 
clinically significant higher DBP levels. 
Poor compliance of 
anti-hypertensive 
treatment regimes 
Chapter 3 Only 3 out of 13 women using anti-hypertensive medication were 






The presentation of dyslipidaemia, and in particular the relatively high percentage of women with 
elevated Lp (a) concentrations (74.5%; n = 38/51) in the present study also requires specific attention as 
it contributes to an increased overall risk for CVD and T2DM (i.e. > 50 mg/dL). Furthermore, the 
relatively low mean HDL-C serum concentration (< 1.3 mmol/L) highlights the absence of a potential 
cardio-protective effect which is commonly associated with higher concentrations (i.e. ≥ 1.3 mmol/L).160 
Lastly, the presence of prediabetes (39.2%; n = 20/51), according to HbA1c values ≥ 5.7%, as well as 
undiagnosed T2DM (11.7%; n = 6/51) according to an HbA1c of ≥ 6.5%, must also be noted. Both results 
indicate the presence of uncontrolled plasma glucose levels among the majority of women in this study 
(50.9%; n = 26/51) (median [IQR] HbA1c: 5.7% [5.4 – 5.9]). Our results concur with those previously 
reported by Matsha et al.155 and re-emphasise the high proportion of undiagnosed T2DM among urban-
dwelling women as young as 30-yrs of age.155 
 
Overall, our descriptive cross-sectional data emphasise the high proportions of recognisable intermediate 
NCD-risk factors, namely: obesity, hypertension, dyslipidaemia and prediabetes among the entire group 
of urban-dwelling women (Figure 5.1). Very importantly, the presence of these risk factors extended 
over a wide age range (i.e. 26 to 64 years). 
 
 
Figure 5.1 Percentage (%) of intermediate cardiometabolic disease risk factors associated with CVD and 




































Our study, as well as those by Manning et al.24 and Matsha et al.155 draw attention to the need to promote, 
if not incentivise, routine health-risk screening at an early age. Evidence pertaining to the rollout of a 
novel SA health-incentive programme, under the auspices of a prominent private health care funder (i.e. 
Discovery Health’s Vitality Programme) highlights the pragmatic approach to raising awareness of 
NCD-risk and incentivised management thereof.161 To some degree, however, this excludes the majority 
of South Africans (82%)177 and especially those living in low-socio economic settings, as the cost of 
private health care and incentive programme membership is unattainable.   
 
According to the latest “Poverty Trends in South Africa” a steady rise has been reported since 2015. More 
than half of South Africans are regarded as poor, with the poverty headcount increasing to 56% from 
53% in 2011.177 An amount of 992 ZAR per person per month was shown to represent the upper bound 
poverty line in 2015 prices, which translates into ≥ 30.4 million citizens living in poverty. Thus, poverty 
is an important and recognisable barrier to public health (and education) in South Africa, and argubly 
more so on women compared to men, because of the multiple roles and responsibilities that women are 
expected to fulfil. In most instances, the total monthly medical healthcare premium for one adult (i.e. ≥ 
2029 ZAR/month) amounts to more than their monthly and/or household income. Even with income 
derived from government subsidies, e.g. child grant (410 ZAR/month); childminders grant (700 
ZAR/month); pension grant for senior citizens (≥ 60 yrs) (1900 ZAR/month); and disability grants (1910 
ZAR/month), the cost of private health care remains too high. The same applies to the price of food. Save 
for 19 non-taxed SA food items (e.g. dried beans and mealies [corn], samp, maize meal [corn], rice, 
brown bread, vegetables, fruits, vegetable oil, mealie rice [corn], tinned pilchards, legumes and pulses, 
lentil, eggs, milk, cultured milk, milk powder and dairy powder blend), all other food stuffs are taxed 
and thus more expensive. Furthermore,  a lot of the  non-taxed food items consist of a high proportion of 
refined carbohydrates (e.g. corn) and poor quality fats (e.g. unsaturated vegetable oil) and these are 
specifically  linked to obesity and cardiometabolic risk for CVD and T2DM.175 Those living below the 
poverty line, specifically in low-income (poorer) SA communities are often forced to consume these 
ominous nutrients, which may partly be due to their cheaper cost, but also due to individuals’ lack of 
nutritional knowledge and/or inaccessibility to healthier foodstuffs. Thus, one could argue that national 
government’s attempt to reduce the cost of some food items may assist those who fall below the poverty 







Pending the institutionalisation of SA’s National Health Insurance 6 plan in 2026, the description of 
primary health care services satisfyingly includes both “health promotion” and “disease prevention”. To 
a certain extent, the Western Cape On Wellness (WoW!) Inititative, a provincially funded public health 
and wellness promoting programme initiated in 2015, is an example of how primary health care services 
may look like in future. The WoW! Programme addresses both individual health behavioural and social 
determinants of wellness, in an effort to create enabling environments to prevent, reduce and better 
manage the burden of obesity and NCDs. The initiative follows a settings-based approach which includes 
worksites, primary healthcare community clinics, schools, communities and public spaces. Public health 
activities range from free and fun physical activities to basic health and wellness screening in specific 
communities.  
 
Interestingly, the WoW! Intiative was being launched at the same time as the SUNWELL Community 
Health Programme. Soon after, the SUNWELL Community Health group became a proud community 
club member of the WoW! Initiative. The collaboration brings together three vested role players: the 
Cloetesville community, Stellenbosch University and the Western Cape Department of Health (WCDoH) 
representing provincial/local government. To date, the collaboration has enabled eight members of the 
Cloetesville community group to become WoW! Health Champions. The training they received was 
created and presented by a consortium of public health experts and academics from local universities and 
the WCDoH. This then empowered the WoW! and SUNWELL Health Champions to arrange and 
coordinate activities for themselves and their fellow community club members. The activities aim to 
promote a physically active lifestyle, healthy eating habits, and healthy weight management 
 
Given the positive and proactive strides already made by the WCDoH, it seems imperative for the 
national health department and policy-makers to pilot similar health-based and collaborative initiatives 
such as the WoW! Intiative and the SUNWELL Community Health Programme. At the same time, 
government should seek partnerships with universities, non-profit organisations and/or private 
enterprises to develop and present such programmes on a sustainable basis. Furthermore, such initiatives 
will create the opportunity to make tertiary trained exercise specialists (i.e. biokineticists) part of the 
allied public health team, which currently includes physiotherapists, occupational therapists and 
dieticians. Together, these allied health professionals can make significant contributions to the health and 





5.5 Physical inactivity, physical health-related fitness and sedentarism in women from a low socio-
economic urban community 
 
Physical inactivity is recognised as a key risk factor for NCD and according to the WHO the fourth 
leading global cause of premature mortality.1 Within a SA context, an estimated 14.0% of total NCD-
related mortalities have been attributed to levels of physical inactivity.1  
 
The results from the current study indicate the majority of the women as insufficiently active (72.5%), 
or alternatively described as those not meeting the WHO 2010 Global Recommendations on PA for 
Health17 and thus, physically inactive. In comparison  to the results  from the WHO commissioned World 
Health Survey on South Africa, our results indicate a lower proportion of sufficiently active women 
(27.4% vs. 58.0%).99,100 However, it is important to mention that beyond the larger  number of  women 
investigated, their use of a self-report PA instrument is limiting (i.e. IPAQ). A major limitation includes 
the reliance on subjective recall and thus the possibility of over-reporting of time spent physically 
active,108 as well as over-estimating the intensity of reported PA. Our own results have shown similar 
tendencies, as the difference between the GPAQ-derived and accelerometer PA data differed greatly. The 
average self-report MVPA time for the entire group was ~50 min/day, compared to the lower ~22min/day 
MVPA measured objectively. What’s more is the over-estimation of self-report MVPA time reported by 
the insufficiently active women (i.e. ~41 min/day [GPAQ] vs. ~18 min/day [accelerometry]). Thus, our 
results question the validity of previous SA studies15,16,17 in which self-report PA time was captured; 
however, at the same time we are also cognisant of the limitations associated with our use of pre-
determined accelerometer cut-points.89 Therefore,  our ability to draw direct comparisons with other SA 
studies,10,13,125 which used different cut-points,90,91 is limited. 
 
Despite the above mentioned limitations associated with the use of subjective PA data, recent study 
findings using the GPAQ describe the majority of urban women10,14 as sufficiently active (61.0% and 
75.0%) according to the WHO Global PA criteria.17 More importantly, however, the majority of these 
women are described as BMI-obese. Similary, our results indicate that the sufficiently active women 
were also overweight. Thus a serious concern is the questionable effectiveness of meeting current 





cardiometabolic disease risk for CVD and T2DM. Alarmingly, this is an assumption on which the 
“Strategy for the Prevention and Management of Obesity [2015 – 2020]” policy document is based, 
namely, that increasing physical activity levels is a way to address the national obesity problem.8  
 
Evidence from large randomised clinical trials178,179 found that women who meet global PA 
recommendations through aerobic exercise training programmes showed no statistically significant 
changes in body weight over a 6-month period. In fact, there is strong evidence indicating that dietary 
restriction is vitally important to affect weight loss in  those who are already sufficiently active, and even 
more in those who are insufficiently active and obese. Results from a meta-analysis on “weight-loss 
interventions” determined the rate of weight-loss to be similar between caloric-restriction alone (0.98 
kg/week), and when combined with exercise (1.0 kg/week).180 Notably, the rate of weight loss observed 
in both interventions exceeded that which was achieved by exercise alone (0.2 kg/week). Such findings 
support the inference that the majority of weight loss from the combination of exercise and caloric 
restriction can be attributed to caloric restriction. However, this finding does not negate the importance 
of meeting global PA recommendations, especially given the role PA plays in weight maintenance,181 as 
well as increasing CRF,182 which increases in direct response to aerobic exercise training.178  
 
In chapter 3, the significant health-related benefits associated with higher daily PA volume (steps/day) 
and CRF level, in the presence of reduced BM, BMI and total FM, were highlighted. These findings are 
thus different to those previously published9,14 and indicate a higher percentage of women who are 
physically inactive according to international recommendations.17 Although limited by our use of cross-
sectional data, our results indicate that meeting MVPA guidelines of ≥ 150 min/week counteracts the 
adverse effect of excess weight (i.e. BM or total FM) on cardiometabolic disease risk for CVD and 
T2DM. Most notably, our results do not inform whether an increase in total adiposity is the cause or 
consequence of insufficient PA levels and thus provide no definitive answers to the questions raised in 
the “Strategy for the Prevention and Management of Obesity [2015 – 2020]” policy document aimed at 
reducing the national obesity problem.8 Alternatively, our results highlight the importance of developing 
strategies aimed at incorporating the use of daily step count PA recommendations18 over and above the 
use of the MVPA criteria,17 as well as increasing CRF level as means to lowering NCD-related risk for 
CVD and T2DM. To our knowledge, our descriptive data presented in chapter 3 confirms previous SA 
results, also among urban women and presenting with low or “poorly” rated CRF level.94 Furthermore, 





included as an outcome variable, was rated as “poor” among women and is therefore of equal concern 
than poor levels of aerobic fitness. 
 
In terms of sedentarism, the results from the current study indicate the larger proportion of awake time 
spent sedentary as opposed to physically active among the women investigated. In particular, 57.3% of 
daily wear-time was spent sedentary. The self-reported data showed that women spent most of their time 
during the week and weekend watching television. What’s more is the inference drawn by Cook et al.10 
and the propensity of higher levels of sedentarism among SA women residing in urban vs. rural settings. 
Thus, our results compliment those previously reported among other urban-dwelling women.14,92 
However, having used both objective and subjective sedentary behaviour measurement instruments, our 
data presented in chapter 4 provides a novel description of time spent sedentary, as well as the types of 
sedentary behaviours.  
 
These findings raise pertinent questions as to the likely factors contributing to the poor physical health 
of the women in the present study. One could speculate about the influence of ongoing and rapid 
epidemiological transition which South Africa,4,5 similar to other sub-Saharan African countries, 
continues to undergo. Underpinning this over-arching continental challenge, are those linked to the lack 
of daily PA associated with other work- and leisure-related activities, which are largely influenced by 
technology (e.g. computer games and television). Plus, those factors linked to an individual’s 
geographical location relative to total time spent travelling (e.g. extended travel time to and from work 
and/or other purposeful places) and the mode of transport used (e.g. motorised transport or walking). On 
the other hand, there are other pressing challenges for under-resourced communities, namely the lack of 
an inclusive PA environment (e.g. limited access to exercise facilities and issues of safety) and the lack 
of a social community network to promote PA.8  
 
5.6 Understanding patterns of physical activity and sedentary behaviour 
  
Our combined presentation of objective and subjective PA and sedentary time lends itself to improving 





our administration of the GPAQ indicating work-related PA time as the highest of the three PA domains. 
Although, when the sample of women were categorised according to activity level, the sufficiently active 
sub-group reported significantly more leisure PA time compared to the insufficiently active sub-group. 
 
Of most concern, however, was the subjective account of time spent sedentary while watching television. 
Thus, highlighting the need to explore the women’s barriers to PA. One could speculate that lack of 
knowledge about the detrimental effects of excessive amounts of sedentary time, or perhaps reasons 
pertaining to physical safety and lack of time and/or facilities to participate in leisure/recreational PA, 
may possibly explain their sedentary lifestyles. Therefore it is suggested that public health interventions 
targeting PA domains in which time is already spent physically active, such as walking to the shop or to 
work, but at a faster pace. At the same time, public awareness of the negative health-associated effects 
of time spent sitting, must be increased. 
 
 
5.7 Application of the associations between physical activity, sedentary time and physical health-
related fitness, with cardiometabolic disease risk for cardiovascular disease and type 2 diabetes 
mellitus in women from a low socio-economic urban community 
 
Firstly, clinically significant and positive associations were found between higher PA time (both LPA 
and MVPA) and volume (steps counts per day) with higher CRF level (Figure 5.2). As CRF is described 
as a physiological measure that reflects a combination of PA behaviour and innate genetic potential, we 
could argue that the higher PA levels achieved by the more active women are effective enough to 
maintain their relatively higher CRF levels compared to their less active and unfit counterparts. However, 
as a whole group, the women’s CRF levels were relatively “poor” when compared to international rating 
criteria.   
 
Secondly, statistically significant inverse associations, highlighted in chapter 3, between higher step 
counts per day with lower total (AFM and TFM) and central obesity measures (WC, CFM, and VAT 
area) is  promising and points to  the favourable health benefits associated with higher levels of daily PA 






Thirdly, and similar to the above finding, statistically significant inverse associations were shown 
between the same obesity outcomes measured with CRF level (Figure 5.2). Therefore, the message is 
clear: higher PA and CRF levels are associated with more pronounced health-related benefits, most 
notably, reduced adiposity levels and cardiometabolic disease risk for CVD and T2DM.  Given that PA 
or exercise alone is not an effective strategy for weight loss, we hypothesize that women who are 
physically active are more aware of what constitutes a healthy lifestyle and therefore it is probable that 
they also have healthier dietary habits. 
 
Fourthly, independent of central adiposity (i.e. VAT area), higher PA time (i.e. LPA and MVPA) and 
daily PA volume (i.e. steps/day) (Figure 5.2), as well as higher CRF level (Figure 5.3), were all associated 
with reduced serum lipid concentrations (i.e. TG or TG:HDL-C). Thus, suggestive of reduced 
cardiometabolic disease risk among the more active and/or fitter women who took part in the study. Most 
notably, higher CRF level was associated with women who were younger and with reduced total and 
central adiposity. 
 
Lastly, the application of the results in chapter 3 and 4 should be viewed as exploratory, and thus aimed 
at generating hypotheses for a future follow-up (longitudinal) study. Our results provide valuable insight 
as to the direction of the relationships explored between PA and CRF as modifiable behavioural/ lifestyle 
factors and obesity-related risk for CVD and/or T2DM, specifically among urban-dwelling women from 
an under-resourced SA community. It is equally important to stress that clinically significant results are 
not necessary statistically significant and given our interest in cardiometabolic health-related outcomes, 
one could argue that clinical significant results, for example lower DBP, is far more important then 
statistical significance between two different groups with differing DBP levels.183 Lastly, the use of effect 
sizes is not dependent on sample size as is the case with probability testing,  thus in support of the small 













Ch. 3 A  Clinically significant, 
positive associations 
Higher PA time (LPA and MVPA)  
Higher PA volume (steps/day) 
Higher CRF level 
B Statistically significant, 
negative associations 
 
Higher PA volume (steps/day)  Lower total adiposity (AFM and TFM)  
Lower central adiposity (WC, CFM, VAT)   
C Statistically significant, 
negative associations 
Higher CRF level  Lower total adiposity (AFM and TFM)  
Lower central adiposity (WC, CFM, VAT) 
D Statistically significant, 
negative associations 
Higher CRF level  Lower SMI  
Lower FFSTM 
E Statistically significant, 
negative associations 
Higher CRF level Age  
F Statistically significant, 
negative associations 
Higher PA time (LPA and MVPA) 
Higher PA volume (steps/day)  
Reduced TG  
Reduced TG:HDL-C 
(both independent of central adiposity) 
 
Figure 5.2 Independent associations between PA variables and CRF level with body composition 







Ch. 4 A  Statistically significant, 
negative associations 
 
Higher CRF level Lower clustered cardiometabolic risk score 
(independent of MVPA and ST) 
B Statistically significant, 
negative associations 
 
Higher muscular strength Reduced TG serum concentrations   
(independent of MVPA and ST) 
C Statistically significant, 
negative associations 
Higher ST  Lower muscular strength 
 
Figure 5.3 Independent associations between physical-health-related measures and cardiometabolic 











5.8 Novel findings 
  
To my knowledge the novel findings of the study indicate that less than a third of the women met the 
WHO Global Health Recommendations for MVPA using accelerometry. Secondly, that even though the 
sufficiently active sub-group of women were on average “overweight”, they presented with more 
favourable body composition and regional body fat measures, as well as  reduced cardiometabolic disease 
risk when compared to their insufficiently active counterparts. Following on from these, the secondary 
findings indicated the associations between PA intensities and volume; and CRF level, were positive and 
showed clinically important associations, although they were not statistically significant. Independent of 
steps/day, higher CRF level was associated with women who were younger and with reduced measures 
of adiposity. Alternatively, higher physical health-related fitness, as opposed to ST and MVPA, was 
independently associated with reduced cardiometabolic risk but potentially mediated by adiposity.  
 
5.9 Strengths and limitations  
 
As mentioned in each of the study chapters presented, our novel use of the sophisticated measurement 
equipment (e.g. DXA-scanner, accelerometry and VO2max) afforded us the opportunity to characterise 
body composition and regional fat distribution, PA level and CRF level objectively and with high 
accuracy. This is especially significant considering that, to our knowledge, little is known about the 
behavioural/lifestyle factors impacting the health of (previously) under-studied sub-population. 
 
Notable limitations include the cross-sectional study design, our sample of convenience, as well as 
relatively smaller sample sizes when classifying our activity sub-groups according to the WHO PA 
recommendations.  A priori power and sample size calculations were computed by a biostatistican before 
ethical approval of the study was attained. Although the sample size of the cohort constituted 200 
participants, the cost to complete the testing protocol was too expensive for the approved research study 
budget (Appendix B). The merits of including a larger sample size with fewer tests and measurements 
were weighed against the use of a smaller sample size, inclusive of more tests and measurements. It was 
decided to limit the sample size  and rather provide an in-depth and comprehensive picture of the health 
status of the women from the community of interest. The sample is therefore not representative of the 





One must also state that although there is a lack of universally accepted PA measurement methods, 
accelerometer derived PA estimates offer numerous advantages, compared to self-report PA estimates. 
Importantly however, the variation in cut-points defined makes comparison with other research studies 
challenging. Furthermore, the loss of PA and ST data due to some participants’ non-compliance in the 
wearing of their accelerometer requires consideration.  
 
Lastly, it is important to highlight our awareness of other factors which are critically importantly in the 
context of this study, but which fall beyond the scope of the current dissertation (e.g. poor dietary 
practices,23,24,25 food insecurity,26 exercise,27,28 genetic influences,29,30,31 sleep deprivation,32 chemical 
and air pollutants33). All of which, contribute towards the prevalence of cardiometabolic disease risk for 
both CVD and T2DM in adults. 
 
Overall, our results provide valuable insight as to the direction of the relationships between 
behavioural/lifestyle factors (i.e. LPA, MVPA, steps/day, ST and physical health-related fitness 
components) and obesity-related risk for CVD and/or T2DM, specifically in women living in an under-
resourced and low socio-economic urban community. 
 
5.10 Recommendations for future research studies 
 
5.10.1 Follow-up study and longitudinal studies 
  
Prior to the design and implementation of a context-specific behavioural/lifestyle intervention study, a 
follow-up investigation of the same parameters using the same methodological approach among the 
entire group of women is required. These results would prove beneficial and assist in answering questions 
related to both changes in cardiometabolic disease risk for CVD and T2DM, as well as weight status over 
time. For example, it is imperative to understand whether an increase in total adiposity is the cause or 
consequence of insufficient PA levels. Such information would indicate whether the “Strategy for the 
Prevention and Management of Obesity [2015 – 2020]” policy document, aimed at reducing the national 






5.10.2 Barriers to physical activity and healthy behaviour change 
 
We acknowledge that the success of designing and implementing a context-specific behavioural/lifestyle 
intervention is dependent on our understanding of the community’s specific barriers to PA and healthy 
dietary habits. Furthermore, one also needs to investigate other equally important behavioural/lifestyle 
factors (e.g. poor dietary practices,23,24,25 food insecurity,26 sleep deprivation32), which have all been 
shown previously to contribute towards the prevalence of cardiometabolic disease risk for both CVD and 
T2DM in adults. 
 
5.11 Conclusion  
 
Within the current SA context, this dissertation has important implications. Given that the higher PA 
levels achieved by the more active women were shown to be effective to maintain their relatively higher 
CRF levels, in comparison with their less active and unfit counterparts, the importance of raising 
awareness among community dwellers of the current PA guidelines is underlined. Furthermore, the 
statistically significant inverse associations between both higher PA and higher CRF levels and lower 
obesity measures and lower serum lipid concentrations (and independent of central adiposity) highlights 
the need for public health messaging campaigns centred on modifiable behavioural/lifestyle changes. For 
example, a campaign aimed at public health messaging entitled: “Move more and sit less”. Which speaks 
to the application of a context-specific intervention-based study aimed at increasing daily PA, reducing 
time spent sedentary, and developing strategies to increase physical health-related fitness, and thus to 
measure direct effects potentially caused by the intervention being studied. 
 
To conclude, context-specific intervention-based studies should aim to encourage an increase in daily 
PA (LPA, MVPA, and steps/day), while at the same time reducing sedentary behaviours, and developing 
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Appendix D: Author guidelines for Article One 
BMC Public Health Journal 
 
1.1 Criteria for submitting a research article  
Research articles should report on original primary research, but may report on systematic reviews of 
published research provided they adhere to the appropriate reporting guidelines which are detailed in our 
editorial policies. Please note that non-commissioned pooled analyses of selected published research will 
not be considered. Studies reporting descriptive results from a single institution will only be considered 
if analogous data have not been previously published in a peer reviewed journal and the conclusions 
provide distinct insights that are of relevance to a regional or international audience. 
 
Authors who need help depositing and curating data may wish to consider uploading their data to 
Springer Nature’s Research Data Support or contacting our Research Data Support Helpdesk. Springer 
Nature’s Research Data Support provides data deposition and curation to help authors follow “good 
practice” in sharing and archiving of research data, and can be accessed via an online form. The services 
provide secure and private submission of data files, which are curated and managed by the Springer 
Nature Research Data team for public release, in agreement with the submitting author. These services 
are provided in partnership with figshare. Checks are carried out as part of a submission screening process 
to ensure that researchers who should use a specific community-endorsed repository are advised of the 
best option for sharing and archiving their data. Use of Research Data Support is optional and does not 
imply or guarantee that a manuscript will be accepted. 
 
1.2 Preparing your manuscript 
The information below details the section headings that you should include in your manuscript and what 
information should be within each section. 
Please note that your manuscript must include a 'Declarations' section including all of the subheadings 
(please see below for more information). 
 
1.2.1 Title page 
The title page should: present a title that includes, if appropriate, the study design e.g."A versus B in the 
treatment of C: a randomized controlled trial", "X is a risk factor for Y: a case control study", "What is 





description of what the article report list the full names and institutional addresses for all authors if a 
collaboration group should be listed as an author, please list the Group name as an author. If you would 
like the names of the individual members of the Group to be searchable through their individual PubMed 
records, please include this information in the “Acknowledgements” section in accordance with the 
instructions below indicate the corresponding author 
 
1.2.2 Abstract 
The Abstract should not exceed 350 words. Please minimize the use of abbreviations and do not cite 
references in the abstract. Reports of randomized controlled trials should follow the CONSORT extension 
for abstracts. The abstract must include the following separate sections: 
 Background: the context and purpose of the study 
 Methods: how the study was performed and statistical tests used 
 Results: the main findings 
 Conclusions: brief summary and potential implications 
 Trial registration: If your article reports the results of a health care intervention on human 
participants, it must be registered in an appropriate registry and the registration number 
and date of registration should be in stated in this section. If it was not registered 
prospectively (before enrollment of the first participant), you should include the words 




Three to ten keywords representing the main content of the article. 
 
1.2.4 Background 
The Background section should explain the background to the study, its aims, a summary of the existing 
literature and why this study was necessary or its contribution to the field. 
 
1.2.5 Methods 
The methods section should include: 
 the aim, design and setting of the study 





 a clear description of all processes, interventions and comparisons. Generic drug names 
should generally be used. When proprietary brands are used in research, include the brand 
names in parentheses 
 the type of statistical analysis used, including a power calculation if appropriate 
 
1.2.6 Results 
This should include the findings of the study including, if appropriate, results of statistical analysis which 
must be included either in the text or as tables and figures. 
 
1.2.7 Discussion 
This section should discuss the implications of the findings in context of existing research and highlight 
limitations of the study. 
 
1.2.8 Conclusions 
This should state clearly the main conclusions and provide an explanation of the importance and 
relevance of the study reported. 
 
1.2.9 List of abbreviations 
If abbreviations are used in the text they should be defined in the text at first use, and a list of 
abbreviations should be provided. 
 
1.2.10 Declarations 
All manuscripts must contain the following sections under the heading 'Declarations': 
 Ethics approval and consent to participate 
 Consent for publication 
 Availability of data and materials 
 Competing interests 
 Funding 
 Authors' contributions 
 Acknowledgements 






Please see below for details on the information to be included in these sections. If any of the sections are 
not relevant to your manuscript, please include the heading and write 'Not applicable' for that section. 
Ethics approval and consent to participate. Manuscripts reporting studies involving human participants, 
human data or human tissue must: include a statement on ethics approval and consent (even where the 
need for approval was waived) include the name of the ethics committee that approved the study and the 
committee’s reference number if appropriate. Studies involving animals must include a statement on 
ethics approval.See our editorial policies for more information. 
 
If your manuscript does not report on or involve the use of any animal or human data or tissue, please 
state “Not applicable” in this section. 
 
1.2.11 Consent for publication 
If your manuscript contains any individual person’s data in any form (including any individual details, 
images or videos), consent for publication must be obtained from that person, or in the case of children, 
their parent or legal guardian. All presentations of case reports must have consent for publication. You 
can use your institutional consent form or our consent form if you prefer. You should not send the form 
to us on submission, but we may request to see a copy at any stage (including after publication). See our 
editorial policies for more information on consent for publication.If your manuscript does not contain 
data from any individual person, please state “Not applicable” in this section. 
1.2.12 Availability of data and materials 
All manuscripts must include an ‘Availability of data and materials’ statement. Data availability 
statements should include information on where data supporting the results reported in the article can be 
found including, where applicable, hyperlinks to publicly archived datasets analysed or generated during 
the study. By data we mean the minimal dataset that would be necessary to interpret, replicate and build 
upon the findings reported in the article. We recognise it is not always possible to share research data 
publicly, for instance when individual privacy could be compromised, and in such instances data 
availability should still be stated in the manuscript along with any conditions for access. Data availability 
statements can take one of the following forms (or a combination of more than one if required for multiple 
dataset.  
 The datasets generated and/or analysed during the current study are available in the [NAME] 





 The datasets used and/or analysed during the current study are available from the corresponding 
author on reasonable request. 
 All data generated or analysed during this study are included in this published article [and its 
supplementary information files]. 
 The datasets generated and/or analysed during the current study are not publicly available due 
[REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on 
reasonable request. 
 Data sharing is not applicable to this article as no datasets were generated or analysed during the 
current study. 
 The data that support the findings of this study are available from [third party name] but 
restrictions apply to the availability of these data, which were used under license for the current 
study, and so are not publicly available. Data are however available from the authors upon 
reasonable request and with permission of [third party name]. 
 Not applicable. If your manuscript does not contain any data, please state 'Not applicable' in this 
section. More examples of template data availability statements, which include examples of 
openly available and restricted access datasets, are available here. 
 
BioMed Central also requires that authors cite any publicly available data on which the conclusions of 
the paper rely in the manuscript. Data citations should include a persistent identifier (such as a DOI) and 
should ideally be included in the reference list. Citations of datasets, when they appear in the reference 
list, should include the minimum information recommended by DataCite and follow journal style. 
Dataset identifiers including DOIs should be expressed as full URLs. For example: Hao Z, AghaKouchak 
A, Nakhjiri N, Farahmand A. Global integrated drought monitoring and prediction system (GIDMaPS) 
data sets. figshare. 2014. http://dx.doi.org/10.6084/m9.figshare.853801  
 
With the corresponding text in the Availability of data and materials statement: 
The datasets generated during and/or analysed during the current study are available in the [NAME] 
repository, [PERSISTENT WEB LINK TO DATASETS].[Reference number]  
If you wish to co-submit a data note describing your data to be published in BMC Research Notes, you 
can do so by visiting our submission portal. Data notes support open data and help authors to comply 
with funder policies on data sharing. Co-published data notes will be linked to the research article the 





1.2.13 Competing interests 
All financial and non-financial competing interests must be declared in this section. See our editorial 
policies for a full explanation of competing interests. If you are unsure whether you or any of your co-
authors have a competing interest please contact the editorial office. Please use the authors initials to 
refer to each authors' competing interests in this section. If you do not have any competing interests, 
please state "The authors declare that they have no competing interests" in this section. 
 
1.2.14 Funding 
All sources of funding for the research reported should be declared. The role of the funding body in the 
design of the study and collection, analysis, and interpretation of data and in writing the manuscript 
should be declared. 
 
1.2.15 Authors' contributions 
The individual contributions of authors to the manuscript should be specified in this section. Guidance 
and criteria for authorship can be found in our editorial policies. Please use initials to refer to each author's 
contribution in this section, for example: "FC analyzed and interpreted the patient data regarding the 
hematological disease and the transplant. RH performed the histological examination of the kidney, and 
was a major contributor in writing the manuscript. All authors read and approved the final manuscript." 
 
1.2.16 Acknowledgements 
Please acknowledge anyone who contributed towards the article who does not meet the criteria for 
authorship including anyone who provided professional writing services or materials. Authors should 
obtain permission to acknowledge from all those mentioned in the Acknowledgements section.See our 
editorial policies for a full explanation of acknowledgements and authorship criteria. If you do not have 
anyone to acknowledge, please write "Not applicable" in this section. Group authorship (for manuscripts 
involving a collaboration group): if you would like the names of the individual members of a 
collaboration Group to be searchable through their individual PubMed records, please ensure that the 
title of the collaboration Group is included on the title page and in the submission system and also include 
collaborating author names as the last paragraph of the “Acknowledgements” section. Please add authors 
in the format First Name, Middle initial(s) (optional), Last Name. You can add institution or country 





individual names may not be present in the PubMed record at the time a published article is initially 
included in PubMed as it takes PubMed additional time to code this information. 
 
1.2.17 Authors' information 
This section is optional.You may choose to use this section to include any relevant information about the 
author(s) that may aid the reader's interpretation of the article, and understand the standpoint of the 
author(s). This may include details about the authors' qualifications, current positions they hold at 
institutions or societies, or any other relevant background information. Please refer to authors using their 
initials. Note this section should not be used to describe any competing interests. 
 
1.2.18 Footnotes 
Footnotes can be used to give additional information, which may include the citation of a reference 
included in the reference list. They should not consist solely of a reference citation, and they should never 
include the bibliographic details of a reference. They should also not contain any figures or tables. 
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript 
lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or 
the authors of the article are not given reference symbols. Always use footnotes instead of endnotes. 
 
1.2.19 References 
Examples of the Vancouver reference style are shown below. See our editorial policies for author 
guidance on good citation practice. Web links and URLs: All web links and URLs, including links to the 
authors' own websites, should be given a reference number and included in the reference list rather than 
within the text of the manuscript. They should be provided in full, including both the title of the site and 
the URL, as well as the date the site was accessed, in the following format: The Mouse Tumor Biology 
Database. http://tumor.informatics.jax.org/mtbwi/index.do. Accessed 20 May 2013. If an author or group 
of authors can clearly be associated with a web link, such as for weblogs, then they should be included 
in the reference. 
 
Example reference style: 
 Article within a journal 






 Article within a journal (no page numbers) 
Rohrmann S, Overvad K, Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjønneland A, et 
al. Meat consumption and mortality - results from the European Prospective Investigation into 
Cancer and Nutrition. BMC Medicine. 2013;11:63. 
 
 Article within a journal by DOI 
Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. Dig J Mol 
Med. 2000; doi:10.1007/s801090000086. 
 Article within a journal supplement 
Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic activity by 
bone marrow scan. Blood 1979;59 Suppl 1:26-32. 
 
 Book chapter, or an article within a book 
Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, 
Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. p. 251-
306. 
 
 OnlineFirst chapter in a series (without a volume designation but with a DOI) 
Saito Y, Hyuga H. Rate equation approaches to amplification of enantiomeric excess and chiral 
symmetry breaking. Top Curr Chem. 2007. doi:10.1007/128_2006_108. 
 
 Complete book, authored 
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common 
illness. 3rd ed. Oxford: Blackwell Science; 1998. 
 
 Online document 
Doe J. Title of subordinate document. In: The dictionary of substances and their effects. Royal 
Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. Accessed 15 
Jan 1999. 
 





Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998. http://www.healthwise.org. 
Accessed 21 Sept 1998. 
 
 Supplementary material/private homepage 
Doe J. Title of supplementary material. 2000. http://www.privatehomepage.com. Accessed 22 
Feb 2000. 
 
 University site 
Doe, J: Title of preprint. http://www.uni-heidelberg.de/mydata.html (1999). Accessed 25 Dec 
1999. 
 
 FTP site 
Doe, J: Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt (1999). Accessed 12 Nov 
1999. 
 
 Organization site 
ISSN International Centre: The ISSN register. http://www.issn.org (2006). Accessed 20  
Feb 2007. 
 
 Dataset with persistent identifier 
Zheng L-Y, Guo X-S, He B, Sun L-J, Peng Y, Dong S-S, et al. Genome data from sweet and grain 
sorghum (Sorghum bicolor). GigaScience Database. 2011. http://dx.doi.org/10.5524/100012. 
 
1.2.20 Figures, tables and additional files 
See General formatting guidelines for information on how to format figures, tables and additional files. 
Appendix E: Author guidelines for Article Two  
International Journal for Behavioural Nutrition and Physical Activity (IJBNPA) 
1.1 Criteria for submitting a research article 
Cover letters must include the names and emails of at least 4 potential reviewers. These must be from a 
different institution to the first author and not have published with any member of the writing group in 
the previous 3 years. Cover letters must contain a rationale for how the manuscript is novel, why it is 





studies testing the effect of an intervention have to be registered with a trials registry to be eligible for 
peer review. We STRONGLY recommend prospective registration but will consider retrospectively 
registered trials with appropriate justification. For completed randomized controlled trials, IJBNPA 
requires the submission of a populated CONSORT checklist and flow diagram. The flow diagram should 
be included in the main body of the text and the checklist should be provided as an additional file. Both 
the flow diagram and the checklist should be referenced in the text. Submissions received without these 
elements will be returned to the authors as incomplete. A Word file of the checklist and flow diagram can 
be downloaded here. For all intervention components, authors are required to use the TIDieR Checklist, 
which should be provided as an additional file. The TIDieR Checklist is available to download as a PDF 
and a Word file. For observational studies, IJBNPA requires the submission of a populated STROBE 
checklist (http://strobe-statement.org/index.php?id=available-checklists) along with the manuscript. For 




The completed checklist should be provided as an additional file. 
 
For all empirical studies, info regarding how the sample was recruited, how representative the sample 
was of the target group, how the analysed sample differed from the recruited sample and how any missing 
data were handled should be made available to editors/reviewers; these materials should be uploaded as 
an addtional file at the time of submission. There is no specific word limit, but articles should be as 
concise as possible. Articles that exceed 5000 words are rarely published. If an article is accepted for 
publication, the submitting author will be asked to provide at least one tweet of about 100 characters, 
together with your (or an institute) Twitter name which will be used to help publicise the paper at the 
point of publication. More general formatting guidelines can be found here. 
 
International Journal of Behavioral Nutrition and Physical Activity strongly encourages that all datasets 
on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure 
that their datasets are either deposited in publicly available repositories (where available and appropriate) 
or presented in the main manuscript or additional supporting files whenever possible. Please see Springer 
Nature’s information on recommended repositories. Where a widely established research community 





repository is mandatory. A list of data where deposition is required, with the appropriate repositories, can 
be found on the Editorial Policies Page. 
 
1.2 Preparing your manuscript 
The information below details the section headings that you should include in your manuscript and what 
information should be within each section. Please note that your manuscript must include a 'Declarations' 
section including all of the subheadings (please see below for more information). 
 
1.2.1 Title page 
The title page should present a title that includes, if appropriate, the study design e.g.:"A versus B in the 
treatment of C: a randomized controlled trial", "X is a risk factor for Y: a case control study", "What is 
the impact of factor X on subject Y: A systematic review" or for non-clinical or non-research studies a 
description of what the article reports list the full names and institutional addresses for all authors if a 
collaboration group should be listed as an author, please list the Group name as an author. If you would 
like the names of the individual members of the Group to be searchable through their individual PubMed 
records, please include this information in the “Acknowledgements” section in accordance with the 




The Abstract should not exceed 350 words. Please minimize the use of abbreviations and do not cite 
references in the abstract. Reports of randomized controlled trials should follow the CONSORT extension 
for abstracts. The abstract must include the following separate sections: 
 Background: the context and purpose of the study 
 Methods: how the study was performed and statistical tests used 
 Results: the main findings 
 Conclusions: brief summary and potential implication 
 
Trial registration: If your article reports the results of a health care intervention on human participants, it 
must be registered in an appropriate registry and the registration number and date of registration should 





you should include the words 'retrospectively registered'. See our editorial policies for more information 
on trial registration 
 
1.2.3 Keywords 
Three to ten keywords representing the main content of the article. 
 
1.2.4 Background 
The Background section should explain the background to the study, its aims, a summary of the existing 
literature and why this study was necessary or its contribution to the field. 
 
1.2.5 Methods 
The methods section should include: 
 the aim, design and setting of the study 
 the characteristics of participants or description of materials 
 a clear description of all processes, interventions and comparisons. Generic drug names 
should generally be used. When proprietary brands are used in research, include the brand 




This should include the findings of the study including, if appropriate, results of statistical analysis which 
must be included either in the text or as tables and figures. 
 
1.2.7 Discussion 
This section should discuss the implications of the findings in context of existing research and highlight 
limitations of the study. 
 
1.2.8 Conclusions 
This should state clearly the main conclusions and provide an explanation of the importance and 
relevance of the study reported. 
 





If abbreviations are used in the text they should be defined in the text at first use, and a list of 
abbreviations should be provided. 
 
1.2.10 Declarations 
All manuscripts must contain the following sections under the heading 'Declarations': 
 Ethics approval and consent to participate 
 Consent for publication 
 Availability of data and materials 
 Competing interests 
 Funding 
 Authors' contributions 
 Acknowledgements 
 Authors' information (optional) 
 
Please see below for details on the information to be included in these sections. If any of the sections are 
not relevant to your manuscript, please include the heading and write 'Not applicable' for that section. 
Ethics approval and consent to participate. Manuscripts reporting studies involving human participants, 
human data or human tissue must: 
 include a statement on ethics approval and consent (even where the need for approval was 
waived) 
 include the name of the ethics committee that approved the study and the committee’s 
reference number if appropriate 
 Studies involving animals must include a statement on ethics approval. 
 
See our editorial policies for more information. 
If your manuscript does not report on or involve the use of any animal or human data or tissue, please 
state “Not applicable” in this section. 
1.2.11Consent for publication 
If your manuscript contains any individual person’s data in any form (including any individual details, 
images or videos), consent for publication must be obtained from that person, or in the case of children, 
their parent or legal guardian. All presentations of case reports must have consent for publication. You 





to us on submission, but we may request to see a copy at any stage (including after publication). See our 
editorial policies for more information on consent for publication. 
 
If your manuscript does not contain data from any individual person, please state “Not applicable” in this 
section.Availability of data and materials 
 
All manuscripts must include an ‘Availability of data and materials’ statement. Data availability 
statements should include information on where data supporting the results reported in the article can be 
found including, where applicable, hyperlinks to publicly archived datasets analysed or generated during 
the study. By data we mean the minimal dataset that would be necessary to interpret, replicate and build 
upon the findings reported in the article. We recognise it is not always possible to share research data 
publicly, for instance when individual privacy could be compromised, and in such instances data 
availability should still be stated in the manuscript along with any conditions for access. 
 
Data availability statements can take one of the following forms (or a combination of more than one if 
required for multiple datasets): 
 The datasets generated and/or analysed during the current study are available in the [NAME] 
repository, [PERSISTENT WEB LINK TO DATASETS] 
 The datasets used and/or analysed during the current study are available from the corresponding 
author on reasonable request. 
 All data generated or analysed during this study are included in this published article [and its 
supplementary information files]. 
 The datasets generated and/or analysed during the current study are not publicly available due 
[REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on 
reasonable request. 
 Data sharing is not applicable to this article as no datasets were generated or analysed during the 
current study. 
o The data that support the findings of this study are available from [third party name] but 
restrictions apply to the availability of these data, which were used under license for the 
current study, and so are not publicly available. Data are however available from the 





o Not applicable. If your manuscript does not contain any data, please state 'Not applicable' 
in this section. 
 
More examples of template data availability statements, which include examples of openly available and 
restricted access datasets, are available here. 
 
BioMed Central also requires that authors cite any publicly available data on which the conclusions of 
the paper rely in the manuscript. Data citations should include a persistent identifier (such as a DOI) and 
should ideally be included in the reference list. Citations of datasets, when they appear in the reference 
list, should include the minimum information recommended by DataCite and follow journal style. 
Dataset identifiers including DOIs should be expressed as full URLs. For example: Hao Z, AghaKouchak 
A, Nakhjiri N, Farahmand A. Global integrated drought monitoring and prediction system (GIDMaPS) 
data sets. figshare. 2014. http://dx.doi.org/10.6084/m9.figshare.853801 
With the corresponding text in the Availability of data and materials statement: 
The datasets generated during and/or analysed during the current study are available in the [NAME] 
repository, [PERSISTENT WEB LINK TO DATASETS].[Reference number]  
 
If you wish to co-submit a data note describing your data to be published in BMC Research Notes, you 
can do so by visiting our submission portal. Data notes support open data and help authors to comply 
with funder policies on data sharing. Co-published data notes will be linked to the research article the 
data support (example). 
For more information please email our Research Data Team. 
 
1.2.12 Competing interests 
All financial and non-financial competing interests must be declared in this section. See our editorial 
policies for a full explanation of competing interests. If you are unsure whether you or any of your co-
authors have a competing interest please contact the editorial office. Please use the authors initials to 
refer to each authors' competing interests in this section. If you do not have any competing interests, 









All sources of funding for the research reported should be declared. The role of the funding body in the 
design of the study and collection, analysis, and interpretation of data and in writing the manuscript 
should be declared. 
 
1.2.14 Authors' contributions 
The individual contributions of authors to the manuscript should be specified in this section. Guidance 
and criteria for authorship can be found in our editorial policies. Please use initials to refer to each author's 
contribution in this section, for example: "FC analyzed and interpreted the patient data regarding the 
hematological disease and the transplant. RH performed the histological examination of the kidney, and 
was a major contributor in writing the manuscript. All authors read and approved the final manuscript." 
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Please acknowledge anyone who contributed towards the article who does not meet the criteria for 
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editorial policies for a full explanation of acknowledgements and authorship criteria. If you do not have 
anyone to acknowledge, please write "Not applicable" in this section. Group authorship (for manuscripts 
involving a collaboration group): if you would like the names of the individual members of a 
collaboration Group to be searchable through their individual PubMed records, please ensure that the 
title of the collaboration Group is included on the title page and in the submission system and also include 
collaborating author names as the last paragraph of the “Acknowledgements” section. Please add authors 
in the format First Name, Middle initial(s) (optional), Last Name. You can add institution or country 
information for each author if you wish, but this should be consistent across all authors. Please note that 
individual names may not be present in the PubMed record at the time a published article is initially 
included in PubMed as it takes PubMed additional time to code this information. 
 
1.2.16 Authors' information 
This section is optional.You may choose to use this section to include any relevant information about the 
author(s) that may aid the reader's interpretation of the article, and understand the standpoint of the 





institutions or societies, or any other relevant background information. Please refer to authors using their 
initials. Note this section should not be used to describe any competing interests. 
 
1.2.17 Footnotes 
Footnotes can be used to give additional information, which may include the citation of a reference 
included in the reference list. They should not consist solely of a reference citation, and they should never 
include the bibliographic details of a reference. They should also not contain any figures or tables. 
Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript 
lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or 
the authors of the article are not given reference symbols. Always use footnotes instead of endnotes. 
 
1.2.18 References 
Examples of the Vancouver reference style are shown below. See our editorial policies for author 
guidance on good citation practice. Web links and URLs: All web links and URLs, including links to the 
authors' own websites, should be given a reference number and included in the reference list rather than 
within the text of the manuscript. They should be provided in full, including both the title of the site and 
the URL, as well as the date the site was accessed, in the following format: The Mouse Tumor Biology 
Database. http://tumor.informatics.jax.org/mtbwi/index.do. Accessed 20 May 2013. If an author or group 
of authors can clearly be associated with a web link, such as for weblogs, then they should be included 
in the reference. Example reference style: 
 
 Article within a journal 
Smith JJ. The world of science. Am J Sci. 1999;36:234-5. 
 
 Article within a journal (no page numbers) 
Rohrmann S, Overvad K, Bueno-de-Mesquita HB, Jakobsen MU, Egeberg R, Tjønneland 
A, et al. Meat consumption and mortality - results from the European Prospective 
Investigation into Cancer and Nutrition. BMC Medicine. 2013;11:63. 
 
 Article within a journal by DOI 
Slifka MK, Whitton JL. Clinical implications of dysregulated cytokine production. Dig J 





 Article within a journal supplement 
Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic 
activity by bone marrow scan. Blood 1979;59 Suppl 1:26-32. 
 
 Book chapter, or an article within a book 
Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne 
GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 
1980. p. 251-306. 
 
 OnlineFirst chapter in a series (without a volume designation but with a DOI) 
Saito Y, Hyuga H. Rate equation approaches to amplification of enantiomeric excess and 
chiral symmetry breaking. Top Curr Chem. 2007. doi:10.1007/128_2006_108. 
 
 Complete book, authored 
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of 
common illness. 3rd ed. Oxford: Blackwell Science; 1998. 
 
 Online document 
Doe J. Title of subordinate document. In: The dictionary of substances and their effects. 
Royal Society of Chemistry. 1999. http://www.rsc.org/dose/title of subordinate document. 
Accessed 15 Jan 1999. 
 
 Online database 
Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998. 
http://www.healthwise.org. Accessed 21 Sept 1998. 
 
 Supplementary material/private homepage 
Doe J. Title of supplementary material. 2000. http://www.privatehomepage.com. 
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Doe, J: Title of preprint. http://www.uni-heidelberg.de/mydata.html (1999). Accessed 25 
Dec 1999. 
 
 FTP site 
Doe, J: Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt (1999). Accessed 12 
Nov 1999. 
 
 Organization site 
ISSN International Centre: The ISSN register. http://www.issn.org (2006). Accessed 20 
Feb 2007. 
 
 Dataset with persistent identifier 
Zheng L-Y, Guo X-S, He B, Sun L-J, Peng Y, Dong S-S, et al. Genome data from  
sweet and grain sorghum (Sorghum bicolor). GigaScience Database. 2011.  
http://dx.doi.org/10.5524/100012. 
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Appendix F: Author guidelines for Article Three  
Journal of Physical Activity and Health 
Prior to submission, please carefully read and follow the submission guidelines detailed below. Authors 
must submit their manuscripts through the journal’s ScholarOne online submission system.  
 
1.1 Authorship Guidelines 
The Journals Division at Human Kinetics adheres to the criteria for authorship as outlined by the 
International Committee of Medical Journal Editors*: 
 
Each author should have participated sufficiently in the work to take public responsibility for the content. 
Authorship credit should be based only on substantial contributions to: 
 
    a. Conception and design, or analysis and interpretation of data; and 
    b. Drafting the article or revising it critically for important intellectual content; and 
    c. Final approval of the version to be published. 
 
Conditions a, b, and c must all be met. Individuals who do not meet the above criteria may be listed in 
the acknowledgments section of the manuscript. *Uniform requirements for manuscripts submitted to 
biomedical journals. (1991). New England Journal of Medicine, 324, 424–428. 
 
1.2 Open Access 
Human Kinetics is pleased to allow our authors the option of having their articles published Open Access. 
In order for an article to be published Open Access, authors must complete and return the Request for 
Open Access form and provide payment for this option. To learn more and request Open Access, click 
here. 
 
1.3 Manuscript Guidelines 
Journal of Physical Activity and Health (JPAH) is a peer-reviewed journal. Manuscripts reporting 
Original Research, Public Health Practice, Technical Notes, Brief Reports, or Reviews will be reviewed 
by at least two reviewers with expertise in the topical field, and the review process usually takes 6 to 8 
weeks. A double-blind method is used for the review process, meaning authors and reviewers remain 





All types of manuscripts submitted to JPAH are judged on the following primary criteria: adherence to 
accepted scientific principles and methods, the significant or novel contribution to research or practice 
in the field of physical activity, clarity and conciseness of writing, and interest to the readership. There 
are no page charges to contributors. 
 
Manuscripts generally should not exceed 25 pages (~5,000 words including everything except title and 
abstract pages; the word limit includes the reference section). Reviews should not exceed a total of 30 
pages and Brief Reports should not exceed 15 pages. Major exceptions to these criteria must be approved 
through the Editorial Office before submission. Submissions should not include more than 10 
tables/graphics, and should follow the Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals (visit ICMJE for more detail). JPAH welcomes and encourages the submission of supplementary 
materials to be included with the article. These files are placed online and can be accessed from the JPAH 
website. Supplemental material can include relevant appendices, tables, details of the methods (e.g., 
survey instruments), or images. Contact the Editorial Office for approval of any supplemental materials. 
 
1.4 Standardized Publication Reporting Guides 
JPAH highly recommends that authors refer to relevant published reporting guidelines for different types 
of research studies. Examples of reporting guidelines include: 
 
 Consolidated Standards of Reporting Trials (CONSORT) 
 Meta-analysis of Observational Studies in Epidemiology (MOOSE) 
 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
 STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) 
 Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet 
E-Surveys (CHERRIES) 
 
Manuscripts must be submitted in Microsoft Word® (*.doc) or rich text (*.rtf) format only. Do not submit 
a .pdf file. Graphics should be submitted in .tif or .jpg formats only. Before submitting, authors should 
complete the Manuscript Submission Checklist (see below). Authors may be asked to provide Human 
Kinetics with photo-ready graphics and/or a hard copy of the text. Authors are responsible for confirming 





guard against loss. Final review of the pre-published text is the responsibility of the authors. Authors of 
manuscripts accepted for publication must transfer copyright to Human Kinetics, as applicable. 
 
1.5 Cover Letter 
Submissions must include a cover letter stating that the manuscript has not been previously published 
(except in abstract form), is not presently under consideration by another journal, and will not be 
submitted to another journal before a final editorial decision from JPAH is rendered. Full names, 
institutional affiliations, and email addresses of all authors, as well as the full mailing address, telephone 
number, and fax number of the corresponding author, must be provided. Authors must also provide a 
statement disclosing any relevant financial interests related to the research.  
 
1.6 Manuscript Types 
 
Original Research 
A manuscript describing the methods and results of a research study (quantitative or qualitative), 
including the background and purpose of the study, a detailed description of the research design and 
methods, clear and comprehensive presentation of results, and discussion of the salient findings. 
 
Public Health Practice 
A manuscript describing the development or evaluation of a public health intervention to increase or 




A short article that presents results related to a new or modified method or instrument related to physical 
activity measurement or an important experimental observation. 
Brief Reports 
A short article (15 or fewer pages), usually presenting the preliminary or novel results of an original 







Manuscripts that succinctly review the scientific literature on a specific topic. Traditional narrative 
reviews are discouraged. However, well-conducted systematic reviews and meta-analyses are highly 
encouraged. The Editorial Office may recruit reviews on specific topics. All review articles must have 
approval from the Editorial Office prior to submission. 
 
1.7 Manuscript Sections 
The order of submission must be (1) Title page, (2) Abstract, (3) Text, (4) Acknowledgments, (5) Funding 
source, (6) References, (7) Tables, (8) Figures/Graphics. 
 
1.7.1 Title Page 
The manuscript must include a title page that provides the full title, a brief running head, manuscript type 
(see definitions above), three to five key words not used in the title of the manuscript, abstract word 
count, manuscript word count (inclusive of all pages except the abstract and title page), date of 




All manuscripts must have a structured abstract of no more than 200 words. Required headings are (1) 
Background, (2) Methods, (3) Results, and (4) Conclusions. 
 
1.7.3 Text 
The entire manuscript must be double-spaced, including the abstract, references, and tables. Line 
numbers must appear on each page in the left margin. A brief running head is to be included on the upper 
right corner of each page; page numbers must appear on the bottom right corner of each page. 
 
For studies involving human subjects, the Methods section must include statements regarding 
institutional approval of the protocol and obtaining informed consent. For studies using animals, the 
Methods section must include a statement regarding institutional approval and compliance with 









Provide the names, affiliations, and the nature of the contribution for all persons not included as an author 
who played a critical role in the study. 
 
1.7.4 Funding Source/Trial Registration 
Details of all funding sources for the work should be provided (including agency name, grant numbers, 
etc.). Provide the registry name and registration number for all clinical trials (see JPAH Ethics Policies 
below). Example: “This work was supported by a grant (grant #) from the National Cancer Institute, 
National Institutes of Health. This study is registered at www.clinicaltrials.gov (No. xxxxx).” 
 
1.7.5 References 
For reference lists, authors must follow the guidelines found in the American Medical Association 
Manual of Style: A Guide for Authors and Editors (10th ed.). Examples of reference style: Journal 
articles: Surname of first author, initials, then surname and initials of each coauthor; title of article 
(capitalize only the first word and proper nouns), name of the journal (italicized and abbreviated 
according to style of Index Medicus), year, volume, and inclusive page numbers. 
 
o Melby CL, Osterberg K, Resch A, Davy B, Johnson S, Davy K. Effect of carbohydrate 
ingestion during exercise on post-exercise substrate oxidation and energy intake. Int J 
Sport Nutr Exerc Metab. 2002;12:294–309. 
 
o Book references: Author(s) as above, title of book (italicized and all major words 
capitalized), city and state/province of publication, publisher, and year. 
 
o Pearl AJ. The Female Athlete. Champaign, Ill: Human Kinetics; 1993. 
 
Chapter in an edited book: Same as book references, but add the name of the chapter author(s) 
and title of chapter (capitalize first word and proper nouns) before the book information and 






o Perrin DH. The evaluation process in rehabilitation. In: Prentice WE, ed. Rehabilitation 
Techniques in Sports Medicine. 2nd ed. St Louis, Mo: Mosby Year Book; 1994:253–
276. 
1.7.6 Tables 
Each table must be accompanied by an explanatory title so that it is intelligible without specific reference 
to the text. Column headings and all units of measure must be labeled clearly within each table; 




Graphics should be prepared with clean, crisp lines, and be camera-ready. For shading, stripe patterns or 
solids (black and white) are better choices than colors. Graphics created on standard computer programs 
will be accepted. Graphics should be submitted in .tif or .jpg formats only. Each figure and photo must 
be properly identified. A hard copy may be requested. If photos are used, they should be black and white, 
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Appendix H: Participation Letter and Informed Consent    




CONSENT TO PARTICIPATE IN RESEARCH 
RELATIONSHIPS BETWEEN LIFESTYLE FACTORS, CARDIOMETABOLIC HEALTH, COGNITIVE FUNCTIONING AND 
CARDIORESPIRATORY FITNESS IN SOUTH AFRICAN WOMEN FROM A LOW SOCIOECONOMIC COMMUNITY 
You are asked to participate in a research study conducted by Prof E Terblanche (PhD) from the Department of 
Sport Science at Stellenbosch University. Aspects of this research project will form part of the theses of two PhD 
in Sport Science students (Ms S Nieuwoudt and Ms K Dickie) in the Department of Sport Science. You were 
selected as a possible participant in this study because you are a female between the ages of 18 and 64 years. 
 
1. PURPOSE OF THE STUDY 
 
To investigate the health status and certain lifestyle factors among adult women in your community, and identify 
specific health behaviours where intervention is needed to manage, or at least reduce, the risk of obesity, high 




If you volunteer to participate in the study, we ask your permission to conduct the following tests and 
measurements:  
 
1. measure your resting blood pressure, height, weight, waist and hip circumference; 
2. a urine-pregnancy test (this is a compulsary test if you want to participate in the study).  
3. take a blood sample of  12 mL taken by a qualified nurse from a vein in your arm with a sterile needle 
and blood tubes to determine various indicators of your health; 
4. measure the amount of muscle and fat in various parts of your body. This test will require you to lie on 
a table, dressed in a hospital gown, while a scanner takes pictures of your whole body (almost like an X-
ray). For your safety, this test may not be performed if you are pregnant or breast-feeding. It is for this 
reason that the pregnancy test is compulsory. 




6. walk or run on a treadmill for at least 6 min while the speed of the treadmill is gradually increased. During 
this test you will wear a safety harness around the upper part of your body to prevent you from falling 





well as a mask over your mouth and nose so that we can analyse the air that you are breathing out. You 
will be able to breath freely through the mask. We will ask you to walk or run for as long as you can, 
however, you can stop the test by pressing a red knob on the treadmill when you feel too tired to go on. 
The treadmill will then safely come to a halt. Although you will wear a safety harness, there will also be 
two persons next to the treadmill who will prevent you from falling and hurting yourself. 
7. sit in front of a computer and complete a series of computer tests in your choice of English or Afrikaans. 
These tests will determine your ability to recognise certain patterns or pictures on the screen, as well as 
how quickly you respond to the changing patterns and pictures. This battery of tests will take you 30 min 
to complete. 
8. wear a device on your hip for seven full days so that we can determine how much time you spend sitting, 
standing and lying down. You will also be asked to keep a diary of your physical activity during these 
seven days. 
9. sit by a table and, with the help of one of the researchers, complete questionnaires on your housing, 
finances, education, employement, general health, family health history, activity level, nutrition and 
mental well being. 
 
 
The tests above will be completed over two days seperated by seven full days. All the tests and measurements 
will be done by staff at the Stellenbosch Campus Health Clinic, Winelands Radiology and the Sport Physiology 
Laboratory at the Department of Sport Science on the Stellenbosch University campus. Once you have been 
booked for your testing days you will be transported from a central venue in Cloetesville to all testing facilities 
at 8:00 on the scheduled day. You will also be transported back to the central venue in Cloetesville once all testing 
is complete (approximately 16:00 on each testing day). We will provide you with food and drink during the day. 
 
3. POTENTIAL RISKS AND DISCOMFORTS 
 
There are no serious risks involved in the tests and procedures. No procedures performed in the study will be 
harmful to you as the participant. The only invasive procedure includes the venous blood sample that that will 
be drawn during your first session. However, you may experience dizziness and/or nausea during the exercise 
test on the treadmill. If so, the exercise test will be stopped immediately. In the event that something does go 
wrong, all researchers involved are certified in first aid level 1 and basic life support and are equipped and 
qualified to handle medical emergencies.  
 
  
4. POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
 
The results of all the measurements and tests will be summarised and given to you in an ‘easy to understand 
booklet’. This booklet will help you to learn about your brain health as well as your cardiovascular health and to 
make positive changes to improve these factors. If there are any of your results, which raises our concerns, we 
will advise you to speak to a doctor or nurse at your local clinic.  
We will also be providing feedback to you after the study regarding how you can improve your health, for 
example tips on how to remain active, decrease blood pressure and improve your body measurements. After 
this study you will be equipped to also help those around you in how they can remain healthy and improve their 
physical activity levels – you can help educate your family, friends and community on how to remain fit and 
healthy. 
Furthermore, the results of this study will also allow us as researchers to determine the health status of women 





on how we can improve the SUNWELL health programme of the Department of Sport Science which is currently 
running in your community. 
 
5. PAYMENT FOR PARTICIPATION 
You will receive no compensation for your participation in this study. However, we will provide food packs during 
the two days. In addition, you will receive a participation gift at the end of the study. 
 
Should you incur any research-related injury or incident; all costs will be covered by the insurance of Stellenbosch 
University. To this end, you may contact Mr Van Kerwel (wvankerwel@sun.ac.za), 021 808 2809 for information 




Any information that is obtained in connection with this study and that can be identified with you will remain 
confidential and will be disclosed only with your permission or as required by law. Confidentiality will be 
maintained by assigning a research number to each participant so no one will be identified using their names. 
The research number, and not your name, will be used on all documents and questionnaires. The data collected 
will be stored in a computer which is password protected and only the researchers and the postgraduate 
students will have access to it. This computer will be locked in an office. 
 
You will receive a report on your results on completion of the study. The findings of the study will be published 
in scientific journals and confidentiality will be maintained in that your (or any other participant’s) name will not 
be mentioned. Selected results will form part of the research theses of the two postgraduate students. The 




7. PARTICIPATION AND WITHDRAWAL 
 
All testing procedures and assessments will be explained thoroughly to you beforehand.  You may also choose 
whether to be a part of this study or not. If you volunteer to be in this study, you may withdraw at any time 
without consequences. You may also refuse to answer any questions, or complete any of the tests, and still 
remain in the study. The investigator may withdraw you from this research if circumstances arise which warrant 
doing so. This may happen if you are pregnant, get injured or if there are any adverse events during or after the 
exercise tests.  
 
 
8. IDENTIFICATION OF INVESTIGATORS 
 
If you have any questions or concerns about the research, please feel free to contact any of the following persons: 
 
Prof Elmarie Terblanche (Principle investigator) by 021 808 4817. E-mail: et2@sun.ac.za     
Dr Zarko Krkeljas (Co-investigator) by 021 808 2818. Email: zarko@sun.ac.za  
Dr Carla Coetsee (Co-investigator) by 021 808 3915. Email: 15365484@sun.ac.za  
Ms Kasha Dickie (PhD student) by 021 808 4718 Email: kdickie@sun.ac.za  





Mr Anthony Clarke (MSc student) by 021 808 2818.  E-mail: 17199352@sun.ac.za 
Mr Kyle Basson (MSc student) by 021 808 2818. E-mail: 16484258@sun.ac.za 
Mr Matthew Shone (MSc student) by 021 808 2818. E-mail: 17648890@sun.ac.za   
 
9.   RIGHTS OF RESEARCH SUBJECTS 
 
You may withdraw your consent at any time and discontinue participation without penalty. You are not waiving 
any legal claims, rights or remedies because of your participation in this research study. If you have questions 
regarding your rights as a research subject, contact Ms Maléne Fouché [mfouche@sun.ac.za; 021 808 4622] at 




SIGNATURE OF RESEARCH SUBJECT OR LEGAL REPRESENTATIVE 
 
The information above was described to me _________________________________by 
______________________  in ________________ (language) and I am in command of this language or it was 
satisfactorily translated to me. I was given the opportunity to ask questions and these questions were answered 
to my satisfaction.  
 
I hereby consent voluntarily to participate in this study. I have been given a copy of this form. 
 
________________________________________ 
Name of Subject/Participant 
 
________________________________________ 
Name of Legal Representative (if applicable) 
 
________________________________________   ______________ 




SIGNATURE OF INVESTIGATOR  
 
I declare that I explained the information given in this document to __________________________ and/or 
his/her representative _________________________ . He/she was encouraged and given ample time to ask me 
any questions. This conversation was conducted in Afrikaans/English and no translator was used. 
 
________________________________________            ______________ 




















Appendix K: ACSM Atherosclerotic Disease Classification (2010)  
Participant Code:_________________________ 
Date and Time:___________________________  
 
Instructions: Assess your health needs by marking all true statements.  
History, you have had: 
__ a heart attack  
__ heart surgery  
__ cardiac catheterization  
__ coronary angioplasty (PTCA)  
__ pacemaker/implantable cardiac defibrillator/rhythm disturbance  
__ heart valve disease  
__ heart failure  
__ heart transplantation  
__ congenital heart disease  
Symptoms:  
__ You experienced chest discomfort with exertion.  
__ You experience unreasonable breathlessness.  
__ You experience dizziness, fainting, blackouts.  
__You experience ankle swelling 
__You experience unpleasant awareness of a forceful or rapid heart rate  
__ You take heart medications.  
Other health issues: 
__ You have diabetes. 
__ You have asthma or other lung disease.  
__You have burning or cramping sensation in your lower legs when walking short distance. 
__ You have musculoskeletal problems that limit your physical activity. 
__ You have concerns about the safety of exercise.  
__ You take prescription medication(s) and/or HIV treatment 
__You are pregnant and/or lactating. 
If you marked any of the statements in this section, consult your healthcare provider before 





Cardiovascular Risk Factors:  
__ You are a woman older than ≥ 55-years. 
__ You smoke or quit smoking in the previous 6 months. 
__ Your blood pressure is > 140/90mm Hg.  
__ You don't know your blood pressure.  
__ You take blood pressure medication. 
__Your blood cholesterol level is 5.18mmol/L 
__ You do not know your cholesterol level.  
__ You have a close blood relative who had a heart attack or heart surgery before age 55 (father 
or brother) or age 65 (mother or sister). 
__ You are physically inactive (i.e.: you get < 30 minutes of physical activity on at least 3 days 
per week).  
__ You have a BMI ≥ 30kg/m2. 
__You have pre-diabetes 
__You don’t know if you have pre-diabetes 
If you marked 2 or more of the statements in this section, consult your healthcare provider before 
engaging in exercise. 















Appendix L: Informed Consent for Pregnancy Test 
 
RESEARCH TITLE:  
RELATIONSHIPS BETWEEN LIFESTYLE FACTORS, CARDIOMETABOLIC HEALTH, 
COGNITIVE FUNCTIONING AND CARDIORESPIRATORY FITNESS IN SOUTH AFRICAN 
WOMEN FROM A LOW SOCIOECONOMIC COMMUNITY 
 
Consent: 
I, _________________________, hereby give consent to complete a pregnancy test conducted by 
Stellenbosch Campus Health Clinic for the study titled, RELATIONSHIPS BETWEEN LIFESTYLE 
FACTORS, CARDIOMETABOLIC HEALTH, COGNITIVE FUNCTIONING AND 
CARDIORESPIRATORY FITNESS IN SOUTH AFRICAN WOMEN FROM A LOW 
SOCIOECONOMIC COMMUNITY. I understand that I will be excluded from the study if my 
pregnancy test is positive, as the radiation from the DXA scanner, however minute, may be harmful to 
my baby.  I understand that I will be referred to Cloetesville Community Clinic or my general practitioner 
for counselling and follow-up. I understand that all the information collected during the study will be 
treated with the strictest confidentiality. I understand that for data verification and quality control 
purposes, regulatory authorities and/or members of the Research Ethics Committee may be allowed 
access to my personal data under conditions of strict confidentiality.  
 
I have read and have had explained to me the procedure described. I have had an opportunity to ask 
questions and my questions have been answered in a satisfactory way.  I understand that I am free to 
withdraw from this study at any time.  
 
Name: __________________      Signature: ________________     Date: __________ 
 
Email: ______________________        Telephone number: _____________________ 
 

























































































Appendix O: Asset Index  
Which of the following do you have in your household at the present time? 
 YES NO 
1. Electricity   
2. Television   
3. Radio   
4. Motor vehicle   
5. Fridge   
6. Stove    
7. Oven   
8. Washing machine   
9. Telephone   
10. Video machine   
11. Microwave   
12. Computer/Laptop   
13. Cellular telephone   
























Appendix Q: ActiGraph Participant Instructions  
Instruction sheet for hip-worn monitoring device:  
 
Please wear this hip monitor for 7 days from when you leave Test Day 1. During this time, please carry 
on with all your normal activities.  
 
Description:  
The hip monitor is a movement sensor and should be removed when you go to bed and put back on 
when you get up. The hip monitor is not waterproof; please remove it when showering, bathing and 
swimming. Whenever you need to remove the sensor, please reattach it as soon as you can.  
Placement:  
Place the belt around your waist. Please, make sure that it is placed approximately on the centre of your 
right hip (see picture below).  
 
Please, take care that the monitor sits snugly around your hip and that it is not too loose.  
Return:  
When you have completed your 7-day period of wearing the device, please be sure to bring it back with 
you for test day 2 and hand it back to Ms Kasha Dickie (Student investigator and registered Biokineticist).  
 








Appendix R: ActiGraph Participant Record Sheet 
 
Participant Code: ______________________________  
 
Date and Time: ________________________________ 
 
 TIME PUT  ON TIME TAKEN OFF 
DAY 1   
DAY 2   
DAY 3   
DAY 4   
DAY 5   
DAY 6   
DAY 7   
DAY 8   
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